Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
Desloratadine Impurity 5 | 38092-88-5 | C20H21ClN2 | 324.85 | 8-Dechloro-9-chloro-N-methyl Desloratadine |
Desloratadine Impurity 2 | 117811-13-9 | C19H19ClN2 | 310.82 | 8-Dechloro-9-chloro Desloratadine |
Deslanoside | 17598-65-1 | Deacetyllanatoside C | ||
Desisopropylatrazine-d5 | 1189961-78-1 | C5H3ClN5D5 | 178.64 | 6-Chloro-N2-(ethyl-d5)-1,3,5-triazine-2,4-diamine; 2-Amino-4-chloro-6-(ethylamino-d5) -s-triazine; Atrazine-desisopropyl-d5; DIA-d5; Deethylsimazine-d5; F 703-d5; G 28279-d5; NSC 13909-d5 |
Desipramine-2,4,6,8-D4 Hydrochloride | 61361-34-0 | C18H19D4ClN2 | 306.87 | 10,11-Dihydro-N-methyl-5H-dibenz[b,f]azepine-5-propanamine-d4; G-35020-d4; JB-8181-d4; NSc-114901-d4; Norpramin-d4; Nortimil-d4; Pertofran-d4; Pertofrane-d4; Petylyl-d4; |
Desipramine HCl (D3) | 1435934-62-5 | C18H19D3N2·HCl | 305.86 | 10,11-Dihydro-N-methyl-5H-dibenz[b,f]azepine-5-propanamine-d3 |
Desglucoruscin | 39491-37-7 | C38H58O12 | 706.86 | DESGLUCORUSCIN |
Desglucohellebrin | 20300-44-1 | C30H42O10 | 562.656 | Deglucohellebrin; 3beta-(alpha-L-Rhamnopyranosyloxy)-5,14-dihydroxy-19-oxo-5beta-bufa-20,22-dienolide |
des-Gln14-Ghrelin (rat) | 293735-04-3 | C142H237N43O40 | 3186.7 | |
Desfuroyl Ceftiofur Cysteine Disulfide | 158039-15-7 | C17H20N6O7S4 | 548.64 | (6R,7R)-3-[[[(2R)-2-Amino-2-carboxyethyl]dithio]methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; Desfuroylceftiofur Cysteine Disulfide; DFC-CYS; |
Desfuroyl Ceftiofur | 120882-22-6 | C14H15N5O5S3 | 429.5 | (6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(mercaptomethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; DFC; Defuroylceftiofur; |
Desformylflustrabromine hydrochloride | 951322-11-5 | C16H21BrN2.HCl | 357.72 | 6-Bromo-2-(1,1-dimethyl-2-propenyl)-N-1H-indole-3-ethanamine hydrochloride |
Desfluroenrofloxacin Hydrochloride | 93107-11-0 | C19H24N3O3Cl | 377.87 | 1-Cyclopropyl-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid; 1-Cyclopropyl-7-piperazinyl-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid; |
Desflurane | 57041-67-5 | C3H2F6O | 168.0378 | DIFLUOROMETHYL 1,2,2,2-TETRAFLUOROETHYL ETHER; DESFLURANE; 1,2,2,2-TETRAFLUOROETHYL DIFLUOROMETHYL ETHER; i653; Difluoromethyl 1,2,2,2-tetrafluoroethyl ether 99%; Difluoromethyl1,2,2,2-tetrafluoroethylether99% |
Desfluoro Rosuvastatin sodium salt | 847849-66-5 | C22H28N3O6S.Na | 485.54 | |
Desfluoro Risperidone (Impurity K) | 106266-09-5 | C23H28N4O2 | 392.51 | 3-[2-[4-(1,2-Benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one; |
Desfluoro Iloperidone | 133454-46-3 | C24H28N2O4 | 408.50 | 1-[4-[3-[4-(1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3]methoxyphenyl]ethanone |
Desfluoro Ezetimibe | 302781-98-2 | C24H22FNO3 | 391.45 | (3R,4S)-3-[(3S)-3-(4-Fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-1-phenyl-2-azetidinone; |
Desfluoro Bicalutamide | 90357-05-4 | C18H15F3N2O4S | 412.39 | (+/-)-N-[4-Cyano-3-(trifluoroMethyl)phenyl]-2-hydroxy-2-Methyl-3-(phenylsulfonyl)propanaMide; N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methyl-3-(phenylsulfonyl)propanamide; Bicalutamide EP Impurity A |
Desfesoterodine fumarate | 380636-50-0 | C22H31NO2 | 341.5 | PNU-200577 fumarate; (R)-2-[3-(diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phenol fumaric acid salt; |
Desferioxamine mesylate | 138-14-7 | C26H52N6O11S | 656.79 | Desferioxamine mesylate |
Desethylterbutylazine-d9 | 1219798-52-3 | C7H3ClN5D9 | 210.71 | 6-Chloro-N2-(1,1-dimethylethyl)-1,3,5-triazine-2,4-diamine-d9; 2-Amino-4-(tert-butylamino)-6-chloro-s-triazine-d9; Deethylterbuthylazine-d9; GS 26379-d9 |
DESETHYLOXYBUTYNIN, HYDROCHLORIDE | 80976-67-6 | C20H28ClNO3 | 365.89 | A-CYCLOHEXYL-A-HYDROXYBENZENEACETIC ACID 4-(ETHYLAMINO)-2-BUTYNYL ESTER, HYDROCHLORIDE SALT; DESETHYL OXYBUTYNIN HCL; DESETHYLOXYBUTYNIN, HYDROCHLORIDE; desethyloxybutynin |
Desethylene Gatifloxacin | 172426-87-8 | C17H20FN3O4 | 349.37 | 7-[(2-Aminopropyl)amino]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic Acid; 3-Quinolinecarboxylic acid, 7-[(2-aMinopropyl)aMino]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-4-oxo- |
Descarbon Sildenafil | 466684-88-8 | C20H28N6O4S | 448.54 | |
Deschloro Florfenicol | 138872-73-8 | C12H15ClFNO4S | 323.77 | 2-Chloro-N-[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-[4-(methylsulfonyl)phenyl]ethyl]acetamide; |
Desacetyl-N,O-descarbonyl Linezolid | 333753-72-3 | C13H20FN3O2 | 269.32 | (2S)-1-Amino-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol |
Desacetylcinobufagin | 4026-95-3 | C24H32O5 | 400.51 | Deacetylcinobufagin; Cinobufagin, deacetyl- (6CI); |
Desacetyl-7-desmethyl Agomelatine Hydrobromide | 144705-51-1 | C12H13NO . HBr | 268.15 | 8-(2-Aminoethyl)-2-naphthalenol Hydrobromide; |
Desacetyl Triflusal-13C6 | 1246817-12-8 | C213C6H5F3O3 | 212.07 | -Hydroxy-4-(trifluoromethyl) benzoic Acid-13C6; - alpha;, - alpha;, - alpha;-Trifluoro-2,4-cresotic Acid-13C6; 4-(Trifluoromethyl)salicylic Acid-13C6; 4-Trifluoromethyl-2-hydroxybenzoic Acid-13C6 |
Desacetyl Famciclovir (Famciclovir Related Compound B) | 104227-88-5 | C12H17N5O3 | 279.30 | 2-[2-(2-Amino-9H-purin-9-yl)ethyl]-1,3-propanediol 1-Acetate; |
Desacetyl Diltiazem D4 | 112259-40-2 | C20H20D4N2O3S | 376.51 | (2S-cis)-5-[2-(Dimethylamino)ethyl-1,1,2,2-d4]-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one |
Dermatan sulphate sodium salt | 54328-33-5 | 41000 (ave) | Chondroitin sulfate B sodium salt; b-Heparin | |
D-Erythrose 4-phosphate sodium salt | 103302-15-4 | C4H8NaO7P | 222.07 | |
D-Erythrose - min 75% purity as a 70% aq. solution | 583-50-6 | C4H8O4 | 120.1 | |
D-Erythrono-1,4-lactone | 15667-21-7 | C4H6O4 | 118.09 | (2R,3R)-Butane-2,3,4-triol-1,4-lactone; D-Erythronic acid gamma-lactone; D-Erythronolactone |
D-erythro-MAPP | 143492-38-0 | C23H39NO2 | 361.6 | (1S,2R-D-erythro-2-N-myristoylamino)-1-phenyl-1-propanol; D-e-MAPP; MAPP, D-erythro |
Dermaseptin | 136212-91-4 | C152H257N43O44S2 | 3455.1 | H-Ala-Leu-Trp-Lys-Thr-Met-Leu-Lys-Lys-Leu-Gly-Thr-Met-Ala-Leu-His-Ala-Gly-Lys-Ala-Ala-Leu-Gly-Ala-Ala-Ala-Asp-Thr-Ile-Ser-Gln-Gly-Thr-Gln-OH; L-alanyl-L-leucyl-L-tryptophyl-L-lysyl-L-threonyl-L-methionyl-L-leucyl-L-lysyl-L-lysyl-L-leucyl-glycyl-L-threonyl |
D-Eritadenine | 23918-98-1 | C9H11N5O4 | 253.2 | Eritadenine; Lentysine; Lentinacin |
DERAMCICLANE | 120444-71-5 | C20H31NO | 301.471 | DERAMCICLANE |
Deracoxib-D3 | 2012598-48-8 | C17H11D3F3N3O3S | 400.39 | 4-[3-Difluoromethyl-5-(3- fluoro-4-methoxy-D3- phenyl)-pyrazol-1- yl]benzenesulfonamide |
Deracoxib | 169590-41-4 | C17H14F3N3O3S | 397.37 | Deram; Deramaxx; SC 046; SC 46; SC 59046 |
Dequalinium Chloride | 522-51-0 | C30H40N4.2Cl | 527.57 | |
deptropine | 604-51-3 | C23H27NO | 333.472 | (3-endo)- |
Deoxyviolacein | 5839-61-2 | C20H13N3O2 | 327.3 | |
DEOXYSHIKONIN | 43043-74-9 | C16H16O4 | Arnebin 7; NSC 179184; 1,4-Naphthalenedione, 5,8-dihydroxy-2-(4-methyl-3-pentenyl)-; 5,8-dihydroxy-2-(4-methylpent-3-en-1-yl)naphthalene-1,4-dione | |
Deoxyribonucleic acid low molecular weight from salmon sperm | 100403-24-5 | C9H10FN3O3 | 227.192403;g/mol | DNA |
Delta-7-Campesterol | 70095-94-2 | C28H48O | 400.69 | |
delta3-Isopentenyl methyl sulfide | 5952-75-0 | C6H12S | 116.2245 | delta3-Isopentenylmethylsulfide; 1-Butene,2-methyl-4-(methylthio)-; 5952-75-0; SCHEMBL590950; AC1O585W; CTK1H1213 |
Delta-2-Cefteram Pivoxil | 104712-44-9 | C22H27N9O7S2 | 593.64 | (6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic Acid (2,2-Dimethyl-1-oxopropoxy)methyl Ester; T 2588A; |
Delta-14-Desonide | 131918-67-7 | C24H30O6 | 414.5 | |
delta(7)-Stigmastenol | 6869-99-4 | C29H50O | 414.72 | 22,23-dihydrospinasterol; schottenol; stigmast-7-en-3-ol; stigmast-7-enol; stigmast-7-enol, (3beta,5alpha)-isomer; stigmast-7-enol, (3beta,5alpha,24S)-isomer |
delta(3)-Cefotiam | 142182-63-6 | C18H23N9O4S3 | 525.63 | |
DELTA 14 CIS TRICOSENOIC ACID | 105305-00-8 | C23H44O2 | 352.59 | DELTA 14 CIS TRICOSENOIC ACID; 14-CIS-TRICOSENOIC ACID; C23:1 |
DELTA 10 CIS-13 NONADECADIENOIC ACID | 29204-20-4 | C19H34O2 | 294.47 | DELTA 10 CIS-13 NONADECADIENOIC ACID; 10(Z),13(Z)-NONADECADIENOIC ACID; 10-CIS,13-CIS-NONADECADIENOIC ACID; C19:2 |
Dehydro Clindamycin | 909032-77-5 | C18H31ClN2O5S | 422.97 | Methyl 7-Chloro-6,7,8-trideoxy-6-[[[(2S)-2,3-dihydro-1-methyl-4-propyl-1H- pyrrol-2-yl]carbonyl]amino]-1-thio-L-threo-a-D-galactooctopyranoside |
Dehydro Tizanidine | 125292-34-4 | C9H6ClN5S | 251.7 | 5-Chloro-N-1H-imidazol-2-yl-2,1,3-benzothiadiazol-4-amine |
Dehydro Rifaximin | 80621-76-7 | C43H49N3O11 | 783.86 | [2S-(2R*,16Z,18E,20R*,21R*,22S*,23S*,24S*,25R*,26S*,27R*,28E)]-25-(Acetyloxy)-5,21,23-trihydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-6H-27-(epoxypentadeca[1,11,13]trienonitrilo)benzofuro[4,5-e]pyrido[1,2-a]benzimidazole-1,6,15(2H)-trione; Rifaximi |
Dehydro Olmesartan | 172875-98-8 | C24H24N6O | 428.5 | 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid; |
Dehydro Nitrendipine | 89267-41-4 | C18H18N2O6 | 358.35 | 2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid Ethyl Methyl Ester; BAY-m 4786; |
Dehydro nisoldipine-d7 | 1329836-20-5 | C20H16N2O6D6 | 392.44 | 2,6-Dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-Methyl 5-(2-Methylpropyl-d7) Ester |
Dehydro nisoldipine | 103026-83-1 | C20H22N2O6 | 386.41 | 2,6-Dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-Methyl 5-(2-Methylpropyl) Ester; |
Dehydro Nicardipine HCl | 1216817-27-4 | C26H27N3O6. HCl | 477.52 36.46 | Nicardipine Dehydro HCl ; 2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 2-[methyl(phenyl methyl) amino]ethyl ester HCl ; |
Dehydro Nicardipine (Freebase) | 59875-58-0 | C26H27N3O6 | 477.52 | 2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 2-[methyl(phenyl methyl) amino]ethyl ester; |
Dehydro Manidipine | 104305-93-3 | C35H36N4O6 | 608.70 | |
Dehydro lacidipine | 130996-24-6 | C26H31NO6 | 453.54 | (E)-4-[2-[3-(1,1-Dimethylethoxy)-3-oxo-1-prphenyl]-2,6-dimethyl-3,5 -pyridinedicarboxylic Acid Diethyl Ester; |
Dehydro Ivabradine Oxalate | 1346558-08-4 | C29H36N2O9 | 556.62 | 3-{3-[(3,4-Dimethoxy-bicyclo[4.2.0]octa-1(6),2,4-trien-7-ylmethyl)-methyl-amino]-propyl}-7,8-dimethoxy-1,3,4,5-tetrahydro-benzo[d]azepin-2-one; compound with oxalic acid |
Dehydro Ivabradine (Ivabradine IVA-3 Impurity) | 1086026-31-4 | C27H34N2O5 | 466.58 | 3-[3-[[[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3-dihydro-7,8-dimethoxy-H-3-benzazepin-2-one; |
Dehydro Isradipine Lactone | 107699-91-1 | C18H15N3O5 | 353.34 | 4-(2,1,3-Benzoxadiazol-4-yl)-5,7-dihydro-2-methyl-5-oxo-furo[3,4-b]pyridine-3-carboxylic Acid 1-Methylethyl Ester; |
Dehydro Isradipine Lactone | 1076199-91-1 | C18H15N3O5 | 353.34 | 4-(2,1,3-Benzoxadiazol-4-yl)-5,7-dihydro-2-methyl-5-oxo-furo[3,4-b]pyridine-3-carboxylic Acid 1-Methylethyl Ester; |
Dehydro isradipine | 116169-18-7 | C19H19N3O5 | 369.38 | 4-(2,1,3-Benzoxadiazol-4-yl)-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Methyl 1-Methylethyl Ester; 4-(4-Benzofurazanyl)-2,6-dimethyl -3,5-pyridinedicarboxylic Acid Methyl 1-Methylethyl Ester; |
Dehydro Indapamide | 63968-75-2 | C16H14ClN3O3S | 363.83 | 3-(Aminosulfonyl)-4-chloro-N-(2-methyl-1H-indol-1-yl)benzamide; 4-Chloro-3-sulfamoyl-N-(2-methyl-1H-indol-1-yl)benzamide; USP Indapamide Related Compound A; |
Dehydro Griseofulvin | 3573-90-8 | C17H15ClO6 | 350.76 | (-)-Dehydro Griseofulvin; (1'S)-7-Chloro-2',4,6-triMethoxy-6'-Methylspiro[benzofuran-2(3H),1'-[2,5]cyclohexadiene]-3,4'-dione; Amudene; Dehydrogriseofulvin; (2S)-7-Chloro-3',4,6-Trimethoxy-5'-Methylspiro[1-Benzofuran-2,4'-Cyclohexa-2,5-Diene]-1',3-Dione; |
Dehydro Felodipine | 96382-71-7 | C18H17Cl2NO4 | 382.25 | 4-(2,3-Dichlorophenyl)-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Ethyl Methyl Ester; |
Dehydro Epinastine HCl | 141342-70-3 | C16H13N3.HCl | 283.76 | 9H-Dibenz[c,f]imidazo[1,5-a]azepin-3-amine Hydrochloride |
Dehydro Benidipine | 118935-44-7 | C28H29N3O6 | 503.56 | 2,6-Dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-Methyl 5-[1-(Phenylmethyl)-3-piperidinyl] Ester; DH 124; 3-(1-Benzylpiperidin-3-yl) 5-Methyl 2,6-Dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate |
Dehydro Barnidipine | 172331-68-9 | C27H27N3O6 | 489.53 | Methyl 2,6-DiMethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid (3S)-1-(PhenylMethyl)-3-pyrrolidinyl Ester |
Dehydro Azelnidipine | 918659-10-6 | C33H32N4O6 | 580.65 | 2-Amino-6-methyl-4-(3-nitrophenyl)-3-[1-(diphenylmethyl)-3-azetidinyl]-3,5-pyridinedicarboxylic Acid 5-(1-Methylethyl) Ester |
Dehydro aripiprazole hydrochloride | 1008531-60-9 | C23H25Cl2N3O2·HCl | 482.8 | DTXSID70648054; FT-0665592; J-000235 |
Dehydro Aripiprazole | 129722-25-4 | C23H25Cl2N3O2 | 446.37 | Dehydroaripiprazole; 7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)quinolin-2(1H)-one; Dehydro-aripiprazole |
Dehydro amlodipine fumarate | 2138811-33-1 | C20H23ClN2O5·C4H4O4 | 522.93 | |
Deguelin | 522-17-8 | C23H22O6 | 394.41718 | Deguelin |
Degrasyn | 856243-80-6 | C23H25ClN2O4S | 460.97 | (E)-3-(6-bromopyridin-2-yl)-2-cyano-N-[(1S)-1-phenylbutyl]prop-2-enamide; 2-cyano-N-(1-phenylbutyl)-3-(6-bromopyridin-2-yl)acrylamide; degrasyn; WP1130; WP1130; 856243-80-6; WP 1130; WP-1130; (S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylbutyl)acryla |
Degarelix acetate hydrate | 934246-14-7 | C84H107ClN18O18 | 1692.31 | FE-200486; ASP-3550 |
Degarelix acetate | 934016-19-0 | C82H103ClN18O16·C2H4O2 | 1692.31 | FE 200486; Gonax; UNII-EXT215F4ZU; EXT215F4ZU |
Degarelix | 214766-78-6 | C82H103ClN18O16 | 1632.286 | Degarelix; Firmagon; FE-200486; ASP-3550; Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-Phe(4-S-dihydroorotamido)-D-Phe(4-ureido)-Leu-Lys(iPr)-Pro-D-Ala-NH2 |
Defluoro Linezolid | 556801-15-1 | C16H21N3O4 | 319.36 | N-[[(5S)-3-[4-(4-Morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide |
Defluoro Levofloxacin | 117620-85-6 | C18H21N3O4 | 343.39 | (3S)-2,3-Dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid; Levofloxacin Related Compound F (USP); |
Defluoro Atorvastatin | 433289-84-0 | C33H36N2O5 | 540.65 | (bR,dR)-b,d-Dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid |
Defluoro Aprepitant | 170729-76-7 | C23H22F6N4O3 | 516.45 | Aprepitant EP Impurity A; 5-([(2R,3S)-2-((R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy)-3-phenyl morpholino]methyl)-1H-1,2,4-triazol-3(2H)-one |
Deflazacort Impurity C | 710951-92-1 | C27H33NO7 | 483.55 | |
Deferoxamine | 70-51-9 | C25H48N6O8 | 560.69 | N'-{5-[Acetyl(hydroxy)amino]pentyl}-N-[5-({4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoyl}amino)pentyl]-N-hydroxysuccinamide |
Deferitrin | 239101-33-8 | C11H11NO4S | 253.277 | Deferitrin |
Deferiprone-d3 | 1346601-82-8 | C7H6NO2D3 | 142.17 | 1,2-Dimethyl-3-hydroxypyrid-4-one-d3; 3-Hydroxy-1,2-dimethyl-4(1H)-pyridinone-d3 |
Deferiprone 3-O-b-D-glucuronide | 141675-48-1 | C13H17NO8 | 315.28 | |
Deferasirox-d4 | 1133425-75-8 | C21H11N3O4D4 | 377.4 | 4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic Acid-d4 |
Deferasirox Methyl Ester | 1266741-05-2 | C22H18N3O4 | 387.39 | 4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]-benzoic Acid Methyl Ester |
Deferasirox Impurity 3 | 6543-57-3 | C28H16O8 | 480.43 | 13,14-(1,3-Butadiene-1,4-diyl)-[9,10-(1,3-butadiene-1,4-diyl)-[5,6-(1,3-butadiene-1,4-diyl)-[1,2-(1,3-butadiene-1,4-diyl)-4,8,12,16-tetraoxacyclohexadecane-1,5,9,13-tetraene-3,7,11,15-tetraone]]] |
Deferasirox Fe3(addition) chelate | 554435-83-5 | C21H12FeN3O4 | 426.18 | Exjade Fe3+ chelate |
Deferasirox Ethyl Ester | 201530-79-2 | C23H19N3O4 | 401.43 | 4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]-benzoic Acid Ethyl Ester |
Deferasirox Diacyl Impurity | 1972-71-0 | C14H11NO4 | 257.25 | 2,2'-Dihydroxydibenzamide; Disalicylamide; |
Deferasirox Benzoxazin Impurity | 1218-69-5 | C14H9NO3 | 239.23 | 2-(2-Hydroxyphenyl)-4H-1,3-benzoxazin-4-on; 2-(2-Hydroxyphenyl)benz[e][1,3]oxazin-4-one; |
Deferasirox | 201530-41-8 | C21H15N3O4 | 373.36 | 4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic Acid; Exjade; ICL-670; ICL-670A; CGP-72670 |
Defensamide | 1104874-94-3 | C16H23NO4 | 293.36 | MHP; N-Hexanoyltyrosine methyl ester; UNII-8GJP2KSJ0T; 8GJP2KSJ0T |
Defactinib hydrochloride | 1073160-26-5 | C20H22ClF3N8O3S | 546.95 | N-Methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide monohydrochloride; Defactinib hydrochloride; Defactinib HCl; VS6063; VS 6063; VS-6063; PF04554878; PF-04554878; PF 04554878; PF45 |
Defactinib | 1073154-85-4 | C20H21F3N8O3S | 510.496 | N-methyl-4-((4-(((3-(N-methylmethylsulfonamido)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide; VS6063; VS 6063; VS-6063; PF04554878; PF-04554878; PF 04554878; PF4554878; PF-4554878 |
Deethylindanomycin | 117615-33-5 | C29H39NO4 | 465.6 | 16-Dethylindanomycvin, Omomycin, A 83094A |
DEET-D10 | 1215576-01-4 | N,N-(Diethyl-D10)-3-me- thyl benzamide | ||
Decyl D-glucopyranoside | 54549-25-6 | C16H32O6 | 320.42 | |
Decyl b-D-thiomaltopyranoside | 148565-56-4 | C22H42O10S | 498.63 | n-Decyl b-D-thiomaltoside |
Decyl b-D-thioglucopyranoside | 98854-16-1 | C16H32O5S | 336.49 | |
Decyl b-D-maltopyranoside | 82494-09-5 | C22H42O11 | 482.56 | Decyl maltoside |
Decyl b-D-glucopyranoside | 58846-77-8 | C16H32O6 | 320.42 | |
Decyl a-D-glucopyranoside | 29781-81-5 | C16H32O6 | 320.42 | Decyl a-glucoside |
Decyl 4-O-b-D-lactopyranosyl-b-D-lactopyranoside | 1858224-00-6 | C34H62O21 | 806.84 | Lac b(1-4)Lac-b-C10 |
Decarine | 54354-62-0 | C19H13NO4 | 319.3 | 1-methoxy-[1,3]benzodioxolo[5,6-c]phenanthridin-2-ol |
decaoleic acid, decaester with decaglycerol | 11094-60-3 | C210H382O31 | 0 | decaoleic acid, decaester with decaglycerol; POLYGLYCERYL-10 DECAOLEATE; Decaglycerol decaoleate; 9-Octadecenoic acid (9Z)-, decaester with decaglycerol; 9-Octadecenoic acid (Z)-, decaester with decaglycerol; decaester with decaglycerol; decaoleic; decaol |
Decanoyl-RVKR-CMK | 150113-99-8 | C34H66ClN11O5 | 744.42 | Decanoyl-Arg-Val-Lys-Arg-CMK; N2-(1-Oxodecyl)-L-arginyl-L-valyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(chloroacetyl)butyl]-L-lysinamide |
Decanoyl-N-hydroxyethylglucamide | 139361-84-5 | C18H37NO7 | 379.49 | HEGA-10 |
Decanoyl-L-homoserine lactone | 177315-87-6 | C14H25NO3 | 255.4 | C10-HSL, N-Decanoyl-L-homoserine lactone |
Decanoyl-L-carnitine chloride | 369651-88-7 | C17H34NO4·Cl | 351.91 | C10 Carnitine; (–)-Decanoylcarnitine; L-Decanoylcarnitine |
Decanoyl-L-carnitine | 3992-45-8 | C17H33NO4 | 315.5 | C10 Carnitine; (–)-Decanoylcarnitine; L-Decanoylcarnitine |
Decanoic acid, 6-hydroxy- | 16899-10-8 | C10H20 O3 | 188.264;g/mol | 6-hydroxydecanoicacid;6-hydroxy-decanoicacid;Decanoicacid,6-hydroxy-;16899-10-8;6-hydroxycapricacid;LMFA01050154 |
Decanoic acid, 2-[4-(phenylmethoxy)phenyl]ethyl ester | 848484-93-5 | C25H34O3 | 382.53600 | |
Decanoic Acid Sodium Salt | 1002-62-6 | CH3(CH2)8COONa | 194.25 | |
Decanedioic acid,sodium salt (1:2) | 17265-14-4 | C10H18 O4 . 2 Na | 246.21 | DECANEDIOIC ACID DISODIUM SALT; DISODIUM SEBACATE; IRGACOR DSS G; SEBACIC ACID DISODIUM SALT; sodiumsebacate; SEBACIC ACID DISODIUM SALT 97+% |
De-4'-O-methylyangambin | 149250-48-6 | C23H28O8 | 432.5 | |
DDZ-THR(TBU)-OH CHA | 329323-36-6 | C20H31N1O7 | 496.64 | |
DDZ-PHE-OH | 39508-07-1 | C21H25N1O6 | 387.43 | Ddz-Phe-OH;Ddz-L-phenylalanine;39508-07-1;AC1MBPEU;AC1Q47J1;SCHEMBL11383988 |
DDZ-GLY-OH CHA | 39508-03-7 | C14H19N1O6 | 396.48 | |
DDZ--ALA-OH | 329323-25-3 | C15H21N1O6 | 311.33 | |
ddGTP | 68726-28-3 | C10H16N5O12P3 (free acid) | 491.18 (free acid) | 2',3'-Dideoxyguanosine-5'-triphosphate, Lithium salt |
D-Desosamine | 5779-39-5 | |||
DDD85646 | 1215010-55-1 | C21H24Cl2N6O2S | 495.4 | IMP-366; 2,6-Dichloro-4-(2-Piperazin-1-Ylpyridin-4-Yl)-N-(1,3,5-Trimethyl-1h-Pyrazol-4-Yl)benzenesulfonamide |
ddCTP | 66004-77-1 | C9H16N3O12P3 (free acid) | 451.16 (free acid) | 2',3'-Dideoxycytidine-5'-triphosphate, Lithium salt |
DBO-83 | 195211-53-1 | C10H13ClN4·2HCl | 297.61 | |
D-Cysteine, 2-methyl-,hydrochloride (1:1) | 151062-55-4 | C4H9 N O2 S . Cl H | 171.65 | (S)-2-METHYLCYSTEINE HYDROCHLORIDE |
D-Cycloserine dimer | 16337-02-3 | C6H12N4O4 | 204.18 | (3R,6R)-3,6-Bis[(aminooxy)methyl]-2,5-piperazinedione; D-3,6-Bis(aminooxymethyl)-2,5-diketopiperazine; D-3,6-Bis(aminoxymethyl)-2,5-dioxopiperazine |
D-Cyclobutylglycine | 49067-10-5 | |||
DCVC | 13419-46-0 | C5H7Cl2NO2S | 216.09 | S-(trans-1,2-Dichlorovinyl)-L-cysteine; (E)-S-(1,2-Dichloroethenyl)-L-cysteine; L-Cysteine, S-((1E)-1,2-dichloroethenyl)-; ALANINE, 3-((1,2-DICHLOROVINYL)THIO)-, (E)-L-; AC1O5GGP |
DCU | 116-52-9 | C5H6Cl6N2O3 | 354.83 | 1,3-bis(1-hydroxy-2,2,2-trichloroethyl)urea;1,3-bis(1-hydroxy-2,2,2-trichloroethyl)urea[qr];1,3-bis(2,2,2-trichloro-1-hydroxyethyl)-ure;1,3-bis(2,2,2-trichloro-1-hydroxyethyl)urea;1,3-bis(2,2,2-trichloro-1-hydroxyethyl)urea[qr];cragdcu-73w |
DC-05 | 890643-16-0 | C25H25N3O | 383.49 | 1-Carbazol-9-yl-3-[2-(1H-indol-3-yl)ethylamino]propan-2-ol |
dCTP | 109909-44-6 | C9H13N3Na3O13P3 | 533.102 | dCTP, Thymus; Cytidine 5'-(tetrahydrogen triphosphate), 2'-deoxy-, trisodium salt; Cytidine, 2'-deoxy-, 5'-(tetrahydrogen triphosphate), trisodium salt; Cytidine, 2'-deoxy-, triphosphate trisodium salt; 2'-DeoxyCTP trisodium salt; 2'-Deoxycytidine 5'-trip |
D-CPP-ene | 117414-74-1 | C8H15N2O5P | 250.19 | D-4-[(2E)-3-Phosphono-2-propenyl]-2-piperazinecarboxylic acid |
DCPIB | 82749-70-0 | C22H28Cl2O4 | 427.37 | 4-[(2-Butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy]butanoic acid |
DCPG | 201730-11-2 | C10H9NO6 | 239.18 | (S)-3,4-DCPG; (S)-3,4-Dicarboxyphenylglycine; 4-[Amino(carboxy)methyl]phthalic acid |
DCG04 | 314263-42-8 | C43H66N8O11S | 903.09614 | ethyl 3-(((4S,7S,17S)-17-carbamoyl-7-(4-hydroxybenzyl)-2-methyl-5,8,15,23-tetraoxo-27-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-6,9,16,22-tetraazaheptacosan-4-yl)carbamoyl)oxirane-2-carboxylate; DCG04; DCG-04; DCG 04 |
DCG IV | 147782-19-2 | C7H9NO6 | 203.15 | (2S,2'R,3'R)-2-(2',3'-Dicarboxycyclopropyl)glycine; (1R,2R)-3-[(S)-amino(carboxy)methyl]cyclopropane-1,2-dicarboxylic acid |
D-Cellotriose undecaacetate | 17690-94-7 | C40H54O27 | 966.84 | 2,3,6,2,3,4,6-Hepta-O-acetyl-a-D-maltosyl bromide |
D-Cellotriose | 33404-34-1 | C18H32O16 | 504.44 | 1,4-b-D-Cellotriose |
D-Cellotetraose tetradecaacetate | 83058-25-7 | C52H70O35 | 1255.09 | |
D-Cellotetraose | 38819-01-1 | C24H42O21 | 666.58 | (Glc-b-1,4)3-Glc |
D-Cellopentose heptadecaacetate | 83058-38-2 | C64H86O43 | 1543.34 | |
D-Cellopentaose | 2240-27-9 | C30H52O26 | 828.72 | |
D-Cellohexose eicosaacetate | 355012-91-8 | C76H102O51 | 1831.59 | O-2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl-(1-4)-O-2,3,6-tri-O-acetyl-b-D-glucopyranosyl-(1-4)-O-2,3,6-tri-O-acetyl-b-D-glucopyranosyl-(1-4)-O-2,3,6-tri-O-acetyl-b-D-glucopyranosyl-(1-4)-O-2,3,6-tri-O-acetyl-b-D-glucopyranosyl-(1-4)-D-glucopyranose; tetr |
D-Cellohexaose | 2478-35-5 | C36H62O31 | 990.86 | |
D-Celloheptaose | 52646-27-2 | C42H72O36 | 1153.02 | |
D-Cellobiose octaacetate | 5346-90-7 | C28H38O19 | 678.59 | Octa-O-acetyl D-Cellobiose |
D-Cellobiose | 528-50-7 | C12H22O11 | 342.3 | Glc-b-1,4-Glc; 4-O-(b-D-Glucopyranosyl)-D-glucopyranose |
D-Cellobial | 490-51-7 | C12H20O9 | 308.28 | 1,5-Anhydro-2-deoxy-4-(O-b-D-glucopyranosyl)-D-arabino-hex-1-enitol |
DCEBIO | 60563-36-2 | C9H8Cl2N2O | 231.08 | 5,6-Dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one; Dichloro-EBIO |
DC-Cholesterol | 166023-21-8 | C32H57ClN2O2 | 537.27 | DC-Cholesterol HCl; DC-Chol |
DCC-2618 | 1225278-16-9 | C26H21F2N5O3 | 489.47 | DCC2618; DCC 2618 |
DCB | 6971-97-7 | C14H10Cl2N2 | 277.15 | [(3-Chlorophenyl)methylene]hydrazone-3-chlorobenzaldehyde; (E,E)-Bis[(3-chlorophenyl)methylidene]hydrazine |
D-Carnitine hydrochloride | 16224-32-1 | |||
DCA | 2156-56-1 | C2HCl2NaO2 | 150.92 | Sodium dichloroacetate; Sodium 2,2-dichloroacetate; Dichloroacetic acid sodium salt |
D-Biotin | 10406-89-0 | C10H16N2O3S | 244.3 | |
DBIBB | 1569309-92-7 | C23H20N2O6S | 452.5 | 2-[[[4-(1,3-dioxo-1H-benz[de]isoquinolin-2(3H)-yl)butyl]amino]sulfonyl]-benzoic acid |
DBHDA | 99584-96-0 | C6H10Br2N2O2 | 301.96 | 2,5-Dibromohexanediamide |
DBeQ | 177355-84-9 | C22H20N4 | 340.42 | JRF 12 |
DAU 5884 hydrochloride | 131780-48-8 | C17H21N3O3.HCl | 351.83 | 8-Methyl-8-azabicyclo-3-endo[3.2.1]oct-3-yl-1,4-dihydro-2-oxo-3(2H)-quinazolinecarboxylic acid ester hydrochloride; [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 2-oxo-1,4-dihydroquinazoline-3-carboxylate hydrochloride |
DB-cGMP | 51116-00-8 | C18H23N5O9P · Na | 507.4 | N2, 2'- O- Dibutyrylguanosine- 3', 5'- cyclic monophosphate, sodium salt |
DB-cCMP | 64649-87-2 | C17H23N3O9P · Na | 467.3 | N4, 2'- O- Dibutyrylcytidine- 3', 5'- cyclic monophosphate, sodium salt |
DB-cAMP-AM | 159910-48-2 | C21H28N5O10P | 541.5 | |
DB07268 | 929007-72-7 | C17H15N5O2 | 321.33 | |
Dazomet | 533-74-4 | C5H10N2S2 | 162.27 | 3,5-Dimethyl tetrahydro-2-H,1,3,5-thiadiazone-2-thione; 3,5-Dimethyl-1,3,5-2H-tetrahydrothiadiazine-2-thione; 3,5-Dimethyl-1,3,5-thiadiazinane-2-thione; 3,5-Dimethyl-2-thionotetrahydro-1,3,5-thiadiazine; 3,5-Dimethylperhydro-1,3,5-thiadiazin-2-thion; 3,5- |
Dazidamine | 75522-73-5 | C19H23N3S | 325.47100 | |
Dayecrystal A | 926010-24-4 | C20H32O3 | 320.50 | (14R,16alpha)-14,16-Dihydroxykauran-20-al |
Davercin | 55224-05-0 | C38H65NO14 | 759.92 | |
daurisoline | 70553-76-3 | C37H42N2O6 | 610.73 | Daurisoline; (1R)-1,2,3,4-Tetrahydro-1-[[4-hydroxy-3-[4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]phenoxy]phenyl]methyl]-6-methoxy-2-methyl-7-isoquinolinol; (R,R)-Daurisoline; O7-Demethyldauricine |
Daurinoline | 2831-75-6 | C37H42 N2 O6 | 610.7 | 6-Isoquinolinol,1,2,3,4-tetrahydro-1-[[4-[2-hydroxy-5-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]phenoxy]phenyl]methyl]-7-methoxy-2-methyl-,(1R)- |
Dauricumine | 345641-00-1 | C19H24ClNO6 | 397.855 | |
Dauricinoline | 30984-80-6 | C37H42N2O6 | 610.74 | (1R)-1,2,3,4-Tetrahydro-1-[[4-hydroxy-3-[4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]phenoxy]phenyl]methyl]-7-methoxy-2-methyl-6-isoquinolinol |
Dauricine | 524-17-4 | C38H44N2O6 | 624.77 | 4-[[(1R)-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]-2-[4-[[(1R)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-isoquinolinyl]methyl]phenoxy]phenol; 4-[((1R)-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methylisoquinolin-1-yl)methyl]-2-[4-[[(1R)- |
Daurichromenic acid | 82003-90-5 | C23H30O4 | 370.5 | (2S)-2-[(3E)-4,8-Dimethyl-3,7-nonadien-1-yl]-5-hydroxy-2,7-dimeth yl-2H-chromene-6-carboxylic acid |
DAUNOSAMINE | 4305-54-8 | C6H13NO3 | 147.17 | 3-Amino-2,3,6-trideoxy-L-lyxo-hexose; Daunosamine; 26548-47-0; L-lyxo-Hexose,3-amino-2,3,6-trideoxy-; AC1L4N3B; AC1Q6PO6 |
Daunorubicinol | 28008-55-1 | C27H31NO10 | 529.54 | Daunorubicinol Impurity B |
Daunomycinone | 21794-55-8 | C21H18O8 | 398.37 | Daunomycin Aglicone; Daunomycinon |
Daunomycin hydrochloride | 12182-83-1 | CsHO | 149.91300 | |
Daturataturin A aglycone | 904665-71-0 | C28H38O5 | 454.6 | (7alpha,22R)-7,22,27-Trihydroxy-1-oxoergosta-2,5,24-trien-26-oic acid delta-lactone |
Daturametelin I | 904667-65-8 | C34H48O10 | 616.8 | Daturametelin I |
Daturabietatriene | 65894-41-9 | C20H30O2 | 302.5 | Abieta-8,11,13-triene-15,18-diol |
Darifenacin N-Oxide | 1391080-40-2 | C28H30N2O3 | 442.55 | Darifenacin Impurity C |
dATP | 1927-31-7 | C10H16N5O12P3 | 491.18 | Deoxyadenosine triphosphate; 2'-deoxyadenosine 5'-triphosphate; 2'-deoxyadenosine triphosphate |
Datelliptium chloride | 105118-14-7 | C23H28ClN3O | 397.94 | 2-[2-(diethylamino)ethyl]-5,11-dimethyl-6H-pyrido[4,3-b]carbazol-2-ium-9-ol;chloride; 2-(diethylamino-2-ethyl)-9-hydroxyellipticinium; 2-DEHE; datelliptium chloride; detalliptinium; detalliptinium acetate salt; detalliptinium chloride; detalliptium acetat |
DAT-230 | 1504583-00-9 | C22H20BrN3O2S | 339.45 | DAT-230; DAT 230; DAT230 |
D-Aspartic acid,N-[(1S)-1,2-dicarboxyethyl]-, rel- | 131669-35-7 | C8H11NO8 | 249.17484;g/mol | 2-(1,2-dicarboxyethylamino)butanedioicacid; Iminodisuccinicacid; 131669-35-7; D-Asparticacid,N-[(1S)-1,2-dicarboxyethyl]-,rel-; iminodisuccinicacid; imidodisuccinicacid |
D-Aspartic acid,3-hydroxy-, (3R)- | 16417-36-0 | C4H7 N O5 | 149.10208 | (2R,3R)-2-amino-3-hydroxy-succinic acid |
Darifenacin Morpholine Amide Impurity | 97483-11-9 | C14H17NO2S | 263.36 | 2-(2,3-dihydrobenzofuran-5-yl)-1-Morpholinoethanethione |
Darifenacin Impurity E | 1797983-04-0 | C38H40N2O3 | 572.74 | 4-[2-di-[2-(2,3-Dihydrobenzofuran-4-yl)ethyl]aminoethyl)-3,3-diphenylpyrolidine-2-one; Darifenacin Cyclic Amide |
Darifenacin Hydrobromide | 133099-07-7 | C28H30N2O2.HBr | 507.46 | UK-88525; UK 88525; UK88525 |
Darifenacin Carboxylic Acid Impurity | 69999-16-2 | C10H10O3 | 178.18 | 2,3-Dihydro-5-benzofuranacetic Acid; (2,3-Dihydrobenzofuran-5-yl)acetic Acid; 2,3-Dihydrobenzofuran-5-acetic Acid; 2-(2,3-Dihydrobenzofuran-5-yl)acetic Acid |
Darifenacin | 133099-04-4 | C28H30N2O2 | 426.55 | UK-88525; UK 88525; UK88525 |
Darglitazone | 141200-24-0 | C23H20N2O4S | 420.5 | CP 86325 |
Daratumumab | 945721-28-8 | C6466H9996N1724O2010S42 | 145391.67 | Darzalex; HuMax-CD38; UNII-4Z63YK6E0E |
Danusertib | 827318-97-8 | C26H30N6O3 | 474.55 | PHA-739358 |
Dapoxetine hydrochloride | 129938-20-1 | C21H23NO.HCl | 341.87 | LY-210448 |
Daphnoretin | 2034-69-7 | C19H12O7 | 352.3 | 7-Hydroxy-6-methoxy-3-[(2-oxo-2H-1-benzopyran 7-yl)-oxy]-2H-1-benzopyran-2-one; |
Daphmacrine | 19775-48-5 | C32H49NO4 | ||
Dantrolene sodium hemiheptahydrate | 24868-20-0 | C14H9N4O5·7/2H2O·Na | 399.29 | Dantrolene sodium salt; Dantrium; Sodium dantrolene |
Dantrolene Sodium | 14663-23-1 | C14H9N4NaO5 | 336.239 | Dantrolene sodium salt; Dantrium; Sodium 3-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-2-oxo-4H-imidazol-5-olate |
Dantrolene Related Compo | 301359-05-7 | |||
Dantrolene Impurity 3 | 55227-60-6 | C16H16N4O6 | 360.32 | 2-[1-(Aminocarbonyl)-2-[[5-(4-nitrophenyl)-2-furanyl]methylene]hydrazinyl]-acetic Acid Ethyl Ester |
Dantrolene Impurity 2 | 57268-33-4 | C14H12N4O6 | 332.27 | 5-(4-Nitrophenyl)-2-furaldehyde-(2-carboxymethyl) Semicarbazone; [(Aminocarbonyl)[[5-(4-nitrophenyl)-2-furanyl]methylene]hydrazino]acetic Acid; Dantrolene Impurity |
Dansyl-L-proline | 1239-94-7 | C17H20N2O4S | 348.42 | N-DANSYL-L-PROLINE; DANSYL-L-PROLINE; DANSYL-L-PROLINE PIPERIDINIUM SALT 98+%; freeacid; dansylproline; Dns-Pro-OH.Piperidinium |
Dansyl-L-asparagine | 1100-23-8 | C16H19N3O5S | 365.40416 | DANSYL-L-ASPARAGINE; N2-[[5-(dimethylamino)-1-naphthyl]sulphonyl]-L-asparagine; Dansyl-L-aspsragine; dansyl asparagine; (2S)-2-(5-Dimethylamino-1-naphtylsulfonylamino)-3-carbamoylpropanoic acid; Dansyl-L-Aspargine; Dns-L-Asn-OH; N2-[(5-Dimethylamino-1-nap |
DANSYL-DL-VALINE CYCLOHEXYLAMMONIUM SALT | 42808-05-9 | C17H22N2O4S | 350.43 | DANSYL-DL-VALINE CYCLOHEXYLAMMONIUM SALT |
DANSYL-DL-VALINE CYCLOHEXYLAMMONIUM | 84540-67-0 | C23H36N3O4S+ | 450.61464 | |
Dansyl-DL-phenylalanine cyclohexylammonium salt | 42808-06-0 | C21H22N2O4S | 497.65 | dansyl-phenylalanine; Dansyl-L-phenylalanine; Dansyl-DL-phenylalaninecyclohexylammoniumsalt; 42808-06-0; Dansylphenylalanine; 2-[5-(dimethylamino)naphthalene-1-sulfonamido]-3-phenylpropanoicacid |
DANSYL-DL-NORVALINE PIPERIDINIUM | 102783-76-6 | 435.58 | ||
DANSYL-DL-NORLEUCINE CYCLOHEXYLAMMONIUM SALT | 84540-65-8 | C18H24N2O4S.C6H13N | 463.64 | |
Dansyl-DL-norleucine cyclohexylammonium salt | 84549-65-8 | |||
DANSYL-DL-METHIONINE CYCLOHEXYLAMMONIUM | 42808-13-9 | 481.67 | ||
DANSYL-DL-GLUTAMIC ACID | 102783-69-7 | C17H20N2O6S.2C6H13N | 578.77 | DANSYL-DL-GLUTAMIC ACID; DANSYL-DL-GLUTAMIC ACID*DI(CYCLOHEXYLAMM ONIUM); dansyl-dl-glutamic acid bis(cyclohexylammonium) salt; DANSYL-DL-GLUTAMIC ACID BIS(CYCLOHEXYLAMMONIUM) |
DANSYL-DL-A-AMINO-N-BUTYRIC ACID*PIPERID INIUM | 102783-63-1 | 421.55 | ||
Dansyl-(DL)-leucine dicyclohexylammonium salt | 102783-70-0 | 463.63 | ||
Dansylamidoethyl mercaptan | 5354-61-0 | C14H18N2O2S2 | 310.43 | 2-(5-DIMETHYLAMINONAPHTH-1-YLSULFONAMIDO)ETHYL MERCAPTAN; DANSYLAMIDOETHYL MERCAPTAN |
Dansyl-(D)phenylalanine | 56176-31-9 | C21H22N2O4S | 398.481 | N-[[5-(Dimethylamino)-1-naphthalenyl]sulfonyl]-D-phenylalanine; D-Dansylphenylalanine; Dansyl-(R)-phenylalanine; Dansyl-D-Phe; Dansyl-D-phenylalanine; N-Dansyl-D-phenylalanine |
Dansyl sarcosine piperidinium salt | 72517-44-3 | C20H29N3O4S | 407.529 | DANSYLSARCOSINE PIPERIDINIUM SALT; dansylsarcosine piperidinium |
DANSYL Fluoride | 34523-28-9 | C12H12FNO2S | 253.30 | DNSF |
Danshenxinkun A | 65907-75-7 | C18H16O4 | 296.32 | 2-(1-Methyl-2-hydroxyethyl)-3-hydroxy-8-methylphenanthrene-1,4-dione; 3-Hydroxy-2-(1-hydroxypropan-2-yl)-8-methylphenanthrene-1,4-dione. |
Danshensu | 22681-72-7 | C9H10O5 | alpha-(3,4-Dihydroxyphenyl)lactic acid; Benzeneacetic acid, alpha,3,4-trihydroxy-alpha-methyl-; 2-(3,4-Dihydroxyphenyl)lactic acid | |
D-Allose | 2595-97-3 | C6H12O6 | 180.16 | b-D-Allose |
Damnacanthal | 477-84-9 | C16H10O5 | 282.3 | 1-Methoxy-2-formyl-3-hydroxy-9,10-anthraquinone; |
Dammarenediol II 3-O-caffeate | 171438-55-4 | C39H58O5 | 606.9 | (3beta)-Dammar-24-ene-3,20-diol 3-[3-(3,4-dihydroxyphenyl)-2-propenoate] |
Dammarenediol II | 14351-29-2 | C30H52O2 | 444.7 | Dammar-24-ene-3,20-diol |
Dammaradienyl acetate | 52914-31-5 | C32H52O2 | 468.8 | DaMMara-20,24-dien-3b-yl acetate |
D-Allono-1,4-lactone | 29474-78-0 | C6H10O6 | 178.14 | D-Allonic acid gamma-lactone |
Dalfopristin mesylate | 112362-50-2 | C35H54N4O12S2 | 787.0 | |
Dalcetrapib | 211513-37-0 | C23H35NO2S | 389.59 | JTT-705 |
Dalbergioidin | 30368-42-4 | C15H12O6 | 288.3 | 2',4',5,7-Tetrahydroxyisoflavanone |
Dalbavancin | 171500-79-1 | C88H100Cl2N10O28 | 1816.69 | |
Dalasetron Mesylate hydrate | 878143-33-0 | C20H26N2O7S | 438.49 | rel-(6R,9aS)-Octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl 1H-indole-3-carboxylate methanesulfonate hydrate |
D-alanine-3-13C | 133665-48-2 | 13CH3CH(NH2)COOH | 90.19 | (2R)-2-aminopropanoic acid-3-13C |
D-Alanine-3,3,3-d3-N-t-BOC | 177614-70-9 | CD3CH(NH-t-BOC)COOH | 192.23 | BOC-D-Alanine-d3; BOC-D-Ala-OH-d3; D-Alanine-3,3,3-d3,N-[(1,1-dimethylethoxy)carbonyl]-; (2R)-3,3,3-trideuterio-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid |
D-Alanine | 338-69-2 | C3H7NO2 | ||
D-Alanine-3,3,3-d3 | 177614-69-6 | CD3CH(NH2)COOH | 92.11 | (R)-2-Aminopropionic Acid-d3; H-D-Ala-OH-d3; (2R)-2-amino-3,3,3-trideuteriopropanoic acid |
D-Alanine-2-d1 | 56595-54-1 | CH3CD(NH2)COOH | 90.1 | (R)-2-Aminopropionic Acid-d1; H-D-Ala-OH-d1; (2R)-2-amino-2-deuteriopropanoic acid |
D-Alanine-2-13C,15N | 1217463-19-8 | [13C]C2H7[15N]O2 | 91.08 | |
D-Alanine-13C3 | 286460-72-8 | [13C]H3[13C]H(NH2)[13C]O2H | 92.07 | |
Daidzein | 552-66-9 | C21H20O9 | 416.38 | Daidzein 7-O-b-D-glucopyranoside; 7-(b-D-glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-benzopyran-4-one |
Daidzein-D3-7-O-b-D-glucopyranoside | 220930-97-2 | C22H19O8D3 | 417.43 | |
Daidzein Diacetate | 3682-01-7 | C19H14O6 | 338.31 | [4-(7-acetyloxy-4-oxochromen-3-yl)phenyl] acetate |
d4TMP | 3715-64-8 | C10H13N2O7P (free acid) | 304.19 (free acid) | Stavudine monophosphate, Sodium Salt; 2',3'-Didehydro-2',3'-dideoxythymidine-5'-monophosphate, Sodium salt |
Daidzein 7-b-D-glucuronide 4-sulfate disodium salt | 1041134-19-3 | C21H16Na2O13S | 554.39 | 4-Oxo-3-[4-(sulfooxy)phenyl]-4H-1-benzopyran-7-yl b-D-glucopyranosiduronic acid sodium salt |
Daidzein | 486-66-8 | C15H10O4 | 254.24 | 7-hydroxy-3-(4-hydroxyphenyl)-1-benzopyran-4-one |
Dahurinol | 38908-87-1 | C30H48O5 | 502.73 | |
Daglutril | 182821-27-8 | C31H38N2O6 | 534.64 | SLV-306; SLV306; SLV 306; 2-[(3S)-3-[[1-[(2R)-2-ethoxycarbonyl-4-phenylbutyl]cyclopentanecarbonyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid |
DAF-FM DA | 254109-22-3 | C25H18F2N2O7 | 496.4 | 4-Amino-5-methylamino-2',7'-difluorofluorescein diacetate; DAF-FM Diacetate; 3',6'-bis(acetyloxy)-4-amino-2',7'-difluoro-5-(methylamino)-spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one |
Dafadine-A | 1065506-69-5 | C23H25N3O3 | 391.46 | Dafadine-A; CHEBI:88327; 1065506-69-5; Ambcb24199950; MLS001090772; CHEMBL1585869 |
DAF-2 diacetate | 205391-02-2 | C24H18N2O7 | 446.4 | DAF-2 DA; 4,5-Diaminofluorescein diacetate; 2-(3,6-diacetyloxy-4,5-diamino-9H-xanthen-9-yl)-benzoic acid |
DAF-2 | 205391-01-1 | C20H14N2O5 | 362.3 | 4,5-Diaminofluorescein; 2-(3,6-dihydroxy-4,5-diamino-9H-xanthen-9-yl)-benzoic acid |
DADLE | 63631-40-3 | C29H39N5O7 | 569.66 | [D-Ala2, D-Leu5]-enkephalin |
Dadahol A | 405281-76-7 | C39H38O12 | 698.7 | (2E)-3-(4-{[(1S,2R)-1-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-{[( 2E)-3-(4-hydroxyphenyl)-2-propenoyl]oxy}-2-propanyl]oxy}-3,5-dime thoxyphenyl)-2-propen-1-yl (2E)-3-(4-hydroxyphenyl)acrylate |
Dacuronium bromide | 27115-86-2 | C33H58N2O3Br2 | 690.633 g/mol | [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-hydroxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetate;dibromide;DacuroniumBromide;UNII-33482245B6;27115-86-2;SCHEMBL |
Dactylorhin A | 256459-34-4 | C40H56O22 | 888.86 | |
Dactolisib | 915019-65-7 | C30H23N5O | 469.548 | BEZ235; BEZ-235; BEZ 235; NVP-BEZ235. |
Dacomitinib | 1110813-31-4 | C24H25ClFN5O2 | 469.945 | dacomitinib; PF-00299804; PF00299804; PF 00299804; PF299804; PF-299804; PF 299804; PF-299; |
Daclizumab | 152923-56-3 | C6332H9808N1678O1989S42 | 142612.1 | BIIB-019; DAC HYP; Dacliximab; Daclizumab high-yield process; Daclizumab HYP; HAT antibody; Humanised anti-Tac antibody; R35; RO 247375; SMART anti-Tac antibody; Zenapax; Zinbryta |
Daclatasvir Impurity 6 | 1009117-26-3 | C40H50N8O6 | 738.88 | Daclatasvir SRRS Isomer; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2R)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester |
Daclatasvir Impurity 4 | 1009107-27-0 | C40H50N8O6 | 738.88 | Daclatasvir RSSR Isomer; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1R)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester |
Daclatasvir dihydrochloride | 1009119-65-6 | C40H50N8O6·2HCl | 811.806 | methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate dihydrochloride; Daclatasvir; BMS790052; BMS |
Daclatasvir | 1009119-64-5 | C40H50N8O6 | 738.89 | Daclatasvir; BMS-790052; BMS 790052; BMS790052; EBP-883; EBP 883; EBP883; trade name Daklinza. |
Dacinostat | 404951-53-7 | C22H25N3O3 | 379.46 | NVP-LAQ824. |
Dacetuzmumab | 880486-59-9 | SGN-40; huS2C6; Dacetuzumab | ||
dacemazine | 518-61-6 | C16H16N2OS | 284.381 | dacemazine; 10-(Dimethylamino)acetyl-10H-phenothiazine; 10-(N,N-Dimethylglycyl)-10H-phenothiazine; 10-[(Dimethylamino)acetyl]-10H-phenothiazine; Ahistan; Histantin Richter); 2-(dimethylamino)-1-phenothiazin-10-ylethanone; 2-(dimethylamino)-1-phenothiazin- |
Dacarbazine-d6(N,N-dimethyl-d6) | 1185241-28-4 | C6H4D6N6O | 188.22 | 5-(3,3-Dimethyltriazino)imidazole-4-carboxamide |
Dabigatran etexilate mesylate | 872728-81-9 | C35H45N7O8S | 723.84 | Ethyl 3-(((2-(((4-(((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)(pyridin-2-yl)amino)propanoate, methanesulfonate; Dabigatran etexilate mesylate; BIBR 1048MS; BIBR1048MS; BIBR-1048MS; BIBR 1048; BIBR1048; BI |
DAB-AM-32, POLYPROPYLENIMINE DOTRIACONTA -AMINE DENDRIMER, GENERATION 4.0 | 163611-04-9 | |||
Dabcyl SE | 146998-31-4 | C19H18N4O4 | 366.38 | 2,5-Dioxopyrrolidin-1-yl 4-((4-(dimethylamino)phenyl)diazenyl)benzoate; 4-[4-(Dimethylamino)phenylazo]benzoic acid N-succinimidyl ester |
DAA-1106 | 220551-92-8 | C23H22FNO4 | 395.42 | N-[(2,5-dimethoxyphenyl)methyl]-N-(5-fluoro-2-phenoxyphenyl)acetamide (11C)DAA1106 DAA 1106 DAA-1106 DAA1106 N-(2,5-dimethoxybenzyl)-N-(5-fluoro-2-isophenoxyphenyl)acetamide |
DA-3003-2 | 383907-47-9 | C15H16ClN3O3 | 321.8 | NSC 663285; 7-chloro-6-[[2-(4-morpholinyl)ethyl]amino]-5,8-quinolinedione |
D77 | 497836-10-9 | C28H22BrNO7S | 596.44 | 4-[(5-Bromo-4-{(Z)-[2,4-dioxo-3-(2-oxo-2-phenylethyl)-1,3-thiazolidin-5-ylidene]methyl}-2-ethoxyphenoxy)methyl]benzoic acid; |
D-64131 | 74588-78-6 | C16H13NO2 | 251.28 | 2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol; 1-(3,4,5-trimethoxyphenyl)-2-(3'-hydroxy-4'-methoxyphenyl)ethene; D-64131; 74588-78-6; (5-METHOXY-1H-INDOL-2-YL)PHENYLMETHANONE; CHEMBL140220; C16H13NO2; (5-methoxy-1H-indol-2-yl)-phenylmethanone; |
D609 | 83373-60-8 | C11H15KOS2 | 266.46 | |
D-4-Hydroxyphenyl-d4-alanine-2,3,3-d3 | 1426174-46-0 | HOC6D4CD2CD(NH2)COOH | 188.23 | D-Tyrosine-d7; p-Hydroxyphenyl-D-alanine-d7; H-D-Tyr-OH-d7 |
D-4-Hydroxyphenylalanine-3,3-d2 | 1202064-22-9 | HOC6H4CD2CH(NH2)COOH | 183.2 | D-Tyrosine-d2; p-Hydroxyphenyl-D-alanine-d2; H-D-Tyr-OH-d2; (2R)-2-amino-3,3-dideuterio-3-(4-hydroxyphenyl)propanoic acid |
D-4-Chlorophenylglycine HCl | 108392-76-3 | C8H9Cl2NO2 | 222.06 | D-4-CHLOROPHENYLGLYCINE HCL |
D4476 | 301836-43-1 | C23H18N4O3 | 398.41 | CK1 Inhibitor; Casein kinase I inhibitor; 4-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide |
D-[UL-13C6;UL-2H7]glucose | 201417-01-8 | 13C62H7H5O6 | 193.15 | D-[UL-13C6;1,2,3,4,5,6,6'-2H7]glucose |
D-[UL-2H7]glucose | 66034-51-3 | C62H7H5O6 | 187.2 | D-[1,2,3,4,5,6,6'-2H7]glucose |
d2-Cefteram | 104691-34-1 | C16H17N9O5S2 | 479.5 | (6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic Acid; T 2525A; |
D-2-Amino-5-phenylpentanoic acid | 2046-19-7 | C11H15NO2 | 193.24 | (R)-2-AMINO-5-PHENYL-PENTANOIC ACID; H-D-NVA(5-PHENYL)-OH; D-2-AMINO-5-PHENYL-PENTANOIC ACID; D-Nva(5-phenyl)-OH; D-PEA |
D-2-Amino-3-(6-chloroindolyl)propionic acid | 56632-86-1 | C11H11ClN2O2 | 238.67 | D-2-Amino-3-(6-chloroindolyl)propionic acid; H-6-Chloro-D-Trp-OH; 6-Chloro-D-tryptophan |
D-2-Amino-1,1,1-trifluoro-3-(methyl)butane | 1582-18-9 | C5H10F3N | 141.13 | D-2-Amino-1,1,1-trifluoro-3-(methyl)butane; DL-2-Amino-1,1,1-trifluoro-3-(methyl)butane; 2-Methyl-1-trifluoromethyl-propylamine; 1,1,1-Trifluoro-3-methylbutan-2-amine hydrochloride |
D2343 | 72734-63-5 | C20H27NO3 | 329.43 | 4-[1-hydroxy-2-[[4-(2-methoxyphenyl)-2-methylbutan-2-yl]amino]ethyl]phenol; D 2343; N-(3-(2-methoxyphenyl)-1,1-dimethylpropyl)-1-(p-hydroxyphenyl)ethanolamine hydrochloride |
D-2,6-difluorophenyl-alanine | 266360-62-7 | C9H9F2NO2 | 201.17 | 2,6-Difluoro-D-phenylalanine; D-2,6-Difluorophenyl-alanine |
D-1-N-Boc-prolinamide | 70138-72-6 | C10H18N2O3 | 214.26 | (R)-2-CARBAMOYL-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER; 1-BOC-D-PROLINAMIDE; D-N-BOC-PROLINAMIDE; N-ALPHA-BOC-D-PROLINEAMIDE; (2R)-2-carbamoyl-pyrrolidine-1-carboxylic acid tert-butyl ester |
D-1-Cbz-Nipecotic acid | 160706-62-7 | C14H17NO4 | 263.28 | D-1-CBZ-NIPECOTIC ACID; (R)-PIPERIDINE-1,3-DICARBOXYLIC ACID 1-BENZYL ESTER; (R)-1-CBZ-PIPERIDINE-3-CARBOXYLIC ACID |
D15 | 251939-41-0 | C69H111N23O19 | 1566.78 | |
D149 Dye | 786643-20-7 | C42H35N3O4S3 | 741.94 | D149; Indoline dye D149 |
D-1,2,3,4-Tetrahydro-quinoline-2-carboxylic acid HCl | 75433-76-0 | C10H12ClNO2 | 0 | REF DUPL: D-1,2,3,4-Tetrahydro-quinoline-2-carboxylic acid hydrochloride |
D-[UL-13C6]mannose | 287100-74-7 | 13C6H12O6 | 186.11 | |
D-[UL-13C6]mannitol | 287112-34-9 | 13C6H14O6 | 188.13 | |
D-[UL-13C6]glucose | 110187-42-3 | 13C6H12O6 | 186.11 | |
D-[UL-13C6]glucitol | 121067-66-1 | 13C6H14O6 | 188.13 | D-[UL-13C6]sorbitol |
D-[UL-13C5]ribose | 202114-47-4 | 13C5H10O5 | 155.09 | |
D-[UL-13C6]fructose | 201595-65-5 | 13C6H12O6 | 186.11 | |
d[leu4,Lys8]-VP | 42061-33-6 | C47H67N11O11S2 | 1026.2 | D[Leu4,Lys8]VP; 1-Deamino-4-leu-8-lys-vasopressin; Vasopressin, 1-deamino-leu(4)-lys(8)- |
d[Cha4]-AVP | 500170-27-4 | C50H71N13O11S2 | 1094.31 | |
D-[6-13C]glucose | 106032-62-6 | 13CC5H12O6 | 181.15 | |
D-[6,6'-2H2]glucose | 18991-62-3 | C62H2H10O6 | 182.17 | |
D-[6-13C]galactose | 478518-62-6 | 13CC5H12O6 | 181.15 | |
D-[6-13C]fructose | 287100-63-4 | 13CC5H12O6 | 181.15 | |
D-[5-2H]glucose | 136864-16-9 | C62HH11O6 | 181.16 | |
D-[6,6'-2H2]galactose | 35669-34-2 | C62H2H10O6 | 182.17 | |
D-[6,6'-2H2]fructose | 285979-75-1 | C62H2H10O6 | 182.17 | |
D-[5-13C]xylose | 139657-63-9 | 13CC4H10O5 | 151.12 | |
D-[5-13C]ribose | 139657-62-8 | 13CC4H10O5 | 151.12 | |
D-[3-13C]fructose | 249928-59-4 | 13CC5H12O6 | 181.15 | |
D-[2-2H]xylose | 288846-91-3 | C52HH9O5 | 151.14 | |
D-[2-2H]ribose | 202480-69-1 | C52HH9O5 | 151.14 | |
D-[2-2H]glucose | 106032-60-4 | C62HH11O6 | 181.16 | |
D-[2-2H]glucitol | 75607-68-0 | C62HH13O6 | 183.18 | D-[2-2H]sorbitol |
D-[2-2H]galactose | 64429-86-3 | C62HH11O6 | 181.16 | |
D-[2-13C]xylulose | 131771-47-6 | 13CC4H10O5 | 151.12 | D-[2-13C]threo-pent-2-ulose |
D-[2-2H]arabinose | 288846-87-7 | C52HH9O5 | 151.14 | |
D-[2-13C]xylose | 131771-69-2 | 13CC4H10O5 | 151.12 | |
D-[2-13C]threose | 478506-49-9 | 13CC3H8O4 | 121.1 | |
D-[2-13C]talose | 83379-36-6 | 13CC5H12O6 | 181.15 | |
D-[2-13C]tagatose | 478506-44-4 | 13CC5H12O6 | 181.15 | |
D-[2-13C]ribulose | 131771-71-6 | 13CC4H10O5 | 151.12 | D-[2-13C]erythro-pent-2-ulose |
D-[2-13C]ribose | 83379-40-2 | 13CC4H10O5 | 151.12 | |
D-[2-13C]mannitol | 287100-69-0 | 13CC5H14O6 | 183.17 | |
D-[2-13C]lyxose | 83379-39-9 | 13CC4H10O5 | 151.12 | |
D-[2-13C]gulose | 478529-73-6 | 13CC5H12O6 | 181.15 | |
D-[2-13C]glucose | 105931-74-6 | 13CC5H12O6 | 181.15 | |
D-[2-13C]glucitol | 287100-73-6 | 13CC5H14O6 | 183.17 | D-[2-13C]sorbitol |
D-[2-13C]galactose | 314062-47-0 | 13CC5H12O6 | 181.15 | |
D-[1-2H]ribose | 119540-50-0 | C52HH9O5 | 151.14 | |
D-[2,5-13C2]ribose | 213825-57-1 | 13C2C3H10O5 | 152.11 | |
D-[2-13C]fructose | 117013-19-1 | 13CC5H12O6 | 181.15 | |
D-[2-13C]erythrose | 83434-88-2 | 13CC3H8O4 | 121.1 | |
D-[2-13C]arabinose | 101615-87-6 | 13CC4H10O5 | 151.12 | |
D-[2,5-13C2]glucose | 86595-19-9 | 13C2C4H12O6 | 182.14 | |
D-[2,5-13C2]fructose | 141258-84-6 | 13C2C4H12O6 | 182.14 | |
D-[2,3,4,5-13C4]ribose | 478506-23-9 | 13C4CH10O5 | 154.1 | |
D-[1-2H]xylose | 288846-89-9 | C52HH9O5 | 151.14 | |
D-[1-2H]mannose | 288846-86-6 | C62HH11O6 | 181.16 | |
D-[1-2H]lyxose | 288846-88-8 | C52HH9O5 | 151.14 | |
D-[1-2H]glucose | 106032-61-5 | C62HH11O6 | 181.16 | |
D-[1-2H]galactose | 64267-73-8 | C62HH11O6 | 181.16 | |
D-[1-2H]arabinose | 77583-92-7 | C52HH9O5 | 151.14 | |
D-[1-18O]glucose | 3343-70-2 | C6H1218OO5 | 182.16 | |
D-[1-13C]xylulose | 131771-46-5 | 13CC4H10O5 | 151.12 | D-[1-13C]threo-pent-2-ulose |
D-[1-13C]xylose | 70849-21-7 | 13CC4H10O5 | 151.12 | |
D-[1-13C]threose | 70849-20-6 | 13CC3H8O4 | 121.1 | |
D-[1-13C]talose | 70849-29-5 | 13CC5H12O6 | 181.15 | |
D-[1-13C]tagatose | 478506-42-2 | 13CC5H12O6 | 181.15 | |
D-[1-13C]ribulose | 131771-70-5 | 13CC4H10O5 | 151.12 | D-[1-13C]erythro-pent-2-ulose |
D-[1-13C]ribose | 70849-24-0 | 13CC4H10O5 | 151.12 | |
D-[1-13C]gulose | 70849-25-1 | 13CC5H12O6 | 181.15 | |
D-[1-13C]mannose | 70849-31-9 | 13CC5H12O6 | 181.15 | |
D-[1-13C]mannitol | 132202-29-0 | 13CC5H14O6 | 183.17 | |
D-[1-13C]lyxose | 70849-22-8 | 13CC4H10O5 | 151.12 | |
D-[1-13C]glucose | 40762-22-9 | 13CC5H12O6 | 181.15 | |
D-[1-13C;2-2H]glucose | 201417-06-3 | 13CC52HH11O6 | 182.16 | |
D-[1-13C]glucitol | 132144-93-5 | 13CC5H14O6 | 183.17 | D-[1-13C]sorbitol |
D-[1-13C]galactose | 70849-30-8 | 13CC5H12O6 | 181.15 | |
D-[1-13C]altrose | 70849-27-3 | 13CC5H12O6 | 181.15 | |
D-[1-13C]fructose | 108311-21-3 | 13CC5H12O6 | 181.15 | |
D-[1-13C]erythrose | 70849-19-3 | 13CC3H8O4 | 121.1 | |
D-[1-13C]arabinose | 70849-23-9 | 13CC4H10O5 | 151.12 | |
D-[1-13C]allose | 70849-28-4 | 13CC5H12O6 | 181.15 | |
D-[1-13C;1-2H]glucose | 201136-45-0 | 13CC52HH11O6 | 182.16 | |
D-[1,6-13C2]glucose | 287100-67-8 | 13C2C4H12O6 | 182.14 | |
D-[1,6-13C2]galactose | 478518-64-8 | 13C2C4H12O6 | 182.14 | |
D-[1,6-13C2]fructose | 287100-71-4 | 13C2C4H12O6 | 182.14 | |
D-[1,2,3,3'-2H4]glyceraldehyde | 478529-60-1 | C32H4H2O3 | 94.1 | D-[1,2,3,3'-2H4]2,3-dihydroxypropanal |
D.E.R.(R) 332 | 25085-99-8 | C21H24O4 | 0 | 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis-oxiranhomopol; 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis-oxiranhomopolymer; BisphenolAdiglycidyletherresinE-03; BisphenolAepoxyresinE-03; diglycidyl; diglycidylbisphenolaresin |
2'-Deoxy-5-fluorocytidine | 10356-76-0 | C9H12FN3O4 | 245.21 | 5-FLUORO-2'-DEOXYCYTIDINE; FdCyd |
2'-Deoxy-N4,5-dimethylcytidine | 25406-44-4 | C11H17N3O4 | 255.27 | N,5-Dimethyl-2'-deoxycytidine |
2',3',5'-Tri-O-acetylcytidine HCl | 63639-21-4 | C15H19N3O8·HCl | 405.79 | 2',3',5'-Tri-O-acetylcytidine hydrochloride; (2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate hydrochloride |
Cytidine Diphosphate Ethanolamine (CDPEA) | 3038-18-8 | C11H20N4O11P2 | 446.25 | |
CYM 50260 | 1355026-60-6 | C14H11Cl3FNO2 | 350.60 | 2-Chloro-3-[2-(2,4-dichlorophenoxy)ethoxy]-6-(fluoromethyl)pyridine |
Cylindrospermopsin | 143545-90-8 | C15H21N5O7S | 415.4 | 6-[(R)-hydroxy[(2aS,3R,4S,5aS,7R)-2,2a,3,4,5,5a,6,7-octahydro-3-methyl-4-(sulfooxy)-1H-1,8,8b-triazaacenaphthylen-7-yl]methyl]-2,4(1H,3H)-pyrimidinedione |
Cyhalothrin lambda | 91465-08-6 | C46H38Cl2F6N2O6 | 899.70000 | |
Cyhalothrin | 68085-85-8 | C23H19ClF3NO3 | 449.86 | cyano-3-phenoxybenzyl (1s+1r)-cis-3-(z-2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethyl cyclopropanecarboxylate; cyano(3-phenoxyphenyl)methyl 3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethylcyclopropanecarboxylate; 3-(2-chloro-3,3,3-trifluoro-1-prope |
Cyhalofop | 122008-78-0 | C16H12FNO4 | 301.27 | Cyhalofop acid |
Cyflumetofen | 400882-07-7 | C24H24F3NO4 | 447.4 | 2-methoxyethyl 2-(4-tert-butylphenyl)-2-cyano-3-oxo-3-[2-(trifluoromethyl)phenyl]propanoate |
CYFLUFENAMID | 180409-60-3 | C20H17F5N2O2 | 412.35 | CYFLUFENAMID; cyflufenamid (bsi, pa iso); nf-149; CYFLUFENAMID STANDARD |
cycrimine | 77-39-4 | C19H29NO | 287.4397 | |
CycLuc 1 | 1247879-16-8 | C13H11N3O2S2 | 305.37 | (4S)-2-(6,7-Dihydro-5H-pyrrolo[3,2-f]benzothiazol-2-yl)-4,5-dihydro-4-thiazolecarboxylic acid |
Cyclovirobuxine | 860-79-7 | C26H46N2O | 402.66 | Bebuxine, CVB-D |
Cyclopentanemethanamine, 2-methyl- | 751464-59-2 | C7H15 N | 113.20100 | |
Cyclomusalenone | 30452-60-9 | C30H48O | 424.71 | 24S)-Cyclomusalenone;31-Norcyclolaudenone |
Cyclomorusin | 62596-34-3 | C25H22O6 | 418.45 | Cyclomulberrochromene;6,11-Dihydroxy-3,3-dimethyl-8-(2-methyl-1-propenyl)-3H,7H,8H-bis[1]benzopyrano[4,3-b:6',5'-e]pyran-7-one;Cyclomorusin A |
Cyclomethicone | 69430-24-6 | |||
Cyclododecanol | 1724-39-6 | C12H24 O | 184.3184 | CYCLODODECANOL; CYCLODODECANOLE; HYDROXYCYCLODODECANE; 1-Cyclododecanol; Cyclododecan-1-ol; Cyclododecanol,99% |
CYCLODECENE | 935-31-9 | C10H18 | 138.25 | |
Cyclodecene | 3618-12-0 | C12H22 | 166.3 | CYCLODODECENE; CYCLODECENE |
D,L-Mevalonic Acid, Sodium Salt | 96949-03-0 | C6H11NaO4 | 170.14 | |
D-(-)-Norgestrel (Levonorgestrel) | 797-63-7 | C21H28O2 | 312.45 | SCH29851; SCH 29851; SCH-29851 |
D(-)-4-Fluorophenylglycine | 93939-74-3 | C8H8FNO2 | 169.15 | (R)-AMINO-(4-FLUORO-PHENYL)-ACETIC ACID; (R)-(-)-4-(FLUOROPHENYL)GLYCINE; (R)-4-FLUOROPHENYLGLYCINE; 4-FLUORO-D-PHENYLGLYCINE; 4-FLUORO-D-ALPHA-PHENYLGLYCINE; D-(4-FLUOROPHENYL) GLYCINE; D-AMINO-(4-FLUORO-PHENYL)-ACETIC ACID; (2R)-amino(4-fluorophenyl)eth |
D(-)3-PHOSPHOGLYCERIC ACID DISODIUM SALT | 80731-10-8 | C3H5Na2O7P | 230.02 | D(-)3-PHOSPHOGLYCERIC ACID DISODIUM SALT; D-3-PHOSPHOGLYCERIC ACID DISODIUM SALT; D-3-Phosphoglyceric acid dissodium salt; D(-)3-PHOSPHOGLYCERIC ACID DISODIUM; (-)-disodium d-3-phosphoglycerate; (-)-Disodium D-3-phosphoglycerate, D-Glycerate 3-phosphat |
Cysmethynil | 851636-83-4 | C25H32N2O | 376.544 | Cysmethynil |
CysLT1 Antagonist Q8 | 1541762-55-3 | C17H14ClNO2 | 299.75 | Q8 hydrochloride; (E)-2-(2-Quinolin-2-yl-vinyl)-benzene-1,4-diol Hydrochloride |
CYS-GLY | 19246-18-5 | C5H10N2O3S | 178.21 | L-CYSTEINYL GLYCINE; L-CYSTEINYLGLYCINE MONOHYDRATE; CYS-GLY; H-CYS-GLY-OH; cysteinylglycine; glycine,n-cysteinyl; n-l-cysteinyl-glycin; 2-(2-amino-3-sulfanyl-propanoyl)aminoacetic acid |
Cyromazine-d4 | 1219804-19-9 | C6H6N6D4 | 170.21 | N2-(Cyclopropyl-d4)-1,3,5-triazine-2,4,6-triamine; 2,4-Diamino-6- (cyclopropylamino-d4)-s-triazine; CGA 72662-d4; Citation-d4; Cyclopropylmelamine-d4; Larvadex-d4; N-(Cyclopropyl-d4)-1,3,5-triazine- 2,4,6-triamine; Neporex-d4; Patron-d4; Trigard-d4 |
Cyromazine-13C3 | 1808990-94-4 | N-Cyclopropyl-1,3,5-tria- zin-13C -2,4,6-triamin 3 |
||
Cyclopropyl 2-Fluorobenzyl Ketone | 150322-73-9 | C11H11FO | 178.21 | 1-Cyclopropyl-2-(2-fluorophenyl)ethanone |
Cy5 acid(mono SO3) | 644979-16-8 | C35H44N2O5S | 604.8 | 2-[5-[1-Carboxypentyl-1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene]-penta-1,3-dienyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt |
Cy3 Acid(mono SO3) | 644979-14-6 | C33H42N2O5S | 578.77 | 2-[3-[1-Carboxypentyl-1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene]-propenyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt |
CY 208-243 | 100999-26-6 | C19H18N2 | 274.36 | (-)-(6aR,12bR)-4,6,6a,7,8,12b-Hexahydro-7-methylindolo[4,3-a]phenanthridin |
cXMP | 31319-70-7 | C10H10N4O8P · Na | 368.2 | Xanthosine- 3', 5'- cyclic monophosphate, sodium salt |
CXCR3 Antagonist 6c | 870998-13-3 | C30H32Cl3N5O3 | 616.97 | 4-[2-[(3-chlorobenzoyl)amino]-4-[2-(2,4-dichlorophenyl)ethylcarbamoyl]phenyl]-N-ethyl-1,4-diazepane-1-carboxamide |
CPG52364 | 1093135-60-4 | C27H36N6O3 | 492.62 | CPG-52364;6,7-Dimethoxy-2-(4-(4-methylpiperazin-1-yl)phenyl)-N-(2-morpholinoethyl)quinazolin-4-amine |
cPEPCK inhibitor | 628279-07-2 | C25H26FN5O3 | 463.5 | N-[4-[1-(2-Fluorobenzyl)-3-butyl-2,6-dixo-2,3,6,7-tetrahydro-1H-purin-8-ylmethyl]phenyl]acetamide |
CPDA | 1415834-63-7 | C20H15ClF2N2O2 | 388.79 | N-[4-[(4-chlorophenyl)methoxy]pyridin-2-yl]-2-(2,6-difluorophenyl)acetamide CPDA CHEMBL2337808 SCHEMBL14156872 AKOS027447209 CS-4991 AK517293 HY-18685 N-[4-(4-Chlorobenzyloxy)-2-pyridyl]-2,6-difluorobenzeneacetamide N-(4-((4-Chlorobenzyl)oxy)pyri |
CPD1563 | 2137975-08-5 | C20H26N6O3 | 398.465 | |
Clorprenaline HCl | 6933-90-0 | C11H16ClNO·HCl | 250.16 | |
Clorprenaline | 3811-25-4 | C11H16ClNO | 213.705 | 1-(2-Chlorophenyl)-2-isopropylaminoethanol |
Clormecaine | 13930-34-2 | C11H15ClN2O2 | 0 | clormecaine; 3-Amino-4-chlorobenzoic acid 2-(dimethylamino)ethyl ester |
Clorindanic Acid | 153-43-5 | C10H9CLO3 | 212.62966;g/mol | ClorindanicAcid; WIN19356; Clorindanicacid[INN:DCF]; 153-43-5; Acideclorindanique[INN-French]; Acidoclorindanico[INN-Spanish] |
Clorgyline hydrochloride | 17780-75-5 | C13H15Cl2NO·HCl | 308.6 | N-2,4-Dichlorophenoxypropyl-N-methylpropargylamine |
Clinofibrate Impurity 1 | 30299-29-7 | C25H32O4 | 396.53 | |
D,L-3-Indolylglycine | 6747-15-5 | C10H10N2O2 | 190.2 | Amino-(1H-indol-3-yl)acetic acid; 2-amino-2-(1H-indol-3-yl)acetic acid; |
D,L-2,6-difluorophenyl-alanine | 32133-39-4 | C9H9F2NO2 | 201.17 | Difluorophenylalanine3; 2,6-Difluoro-DL-phenylalanine 97%; 2,6-Difluoro-DL-phenylalanine97% |
D-(2-Chlorophenyl)glycine | 86169-24-6 | C8H8ClNO2 | 185.61 | D-(-)-(2-CHLOROPHENYL)GLYCINE; D-(+)-(2-CHLOROPHENYL)GLYCINE; D-(2-CHLOROPHENYL)GLYCINE; 2-CHLORO-D-PHENYLGLYCINE; (R)-AMINO-(2-CHLORO-PHENYL)-ACETIC ACID; R-(-)-2-Chlorophenylglycine; (S)-2-Amino-2-(2-chlorophenyl)acetic acid; (R)-(-)-2-Chlorophenylglyci |
D-(+)-Threitol | 2418-52-2 | C4H10O4 | 122.12 | (2R,3R)-1,2,3,4-Butanetetrol |
CYT387 sulfate salt | 1056636-06-6 | C23H26N6O10S2 | 610.62 | momelotinib |
CYT387 Mesylate | 1056636-07-7 | C24H26N6O5S | 510.57 | Momelotinib Mesylate |
Cyt387 | 1056634-68-4 | C23H22N6O2 | 414.46 | Momelotinib; N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide |
Cystofur Dihydrochloride | 72545-66-5 | C10H20Cl2N2OS | 287.25 | |
Cysteine Protease inhibitor | 921625-62-9 | C18H14N4O | 302.33 | 2-Pyrimidinecarbonitrile, 4-[[4'-(aminomethyl)[1,1'-biphenyl]-3-yl]oxy]- |
Cyclophosphamide | 50-18-0 | C7H15Cl2N2O2P | 261.09 | Cytoxan; Clafen; Neosar; CTX; 2-Bis(2-chloroethyl)aminotetrahydro-2H-1,3,2-oxazophosphorine-2-oxide; N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide |
Cyclophilin inhibitor 1 | 1509904-96-4 | C31H39N5O7 | 593.67 | |
Cyclopeptine | 50886-63-0 | C17H16N2O2 | 280.3 | Benzyl-3,4-dihydro-4-methyl-1H-1,4-benzodiazepine-2,5-dione |
Cyclopentyl methyl ether | 5614-37-9 | C6H12O | 100.16 | CYCLOPENTYL METHYL ETHER; METHOXYCYCLOPENTANE; Cyclopentyl methyl ether, ReagentPlus(R), >=99.90%; Cyclopentyl methyl ether, anhydrous, >=99.9%; CYCLOPENTYL METHYL ETHER, WITH STABILIZER; Cyclopentyl methyl ether, 99.9+% |
Cyclopentynafil | 1173706-34-7 | C26H36N6O4S | 528.67 | 5-(5-((4-Cyclopentylpiperazin-1-yl)sulfonyl)-2-ethoxyphenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one |
Cyclopentadienyltri-n-butyltin | 3912-86-5 | C17H32Sn 5* | 355.15 | CYCLOPENTADIENYLTRI-N-BUTYLTIN; tributylcyclopenta-2,4-dienylstannane; cyclopentadienyltributyltin; Tributylcyclopentadienyltin; 1-(Tributylstannyl)-2,4-cyclopentadiene; 2,4-Cyclopentadienyltributylstannane; 5-(Tributylstannyl)-1,3-cyclopentadiene; Tribut |
CYCLOPENTADIENYLTHALLIUM | 34822-90-7 | C5H5Tl 5* | 269.48 | THALLIUM CYCLOPENTADIENIDE; 2,4-cyclopentadien-1-yl-thalliu; 2,4-Cyclopentadien-1-ylthallium; 2-Cyclopentadienyl thallium; Thallium(I) cyclopentadienide; Thallium, 2,4-cyclopentadien-1-yl-; Thallium, pi-cyclopentadienyl-; Thallous cyclopentadienide |
Cyclopentadienylmanganese(I) tricarbonyl | 12079-65-1 | C8H5MnO3 | 204.06 | |
CX-6258 | 1202916-90-2 | C26H24ClN3O3 | 461.946 | (E)-5-chloro-3-((5-(3-(4-methyl-1,4-diazepane-1-carbonyl)phenyl)furan-2-yl)methylene)indolin-2-one; CX6258; CX-6258; CX 6258 |
CX-5461 | 1138549-36-6 | C27H27N7O2S | 513.62 | CX-5461; CX 5461; CX5461. |
CX546 | 215923-54-9 | C14H17NO3 | 247.29 | (2,3-Dihydro-1,4-benzodioxin-6-yl)-1-piperidinylmethanone; 1-[(2,3-Dihydro-1,4-benzodioxin-6-yl)carbonyl]piperidine; BDP 17; GR 87; |
CX-5011 | 1009821-06-0 | C20H12N4O2 | 340.342 | CX-5011; CX5011; CX 5011. |
CX-4945 sodium salt | 1309357-15-0 | C19H11ClN3NaO2 | 371.75 | Silmitasertib sodium salt |
CX08005 | 1256341-22-6 | C28H39N04 | 453.61 | 2-[[[2-(Tetradecyl)phenyl]amino]carbonyl]benzoic acid |
CX 614 | 191744-13-5 | C13H13NO4 | 247.25 | 2,3,6a,7,8,9-Hexahydro-11H-1,4-dioxino[2,3-g]pyrrolo[2,1-b][1,3]benzoxazin-11-one |
CP 99433 | 147059-71-0 | C17H17FN4O3 | 344.34 | |
CP 96345 | 132746-60-2 | C28H32N2O | 412.57 | (2S,3S)-N-(2-Methoxyphenyl)methyl-2-diphenylmethyl-1-azabicyclo[2.2.2]octan-3-amine |
CP 94253 hydrochloride | 845861-39-4 | C15H19N3O.HCl | 293.80 | 5-Propoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-pyrrolo[3,2-b]pyridine hydrochloride |
CP 93129 dihydrochloride | 879089-64-2 | C12H13N3O.2HCl | 288.18 | 1,4-Dihydro-3-(1,2,3,6-tetrahydro-4-pyridinyl)-5H-pyrrol[3,2-b]pyridin-5-one dihydrochloride |
CP 84364 | 114457-62-4 | C14H18N2O4 | 278.31 | 4-Cyclohexyl-2-hydroxy-3-(3-methylsulfanyl-2-(2-((morpholine-4-carbonyl)amino)-3-phenylpropionylamino)propionylamino)butyric acid |
CP 81282 | 121584-61-0 | C32H47F2N5O6 | 635.74 | (S)-N-(4-morpholinylcarbonyl)-L-phenylalanyl-N-(1-(cyclohexylmethyl)-3,3-difluoro-4-(methylamino)-2,4-dioxobutyl)-L-Norleucinamide, |
corticosterone-21-hemisuccinate | 10215-77-7 | C25H34O7 | 446.537 | Corticosterone-21-hemisuccinate; Corticosterone21-hemisuccinate; 10215-77-7; Corticosteronehemisuccinate; AC1L4LJR; UNII-IU50V885SP |
Corticosterone 21-hemisuccinate | 10215-74-4 | C25H34O6 | 430.53 | CORTEXONE 21-HEMISUCCINATE; CORTEXONE HEMISUCCINATE; CORTEXONE HEMISUCCINATE:BSA; DOC HEMISUCCINATE; DOC HEMISUCCINATE BSA; DOC HEMISUCCINATE:BSA; DEOXYCORTICOSTERONE 21-HEMISUCCINATE; DESOXYCORTICOSTERONE HEMISUCCINATE |
Corticosterone | 50-22-6 | C21H30O4 | 346.46 | (8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; |
Lactose Monohydrate | 10039-26-6 | C12H24O12 | 360.31 | MILK SUGAR MONOHYDRATE; MILK SUGAR; BETA-D-GAL-(1->4)-D-GLC MONOHYDRATE; LACTOBIOSE MONOHYDRATE; LACTOSUM MONOHYDRICUM; LACTOSE STANDARD; LACTOSE, MONOHYDRATE; L-CYSTEINE HYDROCHLORIDE |
D(+)GLUCOSE-1,6-DIPHOSPHATE, TETRACYCLOHEXYLAMMONIUM SALT | 20514-06-1 | C30 H66 N4 O12 P2 | 736.81 | D(+)GLUCOSE-1,6-DIPHOSPHATE, TETRACYCLOHEXYLAMMONIUM SALT; Glucopyranose, 1,6-bis(dihydrogen phosphate), compd. with cyclohexylamine (1:4), D- |
D-(+)-Glucose monohydrate | 14431-43-7 | C6H12O6.H2O | 198.17 | ALPHA-D-GLUCOSE, MONOHYDRATE; BLOOD SUGAR; GRAPE SUGAR; GLUCOSE, MONOHYDRATE; (GLUCOSUM) MONOHYDRICUM; D(+)-DEXTROSE MONOHYDRATE; DEXTROSE HYDROUS; DEXTROSUM MONOHYDRICUM |
D-(+)-Epinephrine | 150-05-0 | C9H13NO3 | 183.21 | (S)-4-[1-Hydroxy-2-(methylamino)ethyl]pyrocatechol |
D-(+)-Darunavir | 1399859-60-9 | C27H37N3O7S | 547.66 | |
D(+)-Carnitine | 541-14-0 | C7H15NO3 | 161.2 | (3-carboxy-2-hydroxypropyl)trimethyl-,hydroxide,innersalt,d-ammoniu; d-(3-carboxy-2-hydroxypropyl)trimethylammoniumhydroxide,innersalt; DL-CARNITINE BENZYL ESTER CHLORIDE; D-CARNITINE HYDROCHLORIDE; (+)-BETA-HYDROXY-GAMMA-(TRIMETHYLAMMONIO)BUTYRATE HYDROC |
D(+)-Camphor | 464-49-3 | C10H16O | 152.23 | (1R,4R)-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one; |
D(-)-Tartaric acid | 526-83-0 | C4H6O6 | 150.09 | d-2,3-dihydroxysuccinic acid |
D 13223 (Flupirtine Metabolite) | 95777-69-8 | C14H16ClFN4O | 310.754443 | N-[2-Amino-6-[[(4-fluorophenyl)methyl]amino]-3-pyridinyl]acetamide Hydrochloride; |
D 106669 | 938444-93-0 | C17H18N6O | 322.36 | D-106669; N-ethyl-N'-[3-[(4-methylphenyl)amino]pyrido[2,3-b]pyrazin-6-yl]Urea; 3-ethyl-1-{3-[(4-methylphenyl)amino]pyrido[2,3-b]pyrazin-6-yl}urea |
CZC-8004 | 916603-07-1 | C17H16FN5 | 309.3 | Dianilinopyrimidine-01; CZC-00008004 |
CZC-54252 | 1191911-27-9 | C22H25ClN6O4S | 504.99 | |
CZC-25146 hydrochloride | 1330003-04-7 | C22H26ClFN6O4S | 524.996 | CZC25146 hydrochloride; CZC 25146 hydrochloride |
CZC-25146 | 1191911-26-8 | C22H25FN6O4S | 488.54 | CZC25146; CZC 25146 |
CZC24832 | 1159824-67-5 | C15H17FN6O2S | 364.399 | CZC24832; CZC-24832; CZC 24832 |
CZ415 | 1429639-50-8 | C22H29N5O4S | 459.57 | (S)-1-(4-(7,7-dimethyl-4-(3-methylmorpholino)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-2-yl)phenyl)-3-ethylurea |
CYTOTRIENIN A | 208527-57-5 | C37H48N2O8 | 0 | CYTOTRIENIN A |
Cytidine | 65-46-3 | C9H13N3O5 | 243.22 | MK-0431; MK 0431; MK0431 |
2'-Deoxy-N4,N4,5-trimethylcytidine | 25406-45-5 | C12H19N3O4 | 269.30 | 4-Dimethylaminothymidine |
Cytochalasin D | 22144-77-0 | C30H37NO6 | 507.6 | Zygosporin A |
Cytostatin sodium salt | 457070-06-3 | C21H32O7P·Na | 450.4 | (+)-Cytostatin sodium salt; NSC 675266 sodium salt |
Cytostatin | 682329-63-1 | C21H33O7P | 428.5 | (+)-Cytostatin; NSC 675266 |
Cytosporone B | 321661-62-5 | C18H26O5 | 322.4 | 3,5-dihydroxy-2-(1-oxooctyl)-benzeneacetic acid, ethyl ester; Cytosporone B, Csn-B |
Cytosine-5,6-d2 | 106391-24-6 | 113.114324;g/mol | 4-amino-5,6-dideuterio-1H-pyrimidin-2-one; Cytosine-5,6-d2; SCHEMBL13868068; 106391-24-6 | |
Cytosine-2,4-13C2,15N3 | 285978-06-5 | 116.07 | ||
Cytosine | 71-30-7 | C4H5N3O | 111.1 | 4-AMINO-2(1H)-PYRIMIDINONE; 4-AMINO-2(1)-PYRIMIDONE; 4-AMINO-2-PYRIMIDINOL; 4-AMINO-2-OXO-1,2-DIHYDROPYRIMIDINE; 4-AMINO-2-HYDROXYPYRIMIDINE; 2-Oxy-4-amino pyrimidine; AURORA KA-682; CYTOSINE |
Cytochrome C | 9007-43-6 | C42H54FeN8O6S2 | 886.9 | HUMAN CYTOCHROME C; CYT-C; CYTOCHROME C; CYTOCHROME C, ACID MODIFIED; CYTOCHROME C, BOVINE; CYTOCHROME C (BOVINE HEART); CYTOCHROME C PEPTIDE MAP CONTROL; CYTOCHROME C EQUINE HEART |
Cytochlor | 32387-56-7 | C9H12ClN3O5 | 261.66 | CIdC. Cytochlor; Cytidine 5chloro2deoxy. |
Cytochalasin J | 56144-22-0 | C28H37NO4 | 451.6 | Kodocytochalasin 2, Paspalin P11, Deacetylcytochalasin H, 17-Deoxozygosporin D |
Cytochalasin H | 53760-19-3 | C30H39NO5 | 493.64 | Paspalin; Cytochalasin-H; Paspalin P I; Kodocytochalasin-1; NSC 305222; CYTOCHALASIN H; (11)Cytochalasa-6(12),13,19-trien-1-one,; 21-(acetyloxy)-7,18-dihydroxy-16,18-dimethyl-10-phenyl-, (7S,13E,16S,18S,19E,21R)-; 21-Acetoxy-7,18-dihydroxy-16,18-dimethyl- |
Cytochalasin E | 36011-19-5 | C28H33NO7 | 495.6 | |
Cytochalasin C | 22144-76-9 | C30H37NO6 | 507.6 | |
Cytochalasin B | 14930-96-2 | C29H37NO5 | 479.6 | Phomin |
Cytochalasin A | 14110-64-6 | C29H35NO5 | 477.6 | Dehydrophomin |
Cytisine | 485-35-8 | C11H14N2O | 190.246 | Baptitoxin; Citizin; HSDB 3560; HSDB3560; HSDB-3560; Laburnin; NSC 407282; NSC407282; NSC-407282; Sophorin; Cytisine; Cytisinicline; Baptitoxine; Sophorine; (-)-Cytisine; Laburnin |
Cytidylyl-(5'->3')-guanosine | 4785-04-0 | C19H25N8O12P | 588.421962;g/mol | (2r,3s,4r,5r)-5-(2-amino-6-oxo-3,6-dihydro-9h-purin-9-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl[(2r,3s,4r,5r)-5-(4-amino-2-oxopyrimidin-1(2h)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methylhydrogenphosphate(non-preferredname); AC1L32EG; AC1Q6C2S; G |
Cytidylyl(5'->3')adenosine | 4833-63-0 | C19H25N8O11P | 572.423 g/mol | |
Cytidylyl-(3'-5')-guanosine | 2382-65-2 | C19H25N8O12P | 588.4 | 2382-65-2; CPG; AC1L22LG; Cytidylyl-3'-5'-guanosine; CYTIDYLYL--GUANOSINE; Cytidylyl-(3',5')-guanosine |
Cytidine-5,6-d2 | 40632-25-5 | C9H11N3O5D2 | 245.23 | |
2',3'-Dideoxycytidine-5'-triphosphate lithium salt | 132619-66-0 | C9H16N3O12P3 | 451.16 | Zalcitabine triphosphate lithium salt; ddCTP |
Cytidine-2',3'-cyclic Monophosphate Triethylamine Salt | 23316-51-0 | 305.18 | Cytidine Cyclic 2',3'-(Hydrogen Phosphate) Triethylamine Salt; Cyclic(2',3')-CMP Triethylamine Salt; Cytidine 2',3'-Cyclic Phosphate Triethylamine Salt; Triethylamine Cytidine-2',3'-cyclophosphate | |
CYTIDINE-2',3'-MONOPHOSPHORIC ACID | 27214-06-8 | C18H28N6O16P2 | 646.39 | CYTIDINE-2'(3')-MONOPHOSPHATE; CYTIDINE-2',3'-MONOPHOSPHORIC ACID; CYTIDINE-2' AND 3'-MONOPHOSPHATE; CYTIDINE-3'(+2')-MONOPHOSPHATE; 3'(+2')-CMP; 2'(3')-CMP |
Cytidine 5'-Phosphoromorpholidate N,N'-Dicyclohexyl-4-morpholinecarboximidamide | 76742-18-2 | C30H52N7O9P | 685.75 | Cytidine 5'-(Hydrogen 4-Morpholinylphosphonate) N,N'-Dicyclohexyl-4-morpholinecarboximidamide |
Zalcitabine Monophosphate Sodium Salt | 104086-76-2 | C9H13N3NaO6P | 313.18 | 2',3'-Dideoxycytidine 5'-monophosphate Sodium Salt; 2',3'-Dideoxycytidine monophosphate Sodium Salt |
Cytidine 5'-diphosphate trisodium salt | 34393-59-4 | C9H15N3O11P2.3Na | 469.12 | CDP TRISODIUM SALT; CDP; CDP, NA3; CYTIDINE 5'-DIPHOSPHATE; CYTIDINE-5'-DIPHOSPHATE SODIUM; CYTIDINE-5'-DIPHOSPHORIC ACID |
Cytidine 5'-diphosphate disodium salt | 54394-90-0 | C9H13N3O11P2Na2 | 447.14 | CDP-Na2; Disodium cytidine 5'-diphosphate; 5'-CDP disodium salt; Cytidine 5'-(trihydrogen diphosphate), disodium salt; 5'-CDP Na2 |
Cytidine 5'-triphosphate | 65-47-4 | C9H16N3O14P3 | 483.156 | [(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl(hydroxy-phosphonooxyphosphoryl)hydrogen phosphate |
CYTIDINE 2'',3''-CYCLIC MONOPHOSPHATE, SODIUM SALT DIHYDRATE | 41161-51-7 | C9H15N3NaO9P | 363.193631;g/mol | sodium;4-amino-1-[6-(hydroxymethyl)-2-oxido-2-oxo-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-4-yl]pyrimidin-2-one;dihydrate;41161-51-7;NU007982 |
Cytidine 2',3'-(hydrogen phosphate) | 633-90-9 | C9H12N3O7P | 305.182 | |
Cytidine 2, 2'-cyclic-5'-monophosphate (Cyclo-CMP) | 39679-56-6 | C9H12N3O7P | 305.18 | |
Cysteine,S-2-propen-1-yl- | 49621-03-6 | C6H11 N O2 S | 161.22 | S-ALLYL-L-CYSTEINE; (R)-ALLYLTHIO-2-AMINOPROPIONIC ACID; L-DEOXYALLIIN; (L)-3-(ALLYLSULFENYL)-ALANINE; DEOXYALLIIN; CYSTEINE, S-ALLYL-L-; DL-S-Allylcysteine; REF DUPL: DL-S-Allylcysteine |
Cytarabine hydrochloride | 69-74-9 | C9H14ClN3O5 | 279.68 | Cytosine arabinoside hydrochloride; 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrochloride; |
Cytarabine 5'-Monophosphate | 7075-11-8 | C9H14N3O8P (free acid) | 323.20 (free acid) | Cytarabine monophosphate, Sodium salt |
CYR-101 | 359625-79-9 | C22H23FN2O2 | 366.43 | 2-((1-(2-(4-fluorophenyl)-2-oxoethyl)piperidin-4-yl)methyl)isoindolin-1-one; CYR-101; UNII-4P31I0M3BF; MT-210; MIN101; CYR101; MT210; MIN 101; CYR 101; MT 210 |
Cyproterone Acetate | 427-51-0 | C24H29ClO4 | 416.93766 | Androcur, Cyprostat,Cyproteron, Procur, Cyprone, Cyprohexal, Ciproterona, Cyproteronum, Neoproxil, Siterone. |
Cyproheptadine Impurity 1 | 54191-04-7 | C21H21NO | 303.4 | Cyproheptadine epoxide; Cyproheptadine 10,11-epoxide |
Cyproheptadine hydrochloride hydrate | 6032-06-0 | C21H21N.HCl.H2O | 341.879 | Cyproheptadine Hydrochloride Monohydrate; 4-(5H-Dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine hydrochloride hydrate |
Cyproheptadine hydrochloride | 969-33-5 | C21H22ClN | 323.86 | Periactin hydrochloride;Cyproheptadine Hcl;4-(Dibenzo[1,2-a:1',2'-e][7]annulen-11-ylidene)-1-methylpiperidine hydrochloride |
Cyprodime hydrochloride | 118111-54-9 | C22H30NO3Cl | 391.93 | 17-(Cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one hydrochloride |
Cypridinia, vargula luciferin dihydrobromide | 23510-45-4 | C22H29Br2N7O | 567.32 | Cypridinia, vargula luciferin dihydrobromide; Vargula luciferin dihydrobromide |
CyPPA | 73029-73-9 | C16H23N5 | 285.39 | N-Cyclohexyl-N-[2-(3,5-dimethylpyrazol-1-yl)-6-methylpyrimidin-4-yl]amine; N-Cyclohexyl-2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-methyl-4-pyrimidinamine; Cyclohexyl-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-pyrimidin-4-yl]-amine |
Cyperotundone | 3466-15-7 | C15H22O | 218.33 | Cyperenone; Isopatchoulenone |
Cypellocarpin C | 294856-66-9 | C26H32O11 | 520.531 | Camaldulenside |
Cynarin | 1182-34-9 | C25H24O12 | 1,4-Dicaffeoylquinic acid | |
Cynarin | 30964-13-7 | C25H24O12 | 516.45 | (1R,3R,4S,5R)-1,3-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-4,5-dihydroxycyclohexane-1-carboxylic acid; 1,5-dicaffeoylquinic acid; 1-carboxy-4,5-dihydroxy-1,3-cyclohexylenebis-(3,4-dihydroxycinnamate); cinarin; cinarina; cinarine; Cynarex; cynarin |
Cymelarsan | 89141-50-4 | |||
CYMARIN | 508-77-0 | C30H44O9 | 548.66 | 20(22),5BETA-CARDENOLID-19-AL-3BETA,5BETA,14BETA-TRIOL 3BETA-MIXED GLYCOSIDES; CIMARIN; CYMARIN; CYMARINE; K STROPHANTHIN; K-STROPHANTHIN-A; K-STROPHANTHIN-ALPHA; K-STROPHANTHIDIN-D-CYMAROSIDE |
CYMAL-7 Neopentyl Glycol | 1423310-08-0 | C49H88O22 | 1029.21 | 2,2-Bis(3-cyclohexylpentyl) propane-1,3-bis-b-D-maltopyranoside |
CYMAL-6 Neopentyl Glycol | 1423306-24-4 | C47H84O22 | 1001.16 | 2,2-Bis(3-cyclohexylbutyl) propane-1,3-bis-b-D-maltopyranoside |
CYMAL-5 Neopentyl Glycol | 1257853-03-4 | C45H80O22 | 973.10 | 2,2-bis(3-cyclohexylpropyl) propane-1,3-bis-b-D-maltopyranoside |
CYM-5541 | 945128-26-7 | C19H28N2O2 | 316.44 | N,N-dicyclohexyl-5-cyclopropyl-1,2-oxazole-3-carboxamide; CYM-5541; N,N-dicyclohexyl(5-cyclopropylisoxazol-3-yl)carboxamide |
CYM 9484 | 1383478-94-1 | C27H31N3O3S2 | 509.63 | N-[4-[(Dimethylamino)sulfonyl]phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinecarbothioamide |
CYM 5520 | 1449747-00-5 | C21H19N3O2 | 345.4 | 1-[2-[2,5-Dimethyl-1-(phenylmethyl)-1H-pyrrol-3-yl]-2-oxoethyl]-1,6-dihydro-6-oxo-3-pyridinecarbonitrile |
CYM 5442 hydrochloride | 1094042-01-9 | C23H27N3O4.HCl | 445.94 | 2-(4-(5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl amino) ethanol hydrochloride |
CYM 5442 hydrochloride | 1783987-80-3 | C23H27N3O4·HCl | 445.94 | 2-(4-(5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl amino) ethanol hydrochloride |
CYM 50769 | 1421365-63-0 | C24H17ClN2O3 | 416.86 | 5-Chloro-2-(9H-fluoren-9-yl)-4-(4-methoxyphenoxy)-3(2H)-pyridazinone |
CYM 50358 hydrochloride | 1781750-72-8 | C20H18Cl2N2O2·HCl | 425.74 | N-[(4-(Aminomethyl)-2,6-dimethylphenyl]-5-(2,5-dichlorophenyl)-2-furancarboxamide hydrochloride |
Cyanomethyl 2,3,4,6-tetra-O-acetyl-b-D-thiogalactopyranoside | 61145-33-3 | C16H21NO9S | 403.41 | |
CYM 50308 | 1345858-76-5 | C20H21F2N3O2S | 405.46 | (2Z,5Z)-5-[[1-(2,4-Difluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]methylene]-2-[(2-methoxyethyl)imino]-3-methyl-4-thiazolidinone |
Cyclotraxin B | 1203586-72-4 | C48H73N13O17S3 | 1200.36 | L-Cysteinyl-L-asparaginyl-L-prolyl-L-methionylglycyl-L-tyrosyl-L-threonyl-L-lysyl-L-a-glutamylglycyl-L-cysteine, cyclic (1>11)-disulfide |
Cyclothiazide | 2259-96-3 | C14H16ClN3O4S2 | 389.87 | 6-Chloro-3,4-dihydro-3-(5-norbornen-2-yl)-2H-1,2,4-benzothiazidiazine-7-sulfonamide-1,1-dioxide |
CYCLOTETRAMETHYLENEDICHLOROSILANE | 2406-33-9 | C4H8Cl2Si | 155.1 | 1,1-DICHLOROSILACYCLOPENTANE; CYCLOTETRAMETHYLENEDICHLOROSILANE; Cyclotetramethylenedichlorosilane(1,1-Dichlorosilacyclopentane); 1,1-Dichloro-1-silacyclopentane; 1,1-dichloro-silacyclopentan; 1,1-Dichlorosilolane |
CYCLOTETRADECANE | 295-17-0 | C14H28 | 196.37 | CYCLOTETRADECANE |
Cyclosporin U | 108027-45-8 | C61H109N11O12 | 1188.58 | Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-L-leucyl) |
Cyclosporin | 79217-60-0 | C62H111N11O12 | 1202.61 | Restasis; Cyclosporine; Gengraf; Sandimmune; SangCyA; Atopica |
Cyclosporin H | 83602-39-5 | C62H111N11O12 | 1202.6 | 5-(N-methyl-D-valine)cyclosporine A |
Cyclosporin D | 63775-96-2 | C63H113N11O12 | 1216.64 | Val2-cyclosporine |
Cyclosporin C | 59787-61-0 | C62H111N11O13 | 1218.6 | 7-L-Threoninecyclosporin A, WF 3484 |
Cyclosporin B | 63775-95-1 | C61H109N11O12 | 1188.6 | 7-L-Alaninecyclosporine A |
Cyclosporin A | 59865-13-3 | C62H111N11O12 | 1202.61 | Ciclosporin; cyclosporine; Cyclosporine A; Sandimmun; Cyclosporin; Neoral; Ciclosporine; Sandimmune; Ramihyphin A |
Cyclosomatostatin | 84211-54-1 | C44H57N7O6 | 779.98 | Cyclo(7-aminoheptanonyl-Phe-D-Trp-Lys-Thr[Bzl]); Cyclo[7-aminoheptanoyl-L-phenylalanyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-threonyl] |
Cycloshizukaol A | 150033-85-5 | C32H36O8 | 548.62 | Dimethyl (2R,5S,7R,8S,12R,15S,17R,18S,19R,24R)-19,24-dihydroxy-2,8,12,18-tetramethyl-20,23-dioxoheptacyclo[12.6.2.2.0.0.0.0]tetracosa-1(21),4(9),10,14(22)-tetraene-2,12-d icarboxylate |
Cycloserine Impurity 5 | 15996-22-2 | C6H6N2O2 | 138.12 | 3,6-Methylene-2,5-piperazinedione; 3,6-Bis(methylene)-2,5-piperazinedione; 2,5-Dimethylene-3,6-diketopiperazine; 3,6-Dimethylene-2,5-piperazinedione; NSC 278175 |
Cycloserine Diketopiperazine | 1204-99-5 | C6H12N4O4 | 204.18 | 3,6-Bis[(aminooxy)methyl]-2,5-piperazinedione; 2,5-Bis(aminohydroxymethyl)-2,6- diketopiperazine; 2,5-Bis(aminooxymethyl)-3,6-dioxopiperazine; Cycloserine Diketopiperazine; NSC 119130 |
Cyclopropylmethylhydrazine | 40487-93-2 | C4H10N2 | 86.14 | cyclopropylmethylhydrazine;CYCLOPROPYLMETHYL-HYDRAZINE;40487-93-2;Cyclopropylmethylhydrazine;(Cyclopropylmethyl)hydrazine;CTK3J2180 |
Cyclopropyl-acetaldehyde | 72072-03-8 | C5H8O | 252.10600 | |
Cyclopropyl-(tetrahydro-pyran-4-yl)-amine | 211814-16-3 | C8H15NO | 141.21 | Cyclopropyl-(tetrahydro-pyran-4-yl)-amine; N-Cyclopropyl-N-tetrahydro-2H-pyran-4-ylamine |
Cyclopropyl(3-nitrophenyl)-methanone | 5680-51-3 | C10H9NO3 | 191.1834 | CYCLOPROPYL-(3-NITRO-PHENYL)-METHANONE |
Cyclopropanesulfonylchloride, 2-(1-methylethyl)- | 927636-25-7 | C6H11 Cl O2 S | 182.66834 | 2-ISOPROPYL-CYCLOPROPANESULFONYL CHLORIDE |
Cyclopropanemethanol,1-hydroxy- | 42082-92-8 | C4H8 O2 | 88.10512;g/mol | Cyclopropanemethanol,1-hydroxy-; 1-(hydroxymethyl)cyclopropan-1-ol; 42082-92-8; hydroxymethylcyclopropanol; CTK4I5686; MolPort-019-997-149 |
Cyclopropanemethanol, a-cyclopropyl- | 14300-33-5 | C7H12 O | 112.17 | Cyclopropanemethanol, alpha-cyclopropyl-; DCPM-OH; DICYCLOPROPYL CARBINOL; DICYCLOPROPYLMETHANOL; Biscyclopropylmethanol; Dicyclopropylmethyl alcohol; Einecs 238-236-3 |
Cyclopropanecarboxylicacid, 3-[(1E)-3-methoxy-2-methyl-3-oxo-1-propen-1-yl]-2,2-dimethyl-,(1S)-2-methyl-4-oxo-3-(2Z)-2,4-pentadien-1-yl-2-cyclopenten-1-yl ester,(1R,3R)- | 121-29-9 | C22H28 O5 | 372.50 | (+)-pyrethronyl(+)-pyrethrate; 2-methyl-4-oxo-3-(2,4-pentadienyl)-2-cyclopenten-1-yl3-(3-methoxy-2-methyl-3-o; 2-methyl-4-oxo-3-(2,4-pentadienyl)-2-cyclopenten-1-ylester; 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl3-(2-methoxycarbonylprop-1-enyl)- |
Cyclopropanecarboxylicacid, 2,2-dimethyl-3-(2-methyl-1-propen-1-yl)-,(1S)-2-methyl-4-oxo-3-(2Z)-2,4-pentadien-1-yl-2-cyclopenten-1-yl ester,(1R,3R)- | 121-21-1 | C21H28 O3 | 328.49 | PYRETHRIN 1; (+)-pyrethronyl(+)-trans-chrysanthemate; 2,2-dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylicacid2-methyl-4-oxo; 2,2-dimethyl-3-(2-methylpropenyl)-cyclopropaneacrylicaciesterwith4-hydr; 2,2-dimethyl-3-(2-methylpropenyl)-cyclopropanecarb |
Cyclopropanecarboxylic acid, 2-methylene- | 62266-36-8 | C5H6 O2 | 98.09990 | |
Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, (1R,2S)- | 159700-58-0 | C6H9NO2 | 127.14116 | Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, (1R,2S)- (9CI); 1-AMINO-2-ETHENYL-,(1R,2S)-CYCLOPROPANECARBOXYLICACID; Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, (1R,2S)- |
Cyclopropanecarbothioamide | 20295-34-5 | C4H7NS | 0 | CYCLOPROPANECARBOTHIOAMIDE |
Cyclopropanecarbonyl chloride, 1-(acetyloxy)- (9CI) | 253434-23-0 | C6H7ClO3 | 162.57098 | (1-carbonochloridoylcyclopropyl)acetate; 253434-23-0; CYCLOPROPANECARBONYLCHLORIDE,1-(ACETYLOXY)-(9CI); SCHEMBL984906; CTK1A1491; VHLBPPIUDAUUFY-UHFFFAOYSA-N |
Cyclopropaneaceticacid, a-amino- | 15785-26-9 | C5H9 N O2 | 115.13 | AMINO-CYCLOPROPYL-ACETIC ACID; (S)-Cyclopropylglycine |
Cyclopropaneaceticacid, 2-methylene- | 1073-00-3 | C6H8 O2 | ||
Cyclopropanamine,2-(3,4-difluorophenyl)-(1R,2S)-(2R,3R)-2,3-dihydroxybutanedioate | 220352-39-6 | C13H15F2NO6 | 319.258106;g/mol | (1R,2S)-2-(3,4-difluorophenyl)cyclopropan-1-amine; (2R,3R)-2,3-dihydroxybutanedioicacid; 220352-39-6; (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine(2R,3R)-2,3-Dihydroxysuccinate; Cyclopropanamine,2-(3,4-difluorophenyl)-(1R,2S)-(2R,3R)-2,3-dihydroxybutane |
Cyclopropanamine, 1-(3-iodophenyl)-, hydrochloride (1:1)Cyclopropanamine, 1-(3-iodophenyl)-, hydrochloride (1:1) | 597561-47-2 | C9H10IN.ClH | 295.546 | Cyclopropanamine, 1-(3-iodophenyl)-, hydrochloride (1:1)Cyclopropanamine, 1-(3-iodophenyl)-, hydrochloride (1:1); Cyclopropanamine, 1-(3-iodophenyl)-, hydrochloride (1:1) |
Cycloposine | 23185-94-6 | C33H51NO7 | 573.78 | |
Cyclopentylalbendazole sulfoxide | 131454-43-8 | C14H17N3O3S | 307.37 | (5-Cyclopentanesulfinyl-1H-benzoimidazol-2-yl)-ester carbamic acid methyl |
Cyclopentylalbendazole sulfone | 1448346-31-3 | C14H17N3O4S | 323.37 | (5-Cyclopentanesulfonyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester |
Cyclopentylalbendazole | 77723-30-9 | C14H17N3O2S | 291.37 | (5-Cyclopentanesulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester |
CYCLOPENTYL-(TETRAHYDRO-PYRAN-4-YL)-AMINE | 859521-03-2 | C10H19NO | 169.26 | CYCLOPENTYL-(TETRAHYDRO-PYRAN-4-YL)-AMINE |
Cyclopentyl Acetaldehyde | 5623-81-4 | C7H12O | 112.16958 | Cyclopentyl Acetaldehyde; 2-CYCLOPENTYLACETALDEHYDE |
CYCLOPENTYL 3-METHOXYPHENYL KETONE | 339549-67-6 | C13H16O2 | 204.26 | CYCLOPENTYL 3-METHOXYPHENYL KETONE |
Cyclopentene, 3-chloro- | 96-40-2 | C5H7Cl | 102.563 | |
Cyclopentasilane | 289-22-5 | H10Si5 | 150.5069 | Pentasilacyclopentane; |
Cyclopentanone,2,5-dimethyl- | 4041-09-2 | C7H12 O | 112.16958 | 2,5-dimethylcyclopentan-1-one;2,5-Dimethylcyclopentanone;4041-09-2;Cyclopentanone,2,5-dimethyl-;2,5-Dimethylcyclopentan-1-one;Cyclopentanone,2,5-dimethyl- |
CYCLOPENTANONE ETHYLENE KETAL | 176-32-9 | C7H12O2 | 128.17 | 1,4-DIOXASPIRO[4.4]NONANE; CYCLOPENTANONE ETHYLENE KETAL; CYCLOPENTANONE ETHYLENE KETAL 97% |
Cyclopentanol,2-amino-,(1R,2S)-rel-(9CI) | 57070-95-8 | C5H11NO | 101.148 | (1S,2R)-2-aminocyclopentan-1-ol;cis-2-Amino-cyclopentanol;(1S,2R)-2-Aminocyclopentanol;57070-95-8;CYCLOPENTANOL,2-AMINO-,(1R,2S)-REL-(9CI);135969-63-0 |
Cyclopentanol,1,2-dimethyl-3-(1-methylethenyl)- | 72402-00-7 | C10H18 O | 154.25 | 1,2-dimethyl-3-(1-methylethenyl)-cyclopentano; 1,2-dimethyl-3-(1-methylethenyl)-Cyclopentanol; 3-isopropenyl-1,2-dimethylcyclopentan-1-ol; Cyclopentanol, 1,2-dimethyl-3-(1-methylethenyl)-; Einecs 276-639-6 |
Cyclopentanol,(1,3-butadiyne-1,4-diyl)bis- (9CI) | 104766-62-3 | C14H18 O2 | 218.29 | LABOTEST-BB LT00454129; 1,4-BIS(1-HYDROXYCYCLOPENTYL)-1,3-BUTADIYNE; 1,4-BIS(1-HYDROXYCYCLOPENTYL)BUTADIYNE |
cyclopentanesulfonyl chloride | 14395-53-0 | C5H9ClO2S | 168.64 | 2-BROMO-4-METHYL-BENZOTHIOL; 2-Bromo-4-methylbenzyl thiol; 2-Bromo-4-methylbenzenethiol |
Cyclopentanecarboxylicacid, 3-hydroxy-, (1S-cis)- (9CI) | 107983-78-8 | C6H10 O3 | 130.14 | (1S,3S)-3-HYDROXY-CYCLOPENTANECARBOXYLIC ACID; CYCLOPENTANECARBOXYLIC ACID, 3-HYDROXY-, (1S-CIS)-; Cyclopentanecarboxylic acid, 3-hydroxy-, (1S-cis)- (9CI) |
Cyclopentanecarboxylicacid, 2-methyl- | 5454-78-4 | C7H12 O2 | 128.16898;g/mol | 2-methylcyclopentanecarboxylicacid;5454-78-4;Cyclopentanecarboxylicacid,2-methyl-;2-methylcyclopentane-1-carboxylicacid;F9995-1055;NSC23233 |
Cyclopentanecarboxylic acid, 2,2-dimethyl- | 63861-26-7 | C8H14 O2 | 142.19600 | |
Cyclopentanebutanoicacid, b-oxo-, ethyl ester | 68104-99-4 | C11H18 O3 | 198.26 | 4-CYCLOPENTYL-3-OXO-BUTYRIC ACID ETHYL ESTER; ETHYL 4-CYCLOPENTYL-3-OXOBUTANOATE |
Cyclopentaneacetonitrile | 5732-87-6 | C7H11N | 109.16894 | |
Cyclopentaneaceticacid, 3-oxo-2-(2Z)-2-penten-1-yl-, methyl ester, (1R,2R)- | 1211-29-6 | C13H20 O3 | 224.3 | methyl [1R-[1alpha,2beta(Z)]]-3-oxo-2-(pent-2-enyl)cyclopentaneacetate; TRANS-3-OCTEN-2-ONE 98+%; (-)-JASMONIC ACID METHYL ESTER 98% (HPLC); (±)-JASMONIC ACID METHYL ESTER 95% (HPLC); methyljasmonate,(E)-methyljasmonate; Cyclopentaneacetic acid, 3-oxo-2- |
Cyclopentanamine,2-phenyl- | 15301-54-9 | C11H15 N | 0 | Cypenamine; 2-Phenylcyclopentanamine; 2-Phenylcyclopentanamin; 2-Phenylcyclopentylamine; Cipenamina; Cypenamine [inn:ban] |
CYCLOPENTAMETHYLENEDIMETHYLSILANE | 4040-74-8 | C7H16Si | 128.29 | 1,1-Dimethyl-1-silacyclohexane; 1,1-dimethyl-silacyclohexan; 1,1-Dimethylsilacyclohexane; 1,1-dimethyl-Silacyclohexane; 1,1-Dimethylsilinane; Dimethylsilacyclohexane |
Cyclopentadienylindium (I) | 34822-89-4 | C10H10In | 179.91 | CYCLOPENTADIENYLINDIUM (I); Cyclopentadienylindium(I)elec.grade(99.9-in)spectro; Cyclopentadienylindium(I),elec.gr.(99.999+%-In)PURATREM; Indium,(eta5-2,4-cyclopentadien-1-yl)- |
Cyclopentadienylallyl palladium | 1271-03-0 | C8H9Pd- | 211.57706;g/mol | CTK4B5484; Palladium,(h5-2,4-cyclopentadien-1-yl)(h3-2-propen-1-yl)-; 1271-03-0 |
Cyclopentadiene-quinone (2:1)adduct | 5439-22-5 | C16H16O2 | 240.3 | CYCLOPENTADIENE-QUINONE (2:1)ADDUCT; 1,4,4A,5,8,8A,9A,10A-OCTAHYDRO-1,4,5,8-DIMETHANO-9,10-ANTHRAQUINONE; 1,4,4ALPHA,5,8,8ALPHA,9ALPHA,10ALPHA-OCTAHYDRO-1,4,5,8-DIMETHANO-9,10-ANTHRAQUINONE; 1,4:5,8-Dimethanoanthracene-9,10-dione, 1,4,4A,5,8,8A,9A,10A-oct |
Cyclopenta[cd]pyrene | 27208-37-3 | C18H10 | 226.28 | CYCLOPENTA(C,D)PYRENE; Acepyrene; Acepyrylene; Cyclopenteno(c,d)pyrene |
Cyclopenin | 19553-26-5 | C17H14N2O3 | 294.3 | |
Cyclopenin | 20007-87-8 | C17H14N2O3 | 294.3 | NSC 114538; NSC 604989; rel-(-)-4-methyl-3'S-phenyl-spiro[3H-1,4-benzodiazepine-3,2'R-oxirane]-2,5(1H,4H)-dione |
Cyclopamine | 4449-51-8 | C27H41NO2 | 411.62 | HSDB-3505; HSDB 3505; HSDB-3505; Cyclopamine; 11-Deoxojervine. |
cyclooctanecarbaldehyde | 6688-11-5 | C9H16O | 140.22 | CYCLOOCTANECARBALDEHYDE; CYCLOOCTANECARBOXALDEHYDE; RARECHEM AK ML 0064; Formylcyclooctane.; Cyclooctane-1-carbaldehyde; Ai3-39192; Einecs 229-732-0 |
Cyclomaltoheptaose hydrate | 68168-23-0 | C42H70O35 xH2O | 1134.98 (anydrous basis) | b-Cyclodextrin hydrate |
Cyclo-L-Ala-L-Glu(OH) | 16364-36-6 | C8H12N2O4 | 200.2 | |
CYCLOL ACRYLATE | 95-39-6 | C11H14O2 | 178.23 | 2,5-endomethylene-delta(3)-tetrahydrobenzylacrylate; 2,5-endo-methylene-delta(sup3)-tetrahydrobenzylacrylate; 2-propenoicacid,bicyclo(2,2,1)hept-5-en-2-ylmethylester; 2-propenoicacid,bicyclo(2.2.1)hept-5-3n-2-ylmethylester.; 2-propenoicacid,bicyclo(2.2.1) |
Cyclohexylsuccinic acid | 1489-63-0 | 200.23 | ||
Cyclohexylpropanoyl-N-Hydroxyethylglucamide | 864434-14-0 | C17H33NO7 | 363.45 | C-HEGA-9 |
Cyclohexylpentanoyl-N-Hydroxyethylglucamide | 864434-16-2 | C19H37NO7 | 391.50 | C-HEGA-11 |
Cyclohexylmethylhydrazine hydrochloride | 3637-58-9 | C7H17ClN2 | 164.68 | N'-CYCLOHEXYLMETHYL-HYDRAZINIUM, CHLORIDE; CYCLOHEXANEMETHYLHYDRAZINE HYDROCHLORIDE; CYCLOHEXYLMETHYL-HYDRAZINE HYDROCHLORIDE |
Cyclohexylmethyl-4-O-(a-D-glucopyranosyl)-b-D-glucopyranoside | 260804-64-6 | C19H34O11 | 438.47 | Cyclohexylmethyl-b-D-maltoside |
Cyclohexylethanoyl-N-Hydroxyethylglucamide | 603111-75-7 | C16H31NO7 | 349.42 | |
Cyclohexyldiethanolamine | 4500-29-2 | C10H21NO2 | 187.28 | 2,2'-(cyclohexylimino)bis-ethano; 2,2'-(cyclohexylimino)bis-Ethanol; 2,2'-cyclohexyliminodi-ethano; 2,2'-cyclohexyliminodiethanol; abbomeene-2; abbomeene-2aerosol |
Cyclohexyl-d11-amine | 1219805-96-5 | |||
Cyclohexylbutanoyl-N-hydroxyethylglucamide | 864434-15-1 | C18H35NO7 | 377.47 | C-HEGA-10 |
Cyclohexylboronic acid | 4441-56-9 | C6H13BO2 | 127.97 | |
Cyclohexylamine benzoate | 3129-92-8 | C13H13NO2 | 215.25 | CYCLOHEXYLAMINE BENZOATE; benzoicacid,compd.withcyclohexanamine(1:1); benzoicacid,compd.withcyclohexylamine(1:1); cyclohexylammoniumbenzoate; Cyclohexyl-ammoniumbenzoate; n-cyclohexylammoniumbenzoate; benzoic acid, compound with cyclohexylamine (1:1) |
Cyclohexyl Vinyl Ether | 2182-55-0 | C8H14O | 126.2 | (Vinyloxy)cyclohexane; Cyclohexane, (ethenyloxy)-; VINYLCYCLOHEXYL ETHER; CYCLOHEXYL VINYL ETHER; cyclohexylvinylether95+%; (ETHENYLOXY)CYCLOHEXANE |
Cyclohexyl palmitate | 1673-08-1 | C22H42O2 | 338.56768;g/mol | Cyclohexylpalmitate; cyclohexylhexadecanoate; CHEMBL139056; Hexadecanoicacidcyclohexylester; 1673-08-1; Cyclohexylpalmitate# |
CYCLOHEXYL METHYLPHOSPHONIC ACID | 1932-60-1 | C7H15O3P | 178.17 | GF ACID; CYCLOHEXYL METHYLPHOSPHONIC ACID; Cmpa; Phosphonic acid, methyl-, monocyclohexyl ester |
Cyclohexene, 1,4(or 3,6)-dimethyl-(9CI) | 70688-47-0 | C8 H16 | 110.2 | 1,4-DIMETHYLCYCLOHEXENE; 1,4-Dimethyl-1-cyclohexene |
Cyclohexanone,4-[[(1,1-dimethylethyl)diphenylsilyl]oxy]- | 130745-59-4 | C22H28 O2 Si | 352.54202;g/mol | 130745-59-4; Cyclohexanone,4-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-; 4-(TERT-BUTYLDIPHENYLSILYLOXY)CYCLOHEXANONE; ACMC-20mtsa; SCHEMBL1444038; CTK4B6903 |
Cyclohexanone Monooxygenase from Acinetobacter sp. | 52037-90-8 | |||
Cyclohexanol-1-13C | 38134-57-5 | C6H12O | 101.15 | Cyclohexyl alcohol-1-13C |
Cyclohexanol, 4,4-(1-methylethylidene)bis-, polymer with (chloromethyl)oxirane | 30583-72-3 | |||
Cyclohexanol, 2-amino-1-methyl-, (1R,2S)-rel- | 464169-29-7 | C7H15NO | 129.202 | Cyclohexanol,2-amino-1-methyl-,(1R,2S)-rel-(9CI) |
Cyclohexanol | 108-93-0 | C6H12O | 100.16 | 1-Cyclohexanol; Adronal; Adronol; Anol; Cicloesanolo; Cyclohexane, hydroxy-; Cykloheksanol; cykloheksanol(polish) |
Cyclohexanepropionic acid methyl ester | 20681-51-0 | C10H18O2 | 170.25 | CYCLOHEXANEPROPIONIC ACID METHYL ESTER; methyl cyclohexanepropionate; 3-Cyclohexylpropionic acid methyl ester; Cyclohexanepropanoic acid methyl ester; Ai3-14189; Einecs 243-966-0 |
Cyclohexaneethanol,1-(4-methylbenzenesulfonate) | 21336-37-8 | C15H22 O3 S | 282.4 | 2-CYCLOHEXYL-ETHYL TOLUENE-4-SULFONATE; TOLUENE-4-SULFONIC ACID 2-CYCLOHEXYL-ETHYL ESTER |
Cyclohexaneethanamine | 4442-85-7 | C8H17N | 127.23 | Cyclohexaneethanamine; 2-Cyclohexylethanamine; 2-Cyclohexylethylamine |
Cyclohexanedicarboxylicanhydride; 98% | 71749-03-6 | C8H10 O3 | 154.16 | (+)-TRANS-1,2-CYCLOHEXANEDICARBOXYLIC ANHYDRIDE; Cyclohexanedicarboxylicanhydride |
Cyclohexanecarboxylicacid, 1,3-bis[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-4,5-dihydroxy- | 1884-24-8 | C25H24 O12 | 516.45086;g/mol | Cynarine; Cynarin; 1884-24-8; Cynarine[INN]; Cyclohexanecarboxylicacid,1,3-bis[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-4,5-dihydroxy-; Cinarina |
Cyclohexanecarboxylic acid, 4-hydroxy-3-oxo- (9CI) | 606489-88-7 | C7H10O4 | 158.1519 | Cyclohexanecarboxylic acid, 4-hydroxy-3-oxo- (9CI) |
Cyclohexanecarboxylic acid, 4-heptyl-, trans- | 38289-31-5 | C14H26 O2 | 226.35504;g/mol | 4-heptylcyclohexanecarboxylicacid; 4-n-Heptylcyclohexanecarboxylicacid; 4-heptylcyclohexane-1-carboxylicacid; Cyclohexanecarboxylicacid,4-heptyl-; TRANS-4-HEPTYLCYCLOHEXANECARBOXYLICACID; 65355-31-9 |
Cyclohexanecarboxylic acid, 3-[[(2E)-3-[4-(D-glucopyranosyloxy)-3-hydroxyphenyl]-1-oxo-2-propen-1-yl]oxy]-1,4,5-trihydroxy-, (1S,3R,4R,5R)- | 1629852-63-6 | C22H28O14 | 516.45 | |
Cyclohexanebutanamine | 4441-59-2 | C10H21N | 155.28 | 4-CYCLOHEXYL-BUTYLAMINE; 4-Cyclohexyl-1-butylamine |
Cyclohexaneacetic acid,4-amino- | 1197-54-2 | C8H15 N O2 | 157.2102;g/mol | 2-(4-aminocyclohexyl)aceticacid; 2-(4-aminocyclohexyl)aceticAcid; 1197-54-2; Cyclohexaneaceticacid,4-amino-; 2-(trans-4-Aminocyclohexyl)aceticacid; 2952-00-3 |
cyclohexane-1,4-diamine | 3114-70-3 | C6H14N2 | 114.19 | 1,4-cyclohexylenediamine; hexahydro-1,4-phenylenediamine; 1,4-DIAMINOCYCLOHEXANE; 1,4-CYCLOHEXANEDIAMINE; 1,4-DIAMINECYCLOHEXANE; cyclohexane-1,4-diamine |
cyclohexane-1,3-diol | 823-18-7 | C6H12O2 | 116.16 | |
Cyclohexane-1,2-dicarboxylic acid mono-tert-butyl ester | 886365-95-3 | C12H20O4 | 228.28 | |
Cyclohexanamine,2-methyl-, (1R,2R)-rel- | 931-10-2 | C7H15 N | 113.2007 | TRANS-2-METHYLCYCLOHEXYLAMINE |
Cyclohexadecanone | 2550-52-9 | C16H30O | 238.41 | Homoexaltone |
Cyclohex-1-ene-1-methylamine | 32917-19-4 | C7H13N | 111.18482;g/mol | Cyclohex-1-en-1-ylmethanamine; 32917-19-4; Cyclohex-1-ene-1-methylamine; 1-(cyclohex-1-en-1-yl)methanamine; EINECS251-293-9; 1-Cyclohexenylmethylamine |
Cycloheterophyllin | 36545-53-6 | C30H30O7 | 502.56 | (+)-2,3,8-Trihydroxy-11,11-dimethyl-13-(3-methyl-2-butenyl)-6-(2-methyl-1-propenyl)-6H,7H,11H-bis[1]benzopyrano[4,3-b:6',7'-e]pyran-7-one |
Cycloheptanol, 1-(aminomethyl)- | 45732-95-4 | |||
Cycloheptanemethylamine | 4448-77-5 | C8H17N | 127.23 | RARECHEM AL BW 2143; CYCLOHEPTYLMETHYL AMINE; CYCLOHEPTANEMETHYLAMINE; AMINOMETHYLCYCLOHEPTANE; Cycloheptanemethanamine-; (Aminomethyl)cycloheptane~Cycloheptylmethylamine |
CYCLOHEPTANECARBALDEHYDE | 4277-29-6 | C8H14O | 126.2 | CYCLOHEPTANECARBALDEHYDE; CYCLOHEPTANECARBOXALDEHYDE; RARECHEM AK ML 0066; formylcycloheptane |
Cycloguanil Nitrate | 25332-44-9 | C11H15ClN6O3 | 314.73 | |
Cyanoisoxazole | 68776-57-8 | C4H2N2O | 94.07 | ISOXAZOLE-3-CARBONITRILE; 3-Isoxazolecarbonitrile(6CI,7CI,9CI); Cyano-isoxazole |
Cyanohydroxy butene | 6071-81-4 | C5H7NO | 97.12 | |
CYANOFENPHOS | 13067-93-1 | C15H14NO2PS | 303.32 | b-10094; cp19699; ent25,832; ent25,832-a; experimentalinsecticides-4087; monsantocp-19699 |
Curzerene | 17910-09-7 | C15H20O | 216.32 | Isofuranogermacrene; Isogermafuren; Neocurzerene |
Curvulin | 19054-27-4 | C12H14O5 | 238.2 | 2-acetyl-3,5-dihydroxy-benzeneacetic acid ethyl ester |
Curvularin | 10140-70-2 | C16H20O5 | 292.3 | S-Curvularin, NSC 166071 |
Curlignan | 220736-54-9 | C19H20O7 | 360.4 | |
Curdlan | 54724-00-4 | b-1,3-Glucan hydrate | ||
Curcurbitacin IIa | 58546-34-2 | C32H50O8 | 562.73 | Cucurbitacin IIa; 23,24-Dihydrocucurbitacin F-25-O-acetate; 25-Acetoxy-23,24-dihydrocucurbitacin F; 25-O-Acetyl-23,24-dihydrocucurbitacin F; Dihydrocucurbitacin F 25-O-acetate; Dihydrocucurbitacin Q1 |
CRF (human, rat) | 86784-80-7 | C208H344N60O63S2 | 4758.00 | |
CRF (6-33) | 120066-38-8 | C141H231N41O43S | 3220.68 | |
Cresyl glycidyl ether (mixed isomers) | 26447-14-3 | C10H12O2 | 164.20 | ((methylphenoxy)methyl)-oxiran; [(methylphenoxy)methyl]-oxiran; 1,2-epoxy-3-(tolyloxy)-propan; 2,3-epoxypropyltolylether; cresolglycidalether; cresolglycidylether |
CP-744809 | 463976-07-0 | C13H9ClN2O4S | 324.74 | 6-((5-chloro-3-methyl-2-benzofuranyl)sulfonyl)-3(2H)-Pyridazinone |
CP-724714 | 383432-38-0 | C27H27N5O3 | 469.545 | CP-724714 |
CP-724714 | 537705-08-1 | C27H27N5O3 | 469.53 | |
CP-71362 | 112227-15-3 | C51H76N8O9 | 945.20 | CP71362;L-Phenylalanine, N-(N2-(6-cyclohexyl-5-((N-(N-((1,1-dimethylethoxy)carbonyl)-L-phenylalanyl)-L-histidyl)amino)-4-hydroxy-2-(2-methylpropyl)-1-oxohexyl)-L-lysyl)-, (2R-(2R*,4S*,5S*))- |
CP-69799 | 105116-61-8 | C49H73N9O9 | 932.17 | 2-[[6-Amino-2-[[[4-cyclohexyl-2-hydroxy-3-[[3-(4H-imidazol-4-yl)-2-[[2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]amino]propanoyl]amino]butyl]-propan-2-ylcarbamoyl]amino]hexanoyl]amino]-3-phenylpropanoic acid;CP69799;L-Phenylalanine, N-(N2- |
CP-690550A | 1243290-37-0 | C15H21N5O2 | 303.37 | UNII-Q7ZOK859UK; Tofacitinib metabolite M2; Q7ZOK859UK; CHEMBL1630791; 2-hydroxy-1-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]ethanone |
Corchoionol C | 189351-15-3 | C13H20O3 | 224.3 | (4S)-4-Hydroxy-4-[(1E,3S)-3-hydroxy-1-buten-1-yl]-3,5,5-trimethyl -2-cyclohexen-1-one |
COR 170 | 1048039-15-1 | C31H36N2O2 | 468.63 | N-(Adamant-1-yl)-4-oxo-1-pentyl-6-phenyl-1,4-dihydroquinoline-3-carboxamide |
Coptisine Sulfate | 1198398-71-8 | C19H14NO4.H2SO4 | 369.31 | 6,7-Dihydro-bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizinium sulfate; Bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinoliziniuM,6,7-dihydro-,sulfate(1:1) |
Coptisine chloride | 6020-18-4 | C19H14NO4Cl | 355.77 | 6,7-Dihydrobis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizinium Chloride; 7,8,13,13a-Tetradehydro-2,3:9,10-bis(methylenedioxy)berbinium Chloride; |
Colelomycerone A | 1191896-73-7 | C17H18O6 | 318.325 | |
Colchicine-D6 | 1217651-73-4 | C22H19D6NO6 | 405.47 | N-[(7S)-5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]acetamide-d6; (-)-Colchicine-d6; Colchineos-d6; Colchisol-d6; Colcin-d6; Colsaloid-d6; Condylon-d6; NSC 757-d6 |
Colchicine EP impurity D | 477-29-2 | C27H33NO11 | 547.55 | (S)-N-[3-(b-D-Glucopyranosyloxy)-5,6,7,9-tetrahydro-1,2,10-trimethoxy-9-oxobenzo[a]heptalen-7-yl]acetamide; N-[(7S)-3-(b-D-Glucopyranosyloxy)-5,6,7,9-tetrahydro-1,2,10-trimethoxy-9-oxobenzo[a]heptalen-7-yl]acetamide; 3-Demethylcolchicine glucoside |
Colchicine | 64-86-8 | C22H25NO6 | 399.44 | N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide; Colchicine; Colchicine, (+-)-Isomer; Colchicine, (R)-Isomer |
Colchiceine | 477-27-0 | C21H23NO6 | 385.414 | colchiceine; N-[(7S)-5,6,7,9-Tetrahydro-10-hydroxy-1,2,3,-trimethoxy-9-oxobenzo[a]heptalen-7-yl]acetamide; NSC 3341; O10-Demethylcolchicine; NSC 33411; (S)-7-Acetylamino-10-hydroxy-1,2,3-trimethoxy-6,7-dihydrobenzo[a]heptalen-9(5H)-one |
Cycloguanil hydrochloride | 152-53-4 | C11H14ClN5·HCl | 288.2 | Chloroguanide Triazine; NSC 3074; 1-(4-chlorophenyl)-1,6-dihydro-6,6-dimethyl-1,3,5-triazine-2,4-diamine monohydrochloride |
Cycloguanil | 516-21-2 | C11H14ClN5 | 251.72 | 1-hydro-1,3,5- triazine-2,4-diamine |
Cyclogrifolin | 1660156-04-6 | C22H30O2 | 326.48 | |
Cycloeucalenol | 469-39-6 | C30H50O | 426.7 | 24-Methylene-29-norcycloartan-3-ol |
Cycloechinulin | 143086-29-7 | C20H21N3O3 | 351.4 | |
CYCLOCREATINE | 35404-50-3 | C5H9N3O2 | 143.14 | CYCLOCREATINE; 2-IMINO-1-IMIDAZOLIDINEACETIC ACID; 1-CARBOXYMETHYL-2-IMINOIMIDAZOLIDINE; 1-Carboxymethyl-2-iminoimidazolidin; 2-Amino-4,5-dihydro-1H-Imidazole-1-acetic Acid |
Cyclocommunol | 145643-96-5 | C20H16O6 | 352.3 | 3,8,10-Trihydroxy-6-(2-methyl-1-propenyl)-6H,7H-[1]benzopyrano[4,3-b][1]benzopyran-7-one |
Cyclocephaloside II | 215776-78-6 | C43H70O15 | (3beta,6alpha,16beta,20R,24S)-3-[(4-O-Acetyl-beta-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl beta-D-glucopyranoside | |
Cyclocalopin A | 486430-94-8 | C15H20O6 | 296.3 | (1S,2S,2'R,3a'R,4'S,7a'S)-2,2'-Dihydroxy-2',4,4'-trimethyl-3a',4' ,5',7a'-tetrahydro-3H,7'H-spiro[cyclohex-4-ene-1,3'-furo[2,3-c]py ran]-3,7'-dione |
CRT0066101 | 1883545-60-5 | C18H22N6O.2ClH | 411.33 | MolPort-039-101-282; AKOS027470155; 2-[4-[[(2R)-2-aminobutyl]amino]-2-pyrimidinyl]-4-(1-methyl-1H-pyrazol-4-yl)phenol dihydrochloride |
CRT0044876 | 6960-45-8 | C9H6N2O4 | 206.15 | |
CRT 0105950 | 1661845-86-8 | C21H16ClN3OS | 393.89 | 4-[[5-[3-(2-Chloro-4-methylphenyl)-4-pyridinyl]-2-thiazolyl]amino]phenol |
Croverin | 76475-17-7 | C21H22O6 | 370.4 | |
Crovatin | 142409-09-4 | C21H26O6 | 374.43 | |
Crotylalcohol | 504-61-0 | C8H16O2 | 72.1057 | CROTYL ALCOHOL; 3-METHYLALLYL ALCOHOL; 1-HYDROXY-2-BUTENE; 2-BUTENE-1-OL; PROPENYLCARBINOL; (2E)-2-Buten-1-ol |
Coumarin 490 | 53518-15-3 | C10H6F3NO2 | 229.16 | 7-amino-4-(trifluoromethyl)-2H-1-benzopyran-2-one; Coumarin 151; 7-Amino-4-(trifluoromethyl)coumarin |
Coumarin 339 | 62669-73-2 | C13H13NO2 | 215.25 | 4-methyl-6,7,8,9-tetrahydro-2h-pyrano[3,2-g]quinolin-2-one; coumarin 339; 2-g]quinolin-2-one,6,7,8,9-tetrahydro-4-methyl-2h-pyrano[; COUMARIN 339, LASER GRADE, 99 |
Coumarin 175 | 29197-94-2 | C11H10NNaO5S | 291.25 | [(4-methyl-2-oxo-2h-1-benzopyran-7-yl)amino]-methanesulfonicacimonosodium; COUMARIN 175; SODIUM, (4-METHYL-2-OXO-2H-CHROMEN-7-YLAMINO)-METHANESULFONATE; sodium [(4-methyl-2-oxochromen-7-yl)amino]methanesulfonate; (4-METHYL-2-OXO-2H-CHROMEN-7-YLAMINO)-METH |
coumarin 138 | 62669-74-3 | C14H15NO2 | 229.29 | |
Coumarin | 91-64-5 | C9H6O2 | 146.14 | |
CORM 2 | 22594-69-0 | C6Cl4O6Ru2 | 512.01 | TRICARBONYLDICHLORORUTHENATE (II) DIMER; TRICARBONYLDICHLORORUTHENIUM(II) DIMER; DICHLOROTRICARBONYLRUTHENIUM (II) DIMER; Dichlorotricarbonylruthenium(II)dimer,min.98%; Dichlorotricarbonylruthenium dimer; ruthenium(II) tricarbonyl chloride dimer |
corilagin | 23094-69-1 | C27H22O18 | 634.45 | 1-O-Galloyl-3,6-hexahydroxydiphenol-D-glucopyranose |
Coriatin | 91653-75-7 | C15H20O6 | 296.3 | (2R,3S,5R,6R,7R)-2-Hydroxy-12-(2-hydroxy-2-propanyl)-7-methyl-11H-spiro[4,10-dioxatetracyclo[7.2.1.02,7.03,5]dodecane-6,2'-oxiran]-11-one |
Coriander oil | 8008-52-4 | FEMA 2334; CORIANDER HERB (CILANTRO) OIL; CORIANDER OIL; oilofcoriander; Oils,coriander; CORIANDRUM SATIVUM (CORIANDER) FRUIT OIL; CORIANDER OIL FCC; CorianderoilexCoriandrumsativum,CorianderSeedOil | ||
Copper peptide (GHK-Cu) | 89030-95-5 | C14H23CuN6O4 | 402.922 | Prezatide Copper; GHK copper; CG-copper peptide; [n2-(N-Glycyl-L-histidyl)-L-lysinato(2-)]copper |
Copper oxychloride | 1332-65-6 | Cu2Cl.(OH)3 | 213.57 | Dicopper chloride trihydroxide; CEKUCOBRE; CUPROKYLT; CUPRIC OXYCHLORIDE; CUPOX; CUPRAVIT; COPRANTOL; COPTOX |
CMP5 | 1030021-40-9 | C20H22N3.HCl | 351.87 | 1-(9-ethylcarbazol-3-yl)-N-(pyridin-2-ylmethyl)methanamine Hydrochloride; AKOS032401780 |
CMK | 821794-90-5 | C18H19ClN4O2 | 358.82 | 1-(4-Amino-7-(3-hydroxypropyl)-5-(p-tolyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl)-2-chloroethanone |
CMI-977 | 175212-04-1 | C16H19FN2O4 | 322.34 | CMI-977; CMI 977; 1-[4-[(2S,5S)-5-[(4-fluorophenoxy)methyl]oxolan-2-yl]but-3-ynyl]-1-hydroxyurea |
CMI-392 | 205654-37-1 | C31H37ClN2O8S | 633.15 | 3-[[2-[2-(4-chlorophenyl)sulfanylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]methyl]-1-hydroxy-1-methylurea; 2-(3-methoxy-4-(4-chlorophenylthioethoxy)-5-(N-methyl-N-hydroxyureidyl)methylphenyl)-5-(3,4,5-trimethoxyphenyl)tetra |
c-Met inhibitor 1 | 1357072-61-7 | C17H14N8S | 362.41 | c-Met inhibitor 1 |
Clindamycin alcoholate | 58207-19-5 | C18H33ClN2O5S·HCl·H2O | 479.46 | |
Clindamycin 4-Phosphate | 54887-30-8 | C18H34ClN2O8PS | 504.96 | (2R,3R,4R,5R,6R)-2-((1S,2R)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-6-(methylthio)tetrahydro-2H-pyran-3-yl dihydrogen phosphate |
Clindamycin 3-Phosphate | 28708-34-1 | C18H34ClN2O8PS | 504.96 | (2R,3S,4S,5R,6R)-2-((1S,2R)ylpyrrolidineyl)-3,5-dihydroxy-6-(methylthio)tetrahydro-2H-pyran-4-yl dihydrogen phosphate |
Cyclobutylhydrazine | 742673-64-9 | C4H10N2 | 86.13560 | |
Cyclobutylacetaldehyde | 6540-31-4 | 6540-31-4 | 98.143 | CYCLOBUTYLACETALDEHYDE |
Cyclobutyl-(tetrahydro-pyran-4-yl)-amine | 885280-95-5 | C9H17NO | 155.24 | CYCLOBUTYL-(TETRAHYDRO-PYRAN-4-YL)-AMINE |
Cyclobutanone, 2-(5Z)-5-tetradecenyl- | 173074-85-6 | C18H32O | 264.44608;g/mol | 173074-85-6; 2-(5-TETRADECENYL)CYCLOBUTANONE; Cyclobutanone,2-(5Z)-5-tetradecenyl-; 2-tetradec-5-enylcyclobutan-1-one; AC1N38QN; CTK0E4383 |
Cyclobutaneethanol,1-methyl-2-(1-methylethenyl)-, (1R,2S)-rel- | 30820-22-5 | C10H18 O | 154.25 | cis-cyclobutaneethano; cyclobutaneethanol,; GRANDLURE I; cis-1-Methyl-2-(1-methylethenyl)-cyclobutaneethanol |
Cyclobutanecarboxylic Acid | 3721-95-7 | C5H8O2 | 100.12 | Cyclobutane-1-carboxylic Acid; NSC 4535 |
Cyclobutane-1,3-dicarboxylic acid | 2398-16-5 | C6H8O4 | 144.13 | cyclobutane-1,3-dicarboxylicacid; trans-cyclobutane-1,3-dicarboxylicacid; cis-Cyclobutane-1,3-dicarboxylicacid; 2398-16-5; 62184-63-8; 7439-33-0 |
Cyclobenzaprine-d3 Hydrochloride | 1184983-42-3 | C20H19ND3Cl | 314.87 | 3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-N-(methyl-d3)-1-propanamine Hydrochloride; Flexeril-d3; Flexiban-d3 |
Cyclobenzaprine-13C-d3 | 1261394-10-8 | C20H18ND3 | 279.4 | |
Cyclobenzaprine Related Compound A | 18029-54-4 | C20H23NO | 293.4 | 5-Hydroxy-N-methylprotriptyline; 5-[3-(Dimethylamino)propyl]-5H-dibenzo[a,d]cyclohepten-5-ol |
Cyclobenzaprine N-Oxide | 6682-26-4 | C20H21NO | 291.39 | 3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine N-Oxide |
cyclobenzaprine | 303-53-7 | C20H21N | 275.39 | CYCLOBENZAPRINE; CYCLOBENZAPRINE HCL; 10,11-dehydroamitriptyline; 1-Propanamine, 3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-; 3-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-n,n-dimethyl-1-propanamin; 3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimet |
Cycloastragenol | 78574-94-4 | C30H50O5 | 490.725 | Astramembrangenin |
Cycloartenol | 469-38-5 | C30H50O | 426.72 | 9,19-CYCLO-9BETA-LANOST-24-EN-3BETA-OL; 9,19-CYCLO-9 BETA-LANOST-24-EN-3B-OL; 24,(5-ALPHA)-CHOLESTEN-9-19-CYCLO-4,4,14-ALPHA-TRIMETHYL-3-BETA-OL; CYCLOARTENOL; CYCLOARTENOL(RG); 9,19-Cyclolanost-24-en-3-ol |
Cycloartane-3,24,25-triol 24,25-acetonide | 57576-31-5 | C33H56O3 | 500.8 | (24S)-Cycloartane-3,24,25-triol 24,25-acetonide; (2aR,3R,5aS,5bS,7aR,9S,11aR,12aS)-2a,5a,8,8-tetramethyl-3-((R)-4-((S)-2,2,5,5-tetramethyl-1,3-dioxolan-4-yl)butan-2-yl)tetradecahydro-1H,12H-cyclopenta[a]cyclopropa[e]phenanthren-9-ol |
Cycloartane-3,24,25-triol | 57586-98-8 | C30H52O3 | 460.73 | |
Cycloaliphatic epoxy resin | 244772-00-7 | (C8H12O2)n.(C8H12O2)n.(C8H12O2)n.C6H14O3 | Cycloaliphatic epoxy resin; 1-2-Epoxy-4(2-oxiranyl)-cyclohexane of 2,2-bis(hydoroxymethyl)1-butanol | |
Cyclo[2-methylalanyl-L-phenylalanyl-D-prolyl-(aS,2S)-a-amino-h-oxo-2-oxiraneoctanoyl] | 53342-16-8 | C28H38 N4 O6 | 526.62 | CHLAMYDOCIN; 2-Methylcyclo[Ala-L-Phe-D-Pro-6-[(S)-2-oxo-2-oxiranylethyl]-L-Nle-]; Antibiotic SL-3440; SL-3440 |
Cyclo(RGDyK) | 250612-42-1 | C31H43F6N9O12 | 847.72 | |
Cyclo(RADfK) | 756500-23-9 | C28H43N9O7 | 617.70 | Cyclo (Arg-Ala-Asp-d-Phe-Lys);c(RADfK) |
Cyclo(L-Trp-L-Trp) | 20829-55-4 | C22H20N4O2 | 372.4 | Cyclic dioxopiperazine-L-tryptophan-L-tryptophan; 3S,6S-bis(1H-indol-3-ylmethyl)-2,5-piperazinedione |
cyclo(L-Pro-L-Val) | 2854-40-2 | C10H16N2O2 | 196.3 | |
cyclo(L-Pro-L-Tyr) | 4549-02-4 | C14H16N2O3 | 260.3 | |
Cyclo(L-Phe-trans-4-hydroxy-L-Pro) | 118477-06-8 | C14H16N2O3 | 260.293 | L-Phe-trans-4-hydroxy-L-Pro; (3S,7R,8aS)-3-benzyl-7-hydroxy-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione |
cyclo(L-Phe-L-Pro) | 3705-26-8 | C14H16N2O2 | 244.3 | |
Cyclo(L-Leu-trans-4-hydroxy-L-Pro) | 115006-86-5 | C11H18N2O3 | 226.276 | |
Cyclo(L-Leu-L-Trp) | 15136-34-2 | C17H21N3O2 | 299.37 | 3S-(1H-indol-3-ylmethyl)-6S-(2-methylpropyl)-2,5-piperazinedione |
Cyclo(L-Leu-L-Pro) | 2873-36-1 | C11H18N2O2 | 210.27 | Maculosin 6; (3S,8aS)-hexahydro-3-(2-methylpropyl)-pyrrolo[1,2-a]pyrazine-1,4-dione |
Cyclo(L-Ala-L-Pro) | 36357-32-1 | C8H12N2O2 | 168.196 | Cyclo(alanylprolyl); (3S,8aS)-3-methyl-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione |
Cyclo(L-Ala-L-Gln) | 268221-76-7 | C8H13N3O3 | 199.21 | Cyclo(L-Ala-L-Gln); Cyclo(-Ala-Gln) |
CYCLO(-HIS-PRO) | 53109-32-3 | C11H14N4O2 | 234.25 | HIS-PRO, CYCLIC; CYCLO(-HIS-PRO); (3S,6S)-3-(3H-imidazol-4-ylmethyl)-1,4-diazabicyclo[4.4.0]decane-2,5-dione; Histidylproline diketopiperazine; histidylproline dioxopiperazine; Cyclo-Pro-His-HO |
Cyclo(Gly-L-Pro) | 3705-27-9 | C7H10N2O2 | 154.169 | (S)-Hexahydropyrrolo[1,2-a]pyrazine-1,4-dione; (8aS)-octahydropyrrolo[1,2-a]piperazine-1,4-dione |
Cyclo(D-Val-L-Pro) | 27483-18-7 | C10H16N2O2 | 196.25 | (3R,8aS)-3-propan-2-yl-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione |
Cyclo(D-Phe-L-Pro) | 26488-24-4 | C14H16N2O2 | 244.294 | L-Phe-L-Pro lactam; (3R,8aS)-3-benzyl-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione |
Cyclo(D-Leu-L-Pro) | 36238-67-2 | C11H18N2O2 | 210.277 | (3R,8aS)-3-(2-methylpropyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione |
cyclo(delta-Ala-L-Val) | 25516-00-1 | C8H12N2O2 | 168.1 | |
Cyclo(-Arg-Ala-Asp-D-Phe-Val) | 137813-36-6 | C27H40N8O7 | 588.66 | CYCLO(-ARG-ALA-ASP-D-PHE-VAL) |
Cyclo L–Arginine | 28958-90-9 | C6H11N3O2 | 157.17 | (7S)-2-amino-4,5,6,7-tetrahydro-1H-1,3-diazepine-7-carboxylic acid |
Cyclo (-RGDfK) | 161552-03-0 | C29H42F3N9O9 | 717.69 | |
Cyclizine-d3(N-methyl-d3) | 1170155-67-5 | C18H19D3N2 | 269.40 | 1-(Diphenylmethyl)-4-methylpiperazine; N-Benzhydryl-N'-methylpiperazine |
cyclizine hydrochloride | 303-25-3 | C18H22N2 | 266.38 | CYCLIZINE HYDROCHLORIDE (200 MG); 1-(diphenylmethyl)-4-methyl-piperazinhydrochloride; cyclizinechloride; marezinehydrochloride; Piperazine, 1-(diphenylmethyl)-4-methyl-, monohydrochloride; CYCLYZINE HCL; Collox; Cyclizini hydrochloridum |
Cyclizine Dihydrochloride | 5897-18-7 | C18H22N2.2HCl | 339.3 | |
Cyclic GMP sodium salt | 40732-48-7 | C10H11N5O7P·Na | 367.2 | cGMP; Cyclic guanosine monophosphate; Guanosine 3'5'-cyclic monophosphate; Monosodium-GMP |
cyclic dipeptide with proline ;; | 5654-86-4 | C11H18N2O2 | 210.2728 | |
Cyclic di-GMP sodium salt | 2222132-40-1 | C20H22N10O14P2·2Na | 734.37 | c-di-GMP; Cyclic diguanylate; 3',5'-Cyclic diguanylic acid |
Cyclen | 294-90-6 | C8H24N4 | 1,4,7,10-Tetraazacyclododecane; cyclen (1,4,7,10-tetraazacyclododecane) | |
Cycleanine | 518-94-5 | C38H42N2O6 | 622.76 | O-Methylnorcycleanine; Dimethylisochondodendrine |
Cyclapolin 9 | 40533-25-3 | C9H4F3N3O4S | 307.21 | 7-Nitro-5-(trifluoromethyl)-2-benzothiazolecarboxamide-3-oxide |
Cyclandelate | 456-59-7 | C17H24O3 | 276.37 | BS 572 |
Ciclacillin | 3485-14-1 | C15H23N3O4S | 341.42 | Aminocyclohexylpenicillin; Calthor; Ciclacillin; Ciclacillum; Citosarin; Cyclapen; (Aminocyclohexyl)penicillin; Syngacillin; Ultracillin; Vastcillin; Vatracin; Vipicil; Wy 4508; Wyvital; (1-Aminocyclohexyl)penicillin; 6-(1-Aminocyclohexanecarboxamido)peni |
CYC116 | 693228-63-6 | C18H20N6OS | 368.46 | CYC116. |
CYC065 | 1070790-89-4 | C21H31N7O | 397.52 | (2R,3S)-3-[[6-[(4,6-dimethylpyridin-3-yl)methylamino]-9-propan-2-ylpurin-2-yl]amino]pentan-2-ol |
CYAZOFAMID | 120116-88-3 | C13H13ClN4O2S | 324.79 | RANMAN; MILDICUT; IKF-916; DOCIOUS; CYAZOFAMID; 4-CHLORO-1-(DIMETHYLAMINOSULFONYL)-5-(P-TOLYL)IMIDAZOLE-2-CARBONITRILE |
Cyasterone | 17086-76-9 | C29H44O8 | 520.65 | (22r,24s,25s,28r)-gamma-lacton; 2-beta,3-beta,14,20,22,28-hexahydroxy-6-oxo-5-beta-stigmast-7-en-26-oicaci; cyasteron; 7,(5BETA)-CHOLESTEN-26-CARBOXYLIC ACID-24BETA-(1-HYDROXYETHYL)-2BETA, 3BETA, 14ALPHA,20BETA, 22R-PENTOL-6-ONE GAMMA-LACTONE; CYASTERONE; |
Cyanuric acid-13C3 | 201996-37-4 | [1,3,5]Triazine-2,4,6-triol- 2,4,6-13C | ||
Cyantraniliprole | 736994-63-1 | C19H14BrClN6O2 | 473.71 | Exirel; Cyazpyr; HGW-86 |
Cyanopindolol hemifumarate | 69906-86-1 | C18H23N3O5 | 345.40 | 4-[3-[tert-Butylamino]-2-hydroxypropoxy]-1H-indole-2-carbonitrile hemifumarate |
Cyanomethyl-2,3,4,6-tetra-O-acetyl-a-D-thiomannopyranoside | 61145-39-9 | C16H21NO9S | 403.40 | 2-[(2,3,4,6-Tetra-O-acetyl-alpha-D-mannopyranosyl)thio]acetonitrile |
CYANOETHYL PULLULAN | 77466-56-9 | 0 | CYANOETHYL PULLULAN; Pullulan,cyanoethyl ether | |
CYANOETHYL CELLULOSE | 9004-41-5 | C36H46N8O11 | 0 | cellulose,2-cyanoethylether; TRICYANOETHYLCELLULOSE; CELLULOSE, CYANOETHYLATED; CELLULOSE, CYANOETHYLATED POLYMER; CELLULOSE, CYANOETHYL ETHER; CYANOETHYL CELLULOSE |
Cyanocobalamin Impurity H | 41325-63-7 | C63H88CoN14O14P | 1355.37 | |
Cyanocobalamin Impurity F | 23208-66-4 | C63H85CoN13O15P | 1354.33 | |
Cyanoacetone sodium salt | 70807-22-6 | C4H4NNaO | 105.07 | Cyanoacetone sodium salt; Sodium cyanoacetone |
Cyano Temozomide | 287964-59-4 | C6H4N6O | 176.14 | Cyanotemozolomide; 3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carbonitrile |
Cy5 SE(mono SO3) | 400051-84-5 | C39H47N3O7S | 701.88 | 2-(5-[1-[5-(2,5-Dioxo-pyrrolidin-1-yloxycarbonyl)-pentyl]-3,3-dimethyl-1,3-dihydro-indol-2-ylidene]-penta-1,3-dienyl)-3,3-dimethyl-1-(4-sulfobutyl)-4,5-dihydro-3H-indolium hydroxide, inner salt |
CYANIDIN-3-O-ARABINOSIDE(SH)(NEW) | 57186-11-5 | C20H19O10.Cl | 454.81 | |
Cyanidin-3-O-sophoroside chloride | 38820-68-7 | C27H31O16Cl | 646.98 | 2-(3,4-Dihydroxyphenyl)-3-[(2-O-b-D-glucopyranosyl-a-D-glucopyranosyl)oxy]-5,7-dihydroxy-1-benzopyrylium chloride |
Cyanidin-3-O-sambubioside chloride | 33012-73-6 | C26H29O15Cl | 616.95 | |
Cyanidin-3-O-rutinoside chloride | 18719-59-2 | C27H31O15 Cl | 630.98 | Keracyanin chloride |
Cyanidin-3-O-rhamnoside chloride | 38533-30-1 | C21H21O10Cl | 468.84 | |
Cyanidin-3-O-lathyroside chloride | 31073-32-2 | C26H29O15 Cl | 616.95 | |
Cyanidin-3-O-glucuronide | 775284-61-2 | C21H19O12 Cl | 498.82 | |
Cyanidin-3-O-galactoside chloride | 27661-36-5 | C21H21O11 Cl | 484.85 | Ideain chloride |
Cyanidin-3-O-arabinose chloride | 27214-72-8 | C20H19O10Cl | 454.81 | |
CYANIDIN-3-GALACTOSIDE CHLORIDE | 27214-71-7 | C21H21ClO11 | 484.84 | CYANIDIN-3-GALACTOSIDE; CYANIDIN-3-GALACTOSIDE CHLORIDE; CYANIDIN 3-O-GALACTOSIDE CHLORIDE; IDEAIN CHLORIDE; IDEIN CHLORIDE; IDAEIN CHLORIDE; 3-(GALACTOSYLOXY)-3',4',5,7-TETRAHYDROXYFLAVYLIUM CHLORIDE |
Cyanidin-3,5-di-O-glucoside | 2611-67-8 | C27H31O16 Cl | 646.99 | Cyanin chloride |
Cyanidin chloride | 528-58-5 | C15H11O6Cl | 322.7 | CYANIDIN CHLORIDE; CYANIDINE CHLORIDE; 3,3',4',5,7-PENTAHYDROXYFLAVYLIN CHLORIDE; 3,3',4',5,7-PENTAHYDROXYFLAVYLIUM CHLORIDE; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-1-benzopyryliuchloride; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-1-benzopyryliumchloride |
Cyanidin 3-xyloside | 29761-24-8 | C20H19ClO10 | 454.81 | 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-3-(D-xylopyranosyloxy)-1-benzopyrylium chloride |
Cyanidin 3-O-galactoside | 142506-26-1 | C21H21O11+ | 449.38 | Idein |
Cyanidin 3-arabinoside cation | 792868-19-0 | C20H19O10+ | 419.36 | Cyanidin-3-O-alpha-arabinopyranoside |
Cyanamide,N-[methyloxido[1-[6-(trifluoromethyl)-3-pyridinyl]ethyl]-l4-sulfanylidene]- | 946578-00-3 | |||
Cyamemazine-d6 | 1216608-24-0 | C19H15N3SD6 | 329.49 | 10-[3-(Dimethylamino-d6)-2-methylpropyl]-10H-phenothiazine-2-carbonitrile; 2-Cyano-10-[(3-dimethylamino-d6)-2-methylpropyl)phenothiazine; Ciamatil-d6; Cianatil-d6; Cyamemazin-d6; Cyamemazine-d6; Cyamepromazine-d6; Cyamepromezine-d6; F. I. 6229-d6; Kyamepr |
Cyamemazine Sulfoxide | 13384-45-7 | C19H21N3OS | 339.45 | 10-[3-(Dimethylamino)-2-methylpropyl]-10H-phenothiazine-2-carbonitrile 5-Oxide; Cyamepromazine Sulfoxide |
Cyamemazine | 3546-03-0 | C19H21N3S | 323.46 | 10-[3-(Dimethylamino)-2-methylpropyl]-10H-phenothiazine-2-carbonitrile; 2-Cyano-10-(3-dimethylamino-2-methylpropyl)phenothiazine; Ciamatil; Cianatil; Cyamemazin; Cyamemazine; Cyamepromazine; Cyamepromezine; F. I. 6229; Kyamepromazine; R.P. 7204; TH 2602; |
CXCR2-IN-1 | 1873376-49-8 | C19H20Cl2FN3O4S | 476.35 | 1-(2-chloro-3-fluorophenyl)-3-[4-chloro-2-hydroxy-3-(1-methylpiperidin-4-yl)sulfonylphenyl]urea |
CX-6258 hydrochloride hydrate | 1353858-99-7 | C26H27Cl2N3O4 | 516.42 | C26H24ClN3O3.ClH.H2O; 2121AH; HY-18095A; CS-1530; W-6143 |
CX-6258 Hydrochloride | 1353859-00-3 | C26H24ClN3O3.HCl | 498.40 | N/A |
CWHM-12 | 1564286-55-0 | C26H32BrN5O6 | 590.47 | CWHM-12 |
CW-069 | 1594094-64-0 | C23H21IN2O3 | 500.33 | |
CW 008 | 1134613-19-6 | C21H14F2N6O2 | 420.38 | CW-008; 4-Fluoro-N-[5-fluoro-6-(5-methoxypyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl]benzamide |
CVT5440 | 531506-64-6 | C27H28N6O5 | 516.55 | CVT-5440;1H-Purine-2,6-dione, 3,7-dihydro-8-(4-((5-(3-methoxyphenyl)-1,2,4-oxadiazol-3-yl)methoxy)phenyl)-1,3-dipropyl-;8-[4-[[5-(3-Methoxyphenyl)-1,2,4-oxadiazol-3-yl]methoxy]phenyl]-1,3-dipropyl-7H-purine-2,6-dione |
CVT-3369 | 172430-48-7 | C16H24N2O5 | 324.37 | RS-91347; 4-[2-Hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetic Acid; Ranolazine Impurity 16; CVT 3369; CVT3369; RS 91347; RS91347; 1-Piperazineacetic acid, 4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)- |
CVT-3248 | 172430-50-1 | C14H21N3O2 | 263.34 | L58PM3303I; CVT-3248; RS-101647; 1-Piperazineacetamide, N-(2-(hydroxymethyl)-6-methylphenyl)- |
CVT-313 | 199986-75-9 | C20H28N6O3 | 400.47 | CVT 313; NG 26; CVT313; NG26; NG-26 |
CVT-2759 | 342419-10-7 | C17H24N6O6 | 408.17 | Adenosine, N-((3R)-tetrahydro-3-furanyl)-, 5'-(ethylcarbamate); |
CVT-2551 | 172430-44-3 | C24H33N3O5 | 443.54 | CVT-2551; RS-89961; 1-Piperazineacetamide, 4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-N-(2-(hydroxymethyl)-6-methylphenyl)- |
CVT-12012 | 1018675-35-8 | C21H21F3N4O3 | 434.41 | CVT12012;2-Hydroxy-N-(2-(3-methyl-2-oxo-7-(((3-(trifluoromethyl)phenyl)methyl)amino)-1,2-dihydroquinoxalin-1-yl)ethyl)acetamide |
CVT10216 | 1005334-57-5 | C24H19NO7S | 465.48 | CVT-10216;3-[[[3-[4-[(Methylsulfonyl)amino]phenyl]-4-oxo-4H-chromen-7-yl]oxy]methyl]benzoic acid;GS 455534 |
C-Veratroylglycol | 168293-10-5 | C10H12O5 | 212.201 | 2,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)-1-propanone |
cUMP | 56632-58-7 | C9H10N2O8P · Na | 328.2 | Uridine- 3', 5'- cyclic monophosphate, sodium salt |
CV-6209 chloride | 100488-87-7 | C34H60N3O6·Cl | 642.3 | 2-(2-acetyl-6-methoxy-3,9-dioxo-4,8-dioxa-2,10-diazaoctacos-1-yl)-1-ethyl-pyridinium monochloride |
CV 1808 | 53296-10-9 | C16H18N6O4 | 358.36 | CV-1808; CV 1808; CV1808; 2-Phenylaminoadenosine; 2-Phenylamino Adenosine |
Cutamesine | 165377-43-5 | C23H32N2O2 | 368.51 | 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (11C)SA4503 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride cutamesine SA 4503 SA-4503 SA4503 |
CU-T12-9 | 1821387-73-8 | C17H13F3N4O2 | 362.31 | CU-T12-9; SCHEMBL17242578; AKOS025147363; N-Methyl-4-nitro-2-(4-(4-trifluoromethyl)phenyl)-1H-imidazol-1-yl)aniline 1821387-73-8 |
Custirsen | 890056-27-6 | |||
Cussosaponin C | 366814-42-8 | C59H96O25 | ||
Cuspin-1 | 337932-29-3 | C13H10BrNO | 276.13 | 3-bromo-5-(4-methylbenzoyl)pyridine; (5-bromopyridin-3-yl)-(4-methylphenyl)methanone |
Cuspidiol | 51593-96-5 | C14H20O3 | 236.3 | (E)-4-[4-(3-Hydroxypropyl)phenoxy]-2-methyl-2-buten-1-ol; 4-[[(2E)-4-Hydroxy-3-methyl-2-butenyl]oxy]benzenepropanol |
Curzerenone | 20493-56-5 | C15H18O2 | 230.3 | 6,7-Dihydro-5beta-isopropenyl-3,6beta-dimethyl-6-vinyl-4(5H)-benzofuranone |
Curcumol | 4871-97-0 | C15H24O2 | 236.35 | (-)-Curcumol |
Curcumin-d6 | 1246833-26-0 | C21H14O6D6 | 374.42 | (1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione-d6; (E,E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione-d6; C Yellow 15-d6; C.I. 75300-d6; Curcuma-d6; Curcumine-d6; Diferuloylmethane-d6; Haidr-d6; Halad-d6; Haldar-d6 |
Curcumin Sulfate | 339286-19-0 | C37H55NO9S | 689.9 | |
Curcumin | 458-37-7 | C21H20O6 | 368.38 | Curcumin; Diferuloylmethane; Turmeric Yellow; curcumin I; C.I. 75300; Natural Yellow 3; NSC32982; UNIIIT942ZTH98. |
Curcumenol | 19431-84-6 | C15H22O2 | 3,8-dimethyl-5-(1-methylethylidene)-,(3S,3aS,6R,8aS)-; 6H-3a,6-Epoxyazulen-6-ol,1,2,3,4,5,8a-hexahydro-; (3S,3aS,6R,8aS)-3,8-dimethyl-5-(propan-2-ylidene)-1,2,3,4,5,8a-hexahydro-6H-3a,6-epoxyazulen-6-ol; 3,8-dimethyl-5-(1-methylethylidene)-1,2,3,4,5,8a-he | |
Curcumaromin C | 1810034-40-2 | C29H32O4 | 444.57 | (1E,6E)-1,7-bis(4-hydroxyphenyl)-4-[(1R,6R)-3-methyl-6-propan-2-ylcyclohex-2-en-1-yl]hepta-1,6-diene-3,5-dione |
Curcumaromin B | 1810034-39-9 | C29H32O4 | 444.57 | 2-(4-hydroxyphenyl)-6-[(E)-2-(4-hydroxyphenyl)ethenyl]-5-[(1R,6R)-3-methyl-6-propan-2-ylcyclohex-2-en-1-yl]-2,3-dihydropyran-4-one |
Curcumaromin A | 1810034-38-8 | C29H32O4 | 444.57 | (1E,4Z,6E)-5-hydroxy-7-[4-hydroxy-3-[(1R,6R)-3-methyl-6-propan-2-ylcyclohex-2-en-1-yl]phenyl]-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one |
Curculigoside C | 851713-74-1 | C22H26O12 | 482.43 | |
Curculigoside B | 143601-09-6 | C21H24O11 | 452.41 | |
Curculigoside | 85643-19-2 | C22H26O11 | 466.44 | 2-[[(2,6-Dimethoxybenzoyl)oxy]methyl]-4-hydroxyphenyl b-D-glucopyranoside; Curculigoside A |
CUR 61414 | 334998-36-6 | C31H42N4O5 | 550.7 | G-856; N-[(3S,5S)-1-(1,3-benzodioxol-5-ylmethyl)-5-(1-piperazinylcarbonyl)-3-pyrrolidinyl]-N-[(3-methoxyphenyl)methyl]-3,3-dimethyl-butanamide |
Cuprous iodide | 7681-65-4 | CuI | 190.45000 | |
Cuprolinic blue | 41276-95-3 | C36H38CuN12O16S4 | 1086.56 | 4,11,18,25-TETRAAZONIAPHTHALOCYAMINE TETRAKIS(METHYL SULFATE); CUPROLINIC BLUE; CUPROLINIC BLUE(TM); QUINOLINIC PHTHALOCYANINE; [1,8,15,22-tetramethyl-29H,31H-tetrapyrido[2,3-b:2',3'-g:2'',3''-l:2''',3'''-q]porphyraziniumato(2-)-N29,N30,N31,N32]copper(4+) |
Cupric tetrafluoroborate hydrate | 14735-84-3 | Cu.2(BF4).H2O | 255.17 | COPPER FLUOROBORATE, HEXAHYDRATE; COPPER(+2)TETRAFLUOROBORATE; COPPER(+2)BOROFLUORIDE; COPPER (II) FLUOBORATE; CUPRIC TETRAFLUOROBORATE; cupric tetrafluoroborate hydrate; CUPRIC FLUOBORATE; Copper(II)tetrafluoroboratehexahydrate,99% |
CUPRIC SILICATE | 16509-17-4 | CuO3Si | 139.63 | COPPER (II) SLILICATE; COPPER SILICATE; CUPRIC SILICATE; COPPER(II)SILICATE |
Cupric acetate,anhydrous | 142-71-2 | C4H6CuO4 | 181.63 | BARFOED'S REAGENT; COPPER ACETATE; COPPER(II) ACETATE; CUPRIC ACETATE; acetatedecuivre; acetatedecuivre(french); aceticacid,copper(2+); Aceticacid,copper(2+)salt |
Cupric acetate monohydrate | 6046-93-1 | Cu(C2H3O2)2.H2O | 199.65 | Aceticacid,copper(2+)salt,monohydrate; Aceticacidcopper(2+)salt,monohydrate; Copperdiacetatemonohydrate; Kupfer(II)-acetat-hydrat; VERDIGRIS; ACETIC ACID, COPPER SALT; CUPRIC ACETATE 1-HYDRATE; CUPRIC ACETATE H2O |
Cuprate(2-),tetrachloro-, dilithium, (SP-4-1)- (9CI) | 15489-27-7 | Cl4Cu . 2 Li | 219.24 | LITHIUM TETRACHLOROCUPRATE; LITHIUM TETRACHLOROCUPRATE(II); DILITHIUM TETRACHLOROCUPRATE; DI-LITHIUM TETRACHLOROCUPRATE(II); Dilithium tetrachlorocuprate(II) solution; DILITHIUM TETRACHLOROCUPRATE, 0.1M SOLUT ION IN TETRAHYDROFURAN; 0.1MinTHF; Dilithium t |
Cudraxanthone L | 135541-40-1 | C23H24O6 | 396.4 | 2-(1,1-Dimethyl-2-propenyl)-5-(3-methyl-2-butenyl)-1,3,6,7-tetrahydroxy-9H-xanthen-9-one; 1,3,6,7-Tetrahydroxy-2-(2-methyl-3-buten-2-yl)-5-(3-methyl-2-bute n-1-yl)-9H-xanthen-9-one |
Cudraxanthone D | 96552-41-9 | C24H26O6 | 410.5 | 2,3,8-Trihydroxy-6-methoxy-5-(2-methyl-3-buten-2-yl)-1-(3-methyl- 2-buten-1-yl)-9H-xanthen-9-one |
Cudraxanthone B | 84955-05-5 | C23H22O6 | 394.423 | 5,9,11-trihydroxy-3,3-dimethyl-8-(2-methylbut-3-en-2-yl)pyrano[3,2-a]xanthen-12-one |
Cudratricusxanthone A | 740810-42-8 | C23H24O6 | 396.43 | 2,3,6,8-Tetrahydroxy-5-(2-methyl-3-buten-2-yl)-1-(3-methyl-2-bute n-1-yl)-9H-xanthen-9-one |
CUDC-907 | 1339928-25-4 | C23H24N8O4S | 508.557 | CUDC907; CUDC 907; CUDC-907. |
CUDC-101 | 1012054-59-9 | C24H26N4O4 | 434.496 | CUDC-101 |
CUDA | 479413-68-8 | C19H36N2O3 | 340.5 | 12-[[(cyclohexylamino)carbonyl]amino]-dodecanoic acid |
Cucurbitacin Q1 | 99530-82-2 | C32H48O8 | 560.7 | 25-acetylcucurbitacin F; 25-O-Acetylcucurbitacin F |
Cucurbitacin I | 2222-07-3 | C30H42O7 | 514.65 | Cucurbitacin I; Elatericin B; Cucurbitacine (I); 1,2-Dehydroelatericin A; CHEBI:3947 |
cucurbitacin E | 18444-66-1 | C32H44O8 | 556.67 | A-ELATERIN;ALPHA-ELATERIN;CUCURBITACIN E;19-nor-9-beta,10-alpha-lanosta-1,5,23-triene-3,11,22-trione,2,16-alpha,20,25-t;25-acetate;alpha-elaterine;cucurbitacine-e;2,16alpha,20,25-tetrahydroxy-9beta-methyl-10alpha,-19-norlanosta-1,5,23(E)-triene-3,11,22-tr |
Cucurbitacin D | 3877-86-9 | C30H44O7 | 516.67 | 17-[(3E)-1,5-Dihydroxy-1,5-dimethyl-2-oxohex-3-en-1-yl]-2,16-dihydroxy-4,4,9,14-tetramethylestr-5-ene-3,11-dione |
Cucurbitacin C | 5988-76-1 | C32H48O8 | 560.72 | |
Cucurbitacin B | 6199-67-3 | C32H46O8 | 558.7 | |
Cucurbitacin A | 6040-19-3 | C32H46O9 | 574.711 | |
Cucurbita maxima extract | 89998-02-7 | |||
Cucurbit[8]uril | 259886-51-6 | C48H48N32O16 | 1329.12 | CB[8]; Cucurubituril(8) |
Cucurbit[7]uril | 259886-50-5 | C42H42N28O14 | 1162.96 | cucurbit[7]uril; CB[7]; Cucurbituril(7); SCHEMBL16272337; BDBM36281; CHEBI:51434 |
Cucurbit[6]uril hydrate | 80262-44-8 | C36H36N24O12.12(H2O) | 1213.01 | CUCURBITURIL; Cucurbituril[6]; 1H,4H,14H,17H-2,16:3,15-Dimethano-5H,6H,7H,8H,9H,10H,11H,12H,13H,18H,19H,20H,21H,22H,23H,24H,25H,26H-2,3,4a,5a,6a,7a,8a,9a,10a,11a,12a,13a,15,16,17a,18a,19a,20a,21a,22a,23a,24a,25a,26a-tetracosaazabispentaleno1,6:5,6,7cycloo |
Cucurbit[5]uril | 259886-49-2 | C30H30N20O10 | 830.69 | |
Cucumis sativus extract | 89998-01-6 | |||
Cucumegastigmane I | 929881-46-9 | C13H20O4 | 240.3 | (6S,7E)-6,9,10-Trihydroxymegastigma-4,7-dien-3-one |
CU-CPT-9b | 2165340-32-7 | C17H15NO2 | 265.312 | BCP29122; 4-(7-methoxy-1H-quinolin-4-ylidene)-2-methylcyclohexa-2,5-dien-1-one |
CU-CPT-9a | 2162962-69-6 | C16H13NO2 | 251.285 | HY-112667; CS-0059157; 4-(3-methyl-4-oxidanyl-phenyl)quinolin-7-ol; 2-Methyl-4-(7-hydroxyl-4-quinolinyl)-phenol |
CU-CPT-8m | 125079-83-6 | C14H12N4O | 252.277 | 7-(m-tolyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide; 7-(3-methylphenyl) pyrazolo(1,5-a)pyrimidine-3-carboxamide; 7-(3-methylphenyl) pyrazolo[1,5-a]pyrimidine-3-carboxamide; CU-CPT8m |
CU CPT 4a | 1279713-77-7 | C18H13ClFNO3S | 377.82 | N-[(3-Chloro-6-fluorobenzo[b]thien-2-yl)carbonyl]-D-phenylalanine |
CU CPT 22 | 1416324-85-0 | C19H22O7 | 362.37 | 3,4,6-Trihydroxy-2-methoxy-5-oxo-5H-benzocycloheptene-8-carboxylic acid hexyl ester |
CTPB | 586976-24-1 | C31H43ClF3NO2 | 554.1 | N-[4-chloro-3-(trifluoromethyl)phenyl]-2-ethoxy-6-pentadecyl-benzamide |
CTX-0294885 | 1439934-41-4 | C22H24ClN7O | 437.93 | CTX-0294885; CTX 0294885; CTX0294885; CTx 0294885 |
C-type natriuretic peptide (1-22) (human, rat, swine) | 127869-51-6 | C93H157N27O28S3 | 2197.61 | Atriopeptin C (pig) |
CTS-1027 | 193022-04-7 | C19H20ClNO6S | 425.88 | RS 130830; Ro 1130830; CTS1027; CTS 1027; RS130830; Ro1130830; RS-130830; Ro-1130830 |
CTP354 | 1213669-91-0 | C19H10D9F2N7O | 408.46 | CTP354; CTP-354; CTP 354; C-21191; C 21191; C21191 |
CTP-347 | 923932-43-8 | C19H18D2FNO3 | 331.38 | Paroxetine-d2 |
Cromolyn Sodium Relat | 16150-44-0 | |||
CTCE 9908 | 1030384-98-5 | C86H147N27O23 | 1927.27 | UNII-NF0BX95A31; L-Lysinamide, N2,N6-bis(L-lysylglycyl-L-valyl-L-seryl-L-leucyl-L-seryl-L-tyrosyl-L-arginyl)- |
cTMP | 76567-90-3 | C10H12N2O7P · Na | 326.2 | Thymidine- 3', 5'- cyclic monophosphate, sodium salt |
CTLA-4 inhibitor | 635324-72-0 | C21H13F4N5O | 427.363 | 2-(4-Fluorophenyl)-6-methyl-4-(3-(trifluoromethyl)phenyl)-1,2-dihydrodipyrazolo[3,4-b:3',4'-d]pyridin-3(6H)-one; EX-A913 |
CTEP | 871362-31-1 | C19H13ClF3N3O | 391.77 | RO4956371 |
CRSP-1 | 697327-12-1 | C175H294N54O49S5 | 4098.88 | |
CTA056 | 1265822-30-7 | C35H34N6O | 554.698 | CTA056; CTA-056; CTA 056 |
CT7001 hydrochloride | 1805789-54-1 | C22H31ClN6O | 430.97 | ICEC0942 hydrochloride; (3R,4R)-4-[[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol hydrochloride |
CS-M1995 | 876707-99-2 | C9H9N5O5 | 267.20 | Nucleoside-Analog-1;6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 2-azido-2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)-, (2R,3S,3aS,9aR)-;(2R,3S,3aS,9aR)-2-azido-3-hydroxy-2-(hydroxymethyl)-3a,9a-dihydro-3H-furo[1,2][1,3]oxazolo[3,4-a]pyrimidin-6-o |
CS-834 | 157542-49-9 | C20H28N2O7S | 440.51 | CS 834; CS834; CS-834; UNII-H26S03B779; [(2,2-dimethylpropanoyl)oxy]methyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-{[(3R)-5-oxopyrrolidin-3-yl]sulfanyl}-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate |
CS-7017 monohydrate | 1048002-36-3 | C27H30Cl2N4O5S | 593.52 | Efatutazone dihydrochloride monohydrate;5-[[4-[[6-(4-Amino-3,5-dimethylphenoxy)-1-methylbenzimidazol-2-yl]methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione hydrate dihydrochloride;Inolitazone dihydrochloride monohydrate;(+/-)-2,4-Thiazolidinedione, 5-((4- |
CS1 | 1448009-94-6 | C16H12O3 | 252.26 | 4-(6-Hydroxy-2-naphthalenyl)-1,2-benzenediol |
CS-0777-P | 840523-39-9 | C21H31N2O5P | 422.45 | 1-(5-((3R)-3-amino-3-methyl-4-(phosphonooxy)butyl)-1-methyl-1H-pyrrol-2-yl)-4-(4-methylphenyl)-1-Butanone |
CS 722 | 144886-17-9 | C16H20Cl2N2O4 | 375.25 | 4-Chloro-2-(2-hydroxy-3-morpholinopropyl)-5-phenyl-4-isoxazolin-3-one |
CS 476 | 41177-35-9 | C24H29N3O5S | 471.57 | N-(4-(2-(2,3-Dihydrobenzo(b)furan-7-carboxamido)ethyl)benzenesulfonyl)-N'-cyclohexylurea |
CS 2100 | 913827-99-3 | C25H23N3O4S | 461.53 | 1-[[4-Ethyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]-3-azetidinecarboxylic acid |
Crystal violet-D6 hydrate | 1266676-01-0 | 4,4'-Bis-(dimethylamino- phenyl)-4”-dimethyl- amino-D6-phenyltritylium chloride hydrate | ||
Crystal Violet Lactone | 1552-42-7 | C26H29N3O2 | 415.53 | Crystal Violet Lactone |
Crystal Violet | 548-62-9 | C25H30ClN3 | 407.98 | |
Cryptoxanthin | 472-70-8 | C40H56O | 552.87 | Beta-Cryptoxanthin; Cryptoxanthine; Beta-Caroten-3-ol |
Cryptotanshinone | 35825-57-1 | C19H20O3 | 296.36 | Tanshinone C; (R)-1,2,6,7,8,9-Hexahydro-1,6,6-trimethyl-phenanthro(1,2-b)furan-10,11-dione; Cryptotanshinon; (1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[1,2-g][1]benzofuran-10,11-dione |
CRYPTOSTROBIN(P) | 55743-21-0 | C16H14O4 | 270.27996 | CRYPTOSTROBIN(P);CHEBI:70663;55743-21-0;(S)-2,3-Dihydro-5,7-dihydroxy-8-methyl-2-phenyl-4-benzopyrone;EINECS259-785-5;AC1O571N |
Cryptopine | 482-74-6 | C21H23NO5 | 369.41 | CRYPTOPINE; benzo(e)-1,3-dioxolo(4,5-l)(2)benzazecin-12(5h)-one,4,6,7,13-tetrahydro-9,10-d; cryptocavine; cryptopin; imethoxy-5-methyl-; kryptocavin |
Cryptomoscatone D2 | 276856-55-4 | C17H20O4 | 288.34 | (2R)-2-[(E,2R,4R)-2,4-dihydroxy-6-phenylhex-5-enyl]-2,3-dihydropyran-6-one |
Cryptomeridiol 11-rhamnoside | 349112-30-7 | C21H38O6 | 386.53 | 1-[(2R,4aR,8R,8aR)-Decahydro-8-hydroxy-4a,8-dimethyl-2-naphthalenyl]-1-methylethyl 6-deoxy-alpha-L-mannopyranoside |
Cryptomeridiol | 4666-84-6 | C15H28O2 | 240.4 | (1R,4aR,7R,8aR)-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-2,3,4,5,6,7,8,8a-octahydronaphthalen-1-ol |
Cryptofolione | 160098-78-2 | C19H22O4 | 314.38 | (2R)-2-[(1E,4S,6R,7E)-4,6-dihydroxy-8-phenylocta-1,7-dienyl]-2,3-dihydropyran-6-one |
Cryptochlorogenic acid | 905-99-7 | C16H18O9 | 354.31 | 4-O-Caffeoylquinic acid;4-Caffeoylquinic acid;4-O-(3,4-Dihydroxycinnamoyl)-D-quinic acid;Quinic acid, 4-caffeoyl- (3R,5R)-4-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,3,5-trihydroxycyclohexane-1-carboxylic acid;3,4-Dihydroxycinnamic acid 4-carboxy-2 |
Crypthophane E | 102683-14-7 | C57H60O12 | 937.08 | CRYPTHOPHANE E; Cryptophane E,95% |
Cryptanoside A | 98570-81-1 | C30H42O10 | 562.656 | Sarverogenin 3-O-oleandroside |
Cryolite,naturallyoccurringmineral,grains,approximately0.06-19in | 13775-53-6 | Na3AlF6 | 209.95 | |
CRT5 | 1034297-58-9 | C28H30N4O2 | 454.6 | CRT0066051 |
CRT0066854 | 1438881-19-6 | C24H25N5S | 415.55 | (2S)-3-Phenyl-N1-[5,6,7,8-tetrahydro-2-(4-pyridinyl)[1]benzothieno[2,3-d]pyrimidin-4-yl]-1,2-propanediamine |
CRT0066101 hydrochloride | 1781742-22-0 | C18H22N6O·3HCl | 447.8 | |
CROTONYLBETAINE(CARNITINEIMPURITY)(RG) | 927-89-9 | C7H14NO2.Cl | 179.64 | |
Crotonyl chloride | 10487-71-5 | C4H5ClO | 104.53 | 2-Butenoyl chloride; 2-butenoylchloride; but-2-enoylchloride; TRANS-2-BUTENOYL CHLORIDE; CROTONYL CHLORIDE; CROTONOYL CHLORIDE |
CROTON OIL | 8001-28-3 | MFCD00130880 | 0 | TIGLIUM OIL; OIL OF CROTON; crotonoel; crotonresin; crotontigliuml.oil; oils,croton; oleumtiglii; CROTON OIL |
Crosstide | 171783-05-4 | C48H77N17O17 | 1164.23 | H-Gly-Arg-Pro-Arg-Thr-Ser-Ser-Phe-Ala-Glu-Gly-OH; glycyl-L-arginyl-L-prolyl-L-arginyl-L-threonyl-L-seryl-L-seryl-L-phenylalanyl-L-alanyl-L-alpha-glutamyl-glycine; (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[(2-aminoac |
Crospovidone | 9003-39-8 | Povidone; 1-Vinyl-2-pyrrolidinone Polymers; Polyvinylpyrrolidone K-90 | ||
Croscarmellose sodium | 74811-65-7 | C28H30Na8O27 | 982.44 | Sodium carboxymethyl cellulose |
Cromolyn | 16110-51-3 | C23H16O11 | 468.37 | Cromolyn; Cromoglicic acid; Cromoglycate; Acido cromoglicico; Acide cromoglicique |
Cromakalim | 94470-67-4 | C16H18N2O3 | 286.33 | BRL-34915; BRL34915; (±)-Cromakalim; (3R,4S)-rel-3,4-dihydro-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-2H-1-benzopyran-6-carbonitrile; trans-3,4-dihydro-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-2H-1-benzopyran-6-carbonitrile; (±)-trans-6-Cyan |
Crolibulin | 1000852-17-4 | C18H17BrN4O3 | 417.263 | EPC2407; EPC 2407; EPC-2407; Crolibulin, crinobulin. |
Crocin III | 55750-85-1 | C32H44O14 | 652.68 | Crocin 3; Crocin C |
Crocin II | 55750-84-0 | C38H54O19 | 814.42 | Crocetingentiobiosylglucosyl ester; Tricrocin; Crocin 2; b-D-Glucopyranose 6-O-b-D-glucopyranosyl-1-[(2E,4E,6E,8E,10E,12E,14E)-b-D-glucopyranosyl 2,6,11,15-tetramethyl-2,4,6,8,10,12,14-hexadecaheptaenedioate] |
CroCin | 42553-65-1 | C44H64O24 | 976.96 | Bis(6-O-b-D-Glucopyranosyl-b-D-glucopyranosyl) 8,8-diapo-psi,; Crocetin digentiobiose ester |
Gardenia Yellow | 1934-20-9 | C16H11N2NaO4S | 350.32 | Acid Orange 12; Crocein Orange G |
Crizotinib-d5 | 1395950-48-7 | C21H17Cl2FN5OD5 | 455.37 | 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl-d4)-1H-pyrazol-4-yl]-2-pyridinamine-d5; (R)-3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl-d4)-1H-pyrazol-4-yl]pyridin-2-ylamine-d5; PF 02341066-d5; PF 2341066-d5 |
Crizotinib hydrochloride | 1415560-69-8 | C21H23Cl3FN5O | 486.8 | PF-02341066 hydrochloride; PF 02341066 hydrochloride |
Crizotinib | 877399-52-5 | C21H22Cl2FN5O | 450.343 | PF-02341066 |
Cristobalite | 14464-46-1 | SiO2 | 60.08 | 43-63c; alpha-crystobalite; calcineddiatomaceousearth; calcineddiatomite; cristobalite(sio2); crystallinesilica(non-specificname) |
Cristacarpin | 74515-47-2 | C21H22O5 | 354.4 | Erythrabyssin I |
crisaborole | 906673-24-3 | C14H10BNO3 | 251.048 | Eucrisa; 4-((1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile |
Cridanimod sodium salt | 58880-43-6 | C15H10NO3·Na | 275.23 | 10-Carboxymethyl-9-Acridanone; 9-oxo-10(9H)-acridineacetic acid monosodium salt; Camedon |
Creoside III | 1038602-12-8 | C18H24O9 | 384.383 | |
Crenulatin | 63026-02-8 | C11H20O6 | 248.275 | 1,1-Dimethylallyl glucoside; Isopentenyl-3-O-beta-D-glucopyranoside; (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(2-methylbut-3-en-2-yloxy)oxane-3,4,5-triol |
Crenolanib | 670220-88-9 | C26H29N5O2 | 443.551 | CP-868,596; CP-868596; |
CREDAZINE | 14491-59-9 | C11H10N2O | 186.21 | CREDAZINE; Kusakira; Pyridazine, 3-(2-methylphenoxy)-; 3-(2-Methylphenoxy)pyridazine; |
Crebanine | 25127-29-1 | C20H21NO4 | 339.4 | 8,9-Dimethoxy-1,2-methylenedioxyaporphine |
creatinolfosfate | 6903-79-3 | C4H12N3O4P | 197.13 | CREATINOLFOSFATE; creatinol phosphate; 1-(2-hydroxyethyl)-1-methylguanidine dihydrogen phosphate; CREATINOLO-PHOSPHATE; CREATINOLO-PHOSPHATEANDITSSODIUMSALT; 1-[2-(Phosphonooxy)ethyl]-1-methylguanidine; Aplodan; COP |
Creatinine-d3 | 143827-20-7 | C4H4N3OD3 | 116.14 | 2-Amino-1,5-dihydro-1-(methyl-d3)-4H-imidazol-4-one; 1-(Methyl-d3)glycocyamidine; 1-(Methyl-d3)hydantoin-2-imide; 2-Amino-1-(methyl-d3)-1,5-dihydroimidazol-4-one; 2-Amino-1-(methyl-d3)imidazolin-4-one; NSC 13123-d3; TEGO Cosmo C 250-d3 |
Creatinine | 60-27-5 | C4H7N3O | 113.12 | |
Creatine Phosphate Disodium Salt Tetrahydrate | 71519-72-7 | 327.14 | Sodium creatine phosphate dibasic tetrahydrate | |
Creatine phosphate disodium salt hexahydrate | 6190-45-0 | C4H21N3NaO11P | 341.186 | Phosphocreatine |
Creatine Malate | 686351-75-7 | C8H15N3O7 | 265.2206 | Creatine Malate; DICREATINE MALEATE |
Creatine Hydrochloride | 17050-09-8 | C4H10ClN3O2 | 167.593 | Creatine HCl; 2-(1-Methylguanidino)acetic acid hydrochloride; 2-[carbamimidoyl(methyl)amino]acetic acid hydrochloride |
CP-199330 Sodium | 158102-98-8 | C28H23ClF3N2NaO6S | 630.99 | CP-199330 sodium; CP-199330 monosodium salt; Methanesulfonamide, N-(3-((6-((7-chloro-2-quinolinyl)methoxy)-3,4-dihydro-4-hydroxy-2H-1-benzopyran-3-yl)methyl)-4-methoxyphenyl)-1,1,1-trifluoro-, monosodium salt, (3R-cis)-; UNII-74573Q728X component FZCWCSNK |
CPTH2 hydrochloride | 2108899-91-6 | C14H14ClN3S·HCl | 328.3 | 2-[4-(4-chlorophenyl)-2-thiazolyl]hydrazone-cyclopentanone monohydrochloride |
Cratoxylone | 149155-01-1 | C24H28O7 | 428.5 | |
Crassanine | 16790-92-4 | C23H30N2O5 | 414.5 | 8'-Ethyl-1,2,2',3',6',7',8',8'a-octahydro-5,6-dimethoxy-2-oxospiro[3H-indole-3,4'-[4H-1,6]methanoquinoline]-4'a(5'H)-carboxylic acid methyl ester |
CRANAD 2 | 1193447-34-5 | C23H25BF2N2O2 | 410.26 | (T-4)-[(1E,6E)-1,7-Bis[4-(dimethylamino)phenyl]-1,6-heptadiene-3,5-dionato-kO3,kO5]difluoroboron |
CRAC intermediate 1 | 1249343-86-9 | C10H7F2N3O | 223.18 | CRAC intermediate 1; SCHEMBL706559; UMBVHXNGQIFPCN-UHFFFAOYSA-N; AKOS010652441; CS-3896 |
CRAC inhibitor 44 | 944917-72-0 | C22H19F2N3OS | 411.47 | |
CR8 | 294646-77-8 | C24H29N7O | 431.544 | CR8 |
C-QUINOLIN-3-YL-METHYLAMINE | 7521-70-2 | C10H10N2 | 158.2 | C-QUINOLIN-3-YL-METHYLAMINE; QUINOLIN-3-YLMETHYL-AMINE; TIMTEC-BB SBB010402; RARECHEM AL BW 2146; 1-quinolin-3-ylmethanamine |
CPYPP | 310460-39-0 | C18H13ClN2O2 | 324.76 | 4-[3-(2-Chlorophenyl)-2-propen-1-ylidene]-1-phenyl-3,5-pyrazolidinedione |
CPUY201112 | 1860793-58-3 | C19H23N3O4 | 357.41 | |
CPTH2 | 357649-93-5 | C14H14ClN3S | 291.8 | Cyclopentylidene-[4-(4-chlorophenyl)thiazol-2-yl)hydrazone |
CPPHA | 693288-97-0 | C22H15ClN2O4 | 406.82 | |
CPI-637 | 1884712-47-3 | C22H22N6O | 386.459 | (4R)-4-methyl-6-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one; CPI-637; SCHEMBL17673230 |
CPI-455 hydrochloride | 2095432-28-1 | C16H15ClN4O | 314.77 | 7-oxo-5-phenyl-6-propan-2-yl-1H-pyrazolo[1,5-a]pyrimidine-3-carbonitrile hydrochloride |
CPI-444 | 1202402-40-1 | C20H21N7O3 | 407.17 | (S)-7-(5-methylfuran-2-yl)-3-((6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine; CPI-444; CPI 444; CPI444; V81444; V-81444; V 81444 |
CPI-360 | 1802175-06-9 | C25H31N3O4 | 437.53 | CPI360; CPI 360 |
CPI-268456 | 1380087-86-4 | C20H15Cl2N3O2 | 400.3 | 2-[(4S)-8-chloro-6-(4-chlorophenyl)-1-methyl-4H-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide |
CPI-203 | 1446144-04-2 | C19H18ClN5OS | 399.90 | (6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide |
CPI-169 | 1450655-76-1 | C27H36N4O5S | 528.66 | CPI-169 |
CPI-1205 | 1621862-70-1 | C27H33F3N4O3 | 518.57 | N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]indole-3-carboxamide; (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4 |
CPI-1189 | 183619-38-7 | C13H18N2O2 | 234.299 | 4-Acetamido-N-tert-butylbenzamide; REN-1189 |
CPI 455 | 1628208-23-0 | C16H14N4O | 278.31 | CPI-455; 6-Isopropyl-7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile |
CPI 4203 | 1628214-07-2 | C16H14N4O | 278.31 | CPI-4203; 6-ethyl-7-oxo-5-(o-tolyl)-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile |
CPG52364 sulfate | 1093135-62-6 | C27H38N6O7S | 590.70 | CPG-52364 sulfate;6,7-Dimethoxy-2-(4-(4-methylpiperazin-1-yl)phenyl)-N-(2-morpholinoethyl)quinazolin-4-amine sulfate |
CPCCOEt | 179067-99-3 | C13H13NO4 | 247.25 | 7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester |
CPA inhibitor | 223532-02-3 | C18H19NO4 | 313.35 | carboxypeptidase inhibitor; Benzenepropanoic acid, .alpha.-[[hydroxy(2-phenylacetyl)amino]methyl]- |
CP-94707 | 343250-05-5 | C21H16N4OS | 372.44 | 3-[[4-(2-methylimidazo[4,5-c]pyridin-1-yl)phenyl]methyl]-1,3-benzothiazol-2-one; |
CP-91149 | 186392-40-5 | C21H22ClN3O3 | 399.87 | |
CP8754 | 532435-68-0 | C20H25NO5 | 359.42 | CP-8754;Carbamic acid, cyclopropyl-, (4aR,5R,6R,7R)-2,4,4a,5,6,7-hexahydro-7-methoxy-3,4a,5-trimethyl-2-oxonaphtho(2,3-b)furan-6-yl ester;[(4aR,5R,6R,7R)-7-methoxy-3,4a,5-trimethyl-2-oxo-4,5,6,7-tetrahydrobenzo[f][1]benzofuran-6-yl] N-cyclopropylcarbamate |
CP-868388 | 702681-67-2 | C26H33NO5 | 439.55 | (S)-2-(3-(1-((4-Isopropylbenzyloxy)carbonyl)piperidin-3-yl)phenoxy)-2-methylpropanoic acid;UNII-999KY5ZIGB; |
CP-8668 | 209331-43-1 | C21H30N2O4 | 374.47 | [(4aR,5R,6R,7R)-7-methoxy-1,3,4a,5-tetramethyl-2-oxo-4,5,6,7-tetrahydrobenzo[f]indol-6-yl] N-propylcarbamate; (4aR,5R,6R,7R)-7-methoxy-6-(N-propylaminocarbonyl)oxy-4a,5,6,7-tetrahydro-1,3,4a,5-tetramethylbenz(f)indol-2(4H)-one; CP8668 |
CP866087 | 519052-02-9 | C24H30N2O3S | 426.57 | CP-866087;N-[3-[(1R,5S)-6-ethyl-3-[(2-hydroxy-1,3-dihydroinden-2-yl)methyl]-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide;Methanesulfonamide, N-(3-(3-((2,3-dihydro-2-hydroxy-1H-inden-2-yl)methyl)-6-ethyl-3-azabicyclo(3.1.0)hex-6-yl)phenyl)- |
CP-85958 | 134002-60-1 | C25H20FNO5S | 465.50 | UNII-CU98Q2IL7P;3-(((3R,4R)-6-((5-fluoro-2-benzothiazolyl)methoxy)-3,4-dihydro-4-hydroxy-2H-1-benzopyran-3-yl)methyl)-Benzoic acid, |
CP-810123 | 439608-12-5 | C14H18N4O | 258.32 | 4-(5-methyloxazolo(4,5-b)pyridin-2-yl)-1,4-Diazabicyclo(3.2.2)nonane, |
CP-809101 hydrochloride | 1215721-40-6 | C15H18Cl2N4O | 341.24 | CP-809101 (hydrochloride); 479683-64-2; 2-((3-Chlorobenzyl)oxy)-6-(piperazin-1-yl)pyrazine hydrochloride; 2-[(3-Chlorobenzyl)oxy]-6-(piperazin-1-yl)pyrazine hydrochloride; CP809101 hydrochloride; C15H18Cl2N4O |
Cp-76593 | 115898-30-1 | C18H24N2O3 | 316.39 | (+/-)-2(1H)-Pyrimidinone, 5-(3-(bicyclo(2.2.1)hept-2-yloxy)-4-methoxyphenyl)tetrahydro-, exo- |
CP74725 sodium salt | 111477-48-6 | C12H11ClFNaO4 | 296.65 | CP-74725 sodium salt;Sodium 2-[(2R,4R)-7-chloro-6-fluoro-4-hydroxy-2-methyl-2,3-dihydrochromen-4-yl]acetate;(2R,4R)-7-Chloro-6-fluoro-3,4-dihydro-4-hydroxy-2-methyl-2H-1-benzopyran-4-acetic acid sodium salt |
CP-74667 mesylate | 138808-71-6 | C21H26FN3O6S | 467.52 | 1-cyclopropyl-6-fluoro-1,4-dihydro-7-(8-methyl-3,8-diazabicyclo(3.2.1)oct-3-yl)-4-oxo-3-Quinolinecarboxylic acid methanesulfonate (1:1);UNII-96Z3H79YX9 |
CP-74667 | 108461-05-8 | C20H22FN3O3 | 371.41 | CP74667;3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-7-(8-methyl-3,8-diazabicyclo(3.2.1)oct-3-yl)-4-oxo-;1-Cyclopropyl-6-fluoro-1,4-dihydro-7-(8-methyl-3,8-diazabicyclo(3.2.1)oct-3-yl)-4-oxo-3-quinolinecarboxylic acid |
CP-67804 | 103978-08-1 | C18H13F2NO4 | 345.30 | 3-Quinolinecarboxylicacid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(4-hydroxyphenyl)-4-oxo-;CP67804;1-Ethyl-6,8-difluoro-7-(4-hydroxyphenyl)-4-quinolone-3-carboxylic acid |
CP-673451 | 343787-29-1 | C24H27N5O2 | 417.5 | |
CP-671906-01 | 332178-44-6 | C22H27Cl2N5O2 | 464.39 | CP-671906; N'-[3-(2,6-dichloro-4-methoxyphenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-yl]-N-(oxan-4-yl)ethane-1,2-diamine |
CP-671305 | 445295-04-5 | C23H19FN2O7 | 54.4 | (R)-2-(4-((((2-((Benzo(1,3)dioxol-5-yl)oxy)pyridin-3-yl)carbonyl)amino)methyl)-3-fluorophenoxy)propionic acid; |
CP-67015 | 100325-51-7 | C17H12F2N2O3 | 330.29 | 1-Ethyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(4-pyridinyl)-3-quinolinecarboxylic acid;3-Quinolinecarboxylicacid, 1-ethyl-6,8-difluoro-1,4-dihydro-4-oxo-7-(4-pyridinyl)-;CP 67015 |
CP-664511 | 379692-00-9 | C28H34N4O6 | 522.59 | 3-((1S)-1-(((3-methoxy-4-((((2-methylphenyl)amino)carbonyl)amino)phenyl)acetyl)amino)-3-methylbutyl)-5-Isoxazolepropanoic acid; |
CP66,948 | 101189-47-3 | C13H20N6S | 292.40 | 2-(N-Pentyl-N'-guanidino)-4-(2-methylimidazol-4-yl)thiazole;CP-66,948 CP-66,948;1-[4-(2-methyl-1H-imidazol-5-yl)-1,3-thiazol-2-yl]-2-pentylguanidine |
CP654577 | 639087-64-2 | C34H32N4O3 | 544.65 | CP-654577;[(1S,5R)-3-[[4-[4-(3-methoxy-4-phenoxyanilino)quinazolin-6-yl]phenyl]methyl]-3-azabicyclo[3.1.0]hexan-6-yl]methanol;3-Azabicyclo(3.1.0)hexane-6-methanol, 3-((4-(4-((3-methoxy-4-phenoxyphenyl)amino)-6-quinazolinyl)phenyl)methyl)-, (1alpha,5alpha, |
CP640186 HCl | 591778-70-0 | C30H36ClN3O3 | 522.09 | CP640186; CP 640186 |
CP-640186 | 591778-68-6 | C30H35N3O3 | 485.62 | |
CP-609754 | 1190094-64-4 | C29H22ClN3O2 | 479.964 | CP-609754; CP609754; CP 609754; CP-609,754; CP609,754; CP 609,754; LNK 754; LNK754; LNK-754; OSI 754; OSI754; OSI-754 |
CP-60949-4 | 17518-97-7 | C16H18Br2ClN3O3 | 495.60 | CP-60949-4; AC1L1YFM; CP 60949-4; 6-bromo-7-chloro-3-[3-(3-hydroxypiperidin-2-yl)-2-oxopropyl]quinazolin-4-one hydrobromide; 4(3H)-Quinazolinone, 6-bromo-7-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-, monohydrobromide |
CP-608039 | 331727-55-0 | C23H25ClN8O5 | 528.16 | (2S,3S,4R,5R)-3-amino-5-[6-[[5-chloro-2-[(3-methyl-1,2-oxazol-5-yl)methoxy]phenyl]methylamino]purin-9-yl]-4-hydroxy-N-methyloxolane-2-carboxamide; |
CP-601932 | 357425-68-4 | C12H12F3N | 227.23 | 1,5-Methano-1H-3-benzazepine, 2,3,4,5-tetrahydro-7-(trifluoromethyl)-, (1R,5S)- |
CP-601927 | 357425-02-6 | C12H12F3N | 227.09 | 1,5-Methano-1H-3-benzazepine, 2,3,4,5-tetrahydro-7-(trifluoromethyl)-, (1R,5S)-; |
CP-5609 | 432038-96-5 | C23H21N5O6S | 495.51 | Pyridinium, 1-(2-amino-2-oxoethyl)-3-((2-((4S,5R,6S)-2-carboxy-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-en-3-yl)imidazo(5,1-b)thiazol-7-yl)carbonyl)-, inner salt |
CP-5484 | 352308-27-1 | C19H25ClN4O5S2 | 489.00 | (4S,5R,6S)-3-[6-[(2R)-3-amino-2-hydroxypropyl]-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;chloride; |
CP-547632 | 252003-65-9 | C20H24BrF2N5O3S | 532.405 | CP-547632 |
CP-544439 | 230954-09-3 | C18H19FN2O6S | 410.42 | 4-[[4-(4-fluorophenoxy)phenyl]sulfonylamino]-N-hydroxyoxane-4-carboxamide; CP-544439; CP 544439; CP544439 ; UNII-516DO4KL5R |
CP-533536 | 223488-57-1 | C25H28N2O5S | 468.56 | 2-[3-[[(4-tert-butylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]phenoxy]acetic acid (3-((4-tert-butylbenzyl)-(pyridine-3-sulfonylamino)methyl)phenoxy)acetic acid CP-533,536 CP533536 |
CP-532623 | 261947-38-0 | C27H27F9N2O3 | 598.5 | 10-[3-(4-hydroxypiperidin-1-yl)propyl]phenothiazine-2-carbonitrile; |
CP-5068 | 352305-79-4 | C18H20N4O5S2 | 436.08 | (4S,5R,6S)-3-[6-(2-amino-2-oxoethyl)-7-methylsulfanylimidazo[5,1-b][1,3]thiazol-6-ium-2-yl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate; |
Cp4G | 79695-24-2 | C19H28N8O21P4 (free acid) | 828.4 (free acid) | P1- (5'- Cytidyl)- P4- (5'- guanosyl)- tetraphosphate, sodium salt |
CP-481715 | 212790-31-3 | C26H31FN4O4 | 482.55 | N-[(2S,3S,5R)-5-carbamoyl-1-(3-fluorophenyl)-3,8-dihydroxy-8-methylnonan-2-yl]quinoxaline-2-carboxamide; CP 481,715; CP 481715; CP-481,715; CP-481715; CP481,715; CP481715; quinoxaline-2-carboxylic acid (4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methy |
CP-472555 | 305821-96-9 | C31H32N2O2 | 464.24 | 2-Phenanthrenecarboxamide, 4b,5,6,7,8,8a,9,10-octahydro-7-hydroxy-4b-(phenylmethyl)-7-(1-propyn-1-yl)-N-(3-pyridinylmethyl)-, (4bS,7R,8aR)-; |
CP-467688 | 208590-81-2 | C27H27ClF3N3O3 | 533.97 | methyl N-[2-[6-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]-3,4-dihydro-1H-isoquinolin-2-yl]ethyl]carbamate;hydrochloride; 909576-25-6 (CP-467688); 208590-81-2 (CP-467688 free base) |
CP-466722 | 1080622-86-1 | C17H15N7O2 | 349.35 | N/A |